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Abstract 
 
Introduction 
Senecio serratuloides is widely used for wound healing in South Africa but minimal information 
regarding its efficacy is available. Furthermore toxic pyrrolizidine alkaloids may be present. 
The following investigation sought firstly to evaluate the efficacy and safety of Senecio 
serratuloides in a porcine wound model; secondly to assess for a potential mechanism and 
finally isolate and identify fractions in in-vitro assays. 
 
Assessment of Efficacy and Safety 
Materials and Methods: Deep partial thickness and full thickness wounds were created on 9 
pigs. Treatment included an occlusive dressing (negative control), activated carbon, or the 
Senecio preparation. Wounds were monitored using photographic documentation, pH 
measurement and histological analysis (skin thickness and collagen content). Toxicity was 
monitored on blood and liver samples. 
Results and Discussion: Efficacy of Senecio serratuloides was established with a significantly 
thicker epidermis, maximal at day 7 post-operative, 2 days before the controls. Effects on 
collagen content was negligible with no toxicity detected. 
 
Mechanistic investigation 
Materials and Methods: Wound fluid was analysed for IL-10, IL-12, IL-1β, IL-6, IL-8, TNF-α 
using flow cytometry based assays. Tyrosine phosphorylation and cellular proliferation was 
assessed using dual immunofluorescence staining. 
Results and Discussion: IL-1β levels were significantly greater in the Senecio treatment. 
Tyrosine phosphorylation increased to day 9 post-operative where it stabilised in all groups. 
In the same period, cellular proliferation was sustained in the Senecio treated wounds but not 
in the controls. Keratinocyte proliferation was identified as the target for in-vitro assays. 
 
Extraction, Isolation and Partial Identification using In-vitro Proliferation Assays. 
Materials and Methods: The plant was fractionated using solid phase extraction cartridges. 
Keratinocytes were grown under standard conditions in 96-well plates. Cellular proliferation 
was assessed spectrophotometrically using a resazurin dye technique. Active fractions were 
analysed using gas chromatography and mass spectrometry. 
 
 
xv 
Results and Discussion: Identified fractions increased the rate of proliferation by 300-400%. 
Potential lead compounds were identified. Importantly, pyrrolizidine alkaloids could not be 
detected. 
 
Conclusion 
Senecio serratuloides is efficacious in treating deep partial thickness wounds without inducing 
liver toxicity. Sustained keratinocyte proliferation linked to tyrosine phosphorylation may be an 
underlying mechanism. Although successful, in-vitro detection of active fractions requires 
further characterisation. 
 
 
Keywords:  Senecio serratuloides, Wound healing, Porcine Wound Model, Deep partial 
thickness wound, Epidermal thickness, Collagen,  Inflammatory cytokines, Tyrosine 
phosphorylation, Proliferating cell nuclear antigen, Plant extraction and fractionation, 
Proliferation assays, Gas chromatography and mass  spectrometry, Alkaloids.
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Chapter 1 - Introduction and Background 
 
1.1 Introduction  
Traumatic injury and surgical interventions create a wound that normally heals in an 
acceptable time period, leaving a scar that diminishes over time. Although most wounds can 
be treated at a modest cost, wounds in sick or diabetic patients can become infected and take 
longer to heal. Some of these may develop into a chronic wound that fails to heal. These 
wounds are therefore difficult to treat, can impact on the well-being of the patient, and delay 
the discharge of the patient from hospital with an associated cost to the patient or health care 
provider. The cost of caring for wounds to ensure healing in a developed country such as the 
United States of America was estimated to be approximately 16 billion dollars in 2012 (1). The 
increasing prevalence of non-communicable diseases of lifestyle, such as diabetes, will result 
in more diabetic wounds being treated and that often take longer to heal (2). Treating these 
chronic wounds will add significantly to the costs to the health care providers. Therefore 
considerable effort is being invested to find substances that will accelerate or improve 
outcomes in wound healing. 
 
Sophisticated treatments have been developed in first world countries that are simply 
unaffordable and consequently unavailable in poorer developing countries. In these countries, 
the World Health Organisation (WHO) has reported that patients still rely heavily on traditional 
remedies and knowledge when caring for wounds (3). Such remedies are readily accessible 
at a low cost and are widely accepted by the community. However, as the treatment of wounds 
with unregistered remedies is seldom recorded by traditional healers, there is a lack of reliable 
information of the burden and the cost of treating wounds on health care systems in these 
countries. 
 
There has always been an interest in traditional remedies from a personal consumer level, 
and more recently from the multinational pharmaceutical companies (4). It is well known that 
the origins of many pharmaceutical companies were based on traditional or folk remedies. For 
example, the original product of the pharmaceutical giant Bayer AG’s, acetylsalicyclic, was 
marketed as Aspirin. Aspirin is derived from salicyclic acid, a folk remedy for headaches found 
in willow bark. Another instance, Metformin, was originally extracted from the French lilac 
plant, Galega officinalis, and used since the 1400s in the treatment of type 2 diabetes (5). It 
can therefore be seen that traditional remedies offer a potential source of lead compounds to 
treat disease and symptoms, including wound healing (6). 
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However, despite the major efforts invested in identifying novel agents which enhance wound 
healing, the very complexity of the wound healing process makes elucidating the effect of a 
single active compound difficult to determine. Although gross effects of a substance on wound 
healing may be measured, there is often a lack of evidence with regard to the mechanism of 
action to substantiate the use of these products, even when these products are produced by 
major industry players. A recent article has suggested this issue is being addressed (7). 
Furthermore the approach of measuring gross parameters would not be subtle enough to 
detect the effect of a single candidate compounds which acts at a particular point in time, or 
one that is effective only within a narrow concentration range during wound healing (8). 
 
The complexity of wound healing and with somewhat limited samples available from 
experimental animal models, has resulted in a reductionist and simplified approach to 
determining the effects of novel compounds. Parameters and variables (to be discussed at a 
later time point) investigated in many studies describing the wound healing process often do 
not encompass the process entirely and this may simply be due to the overall complexity not 
permitting in-depth analysis (8). Therefore the question posed in the present study queries the 
ideal model with the appropriate variables for evaluation to screen for the efficacy of plant 
based therapeutic agents. 
 
 
1.2 Background 
The literature regarding traditional medicine for the use of wound healing using Mesh search 
including the phrases “wound healing” and “traditional medicine”, yielded 190 search results 
over a time period from 1991 to 2012. Table 1.1 summarises the results arranged by 1) 
geographical region, 2) the wound healing model, including the animal used and the type of 
wound created, 3) the gross, histological and biochemical parameters used to analyse the 
efficacy of the plant and 4) investigations to determine the plant constituents. 
 
 
1.2.1 Regions of Origin 
A vast majority of studies reporting on the efficacy of plant based therapies were sourced from 
developing countries, where, as noted previously, up to 80% of people are reliant on traditional 
medicines. Most reports were from India and Turkey, with reports from Africa, including 
Ghana, Uganda, Ethiopia, and South Africa. Relatively standardised protocols appear to have 
been used, perhaps due in part to previous success, costs and simplicity of the experimental 
approaches. However, two studies from South Africa will be discussed further below as the 
experimental approach was different (9, 10).  
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1.2.2 Wound Models 
To determine the efficacy of a plant based therapies on wound healing in a human, the ideal 
experimental model would be human test subjects. However, obvious ethical considerations 
prohibit this, and therefore alternative models are required. Both in-vitro and in-vivo models 
have been developed. In-vitro models are often culture-based experiments, using either 
individual keratinocyte or fibroblast cell cultures, or as co-cultures of these cell types (11).  
 
Alternatively In-vivo models rely on an “ideal” test animal wherein experimental conditions can 
be controlled. Additional factors in determining such an approach include the cost, the number 
of animal’s required and available veterinary expertise. Furthermore, available analytical 
reagents must be biologically compatible with the chosen models (11). 
 
Rodent models, including the Sprague-Dawley rat, Swiss Albino mouse, Wistar Albino rat and 
Guinea pig, are preferred because of their small size, cost, availability and surgical/operational 
procedure (12). However, a particular disadvantage of rodent models is the primary 
mechanism whereby their cutaneous wounds heal; in rodents, full thickness wounds contract 
such that the free edges oppose, whereas in human skin, wound closure is mediated by active 
keratinocyte migration these cells being derived from both the wound edges and hair follicles 
(13). 
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Table 1.1. Pubmed search results for “wound healing” and “traditional medicine”. Emphasis was placed on the experimental design and “o” indicates that 
these variables and models were used in these studies.  
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Achyranthes aspera 
L. 
Ethiopia Africa Rat 
Incision / 
Excision  o o  o o o o o o   o         (14) 
Ficus asperifolia 
Miq. 
Ghana Africa NA Culture Anti-microbial                o     
(15) 
Gossypium 
arboreum L. 
Ghana Africa NA Culture Anti-microbial                o     
Flabellaria 
paniculata 
Nigeria Africa Rat Excision Anti-microbial o  o                  (16) 
Bulbine Natalensis RSA Africa Pigs Excision  o o o     o o  o o o     
VEGF, TGF-
βR1, TGF-βR1   
(9) (10) 
Bulbine frutescens RSA Africa Pigs Excision  o o o     o o  o o o     
VEGF, TGF-
βR1, TGF-βR1   
Urtica urens RSA Africa NA Culture Anti-microbial          
 
     o     
(17) 
 
Capparis tomentosa RSA Africa NA Culture Anti-microbial                o     
Dicoma anomala RSA Africa NA Culture Anti-microbial                o     
Leonotis leonorus RSA Africa NA Culture Anti-microbial                o     
Xysmalobium 
undulatum 
RSA Africa NA Culture Anti-microbial                o     
Helichrysum 
foetidum 
RSA Africa NA Culture Anti-microbial                o     
Pterocarpus 
angolensis 
RSA Africa NA Culture Anti-microbial                o     
Terminalia sericea RSA Africa NA Culture Anti-microbial 
               
o 
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Gunnera perpensa RSA Africa NA Culture Anti-microbial 
 
              o     
Zantboxylum 
chalybeum 
Uganda Africa Rat Excision 
 
o  o    o  o           o 
 
 
(18) 
Warbugiaugandensi
s 
Uganda Africa Rat Excision  o  o    o  o           o 
MEND 
Zimbab
we 
Africa 
Guinea 
Pig 
Excision  o        o            (19) 
Shibao powder China Asia Rabbit Excision                   TGF - β, b-FGF   (20) 
Siegebeckia 
pubescens 
China Asia 
Rat and 
Culture 
Incision / 
Excision  o o    o  o o o           (21) 
Jatyadi Taila India Asia 
Rat and 
Rabbit 
Excision  o   o o o o o  o o         o (22) 
Acalypha indica India Asia Rat Excision  o o        o  o  o   TNF-α TGF-β 
Col 1 α,  
Col 3 α  (23) 
Semecarpus 
anacardium 
India Asia Rat 
Incision / 
Dead 
Space 
 o o o      o           o (24) 
Tridax Procumbans India Asia Rat Excision   o           o   o     (25) 
Euphorbia 
caducifolia 
India Asia Mouse 
Incision / 
Excision  o o        o  o        o (26) 
Trichosanthes 
dioica 
India Asia Rat 
Incision / 
Excision  o o o   o  o o o          o (27) 
Glycosmis arborea India Asia Rat 
Excision 
/ Incision 
/ Dead 
Space 
Toxicity o o        o          o (28) 
Hypericum patulum India Asia Rat 
Incision / 
Excision  o o       o           o (29) 
Leucus 
lavandulaefolia 
India Asia Rat 
Incision / 
Excision  o o                   (30) 
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Thespesia populnea India Asia Rat 
Incision / 
Excision  o o        o           (31) 
Plagiochasma 
appendiculatum 
Lehm. et Lind. 
India Asia Rat 
Incision / 
Excision 
Anti-microbial o o        o      o    o (32) 
Sesamum indicum 
(L.) 
India Asia Rat 
Incision / 
Excision 
/ Dead 
Space 
 o o o    o o o o  o    o    o (33) 
Ghee based 
formulation 
India Asia Rat 
Incision / 
Excision  o o        o           (34) 
Terminalia arjuna India Asia Rat 
Incision / 
Excision  o o        o          o (35) 
Dendrophthoe 
falcata (L.f) Ettingsh 
India Asia Rat 
Incision / 
Excision 
Anti-microbial o o        o o     o    o (36) 
Holoptelea 
integrifolia 
India Asia Rat 
Incision / 
Excision 
Anti-microbial o o o   o  o  o      o    o (37) 
Aristolochia 
bracteolata Lam. 
India Asia Rat 
Incision / 
Excision 
/ Dead 
Space 
Toxicity  o o      o o      o   
 
 (38) 
Lithospermum 
erythrorhizon 
Korea Asia Culture 
Migratio
n  
                    (39) 
Murraya koenigii L. Malaysia Asia Rat Excision  o  o   o o o o           o (31) 
Sphaeranthus 
indicus 
Pakistan Asia 
Guinae 
Pig 
Excision  o                    (40) 
Opuntia ficus-indica 
South 
Korea 
Asia Rat Incision  o  
 
                 (41) 
Memecylon edule 
Roxb. 
Thailand Asia NA Culture                  IL - 10    (42) 
Abies cilicica subsp. 
cilicica 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o o  o o o o o o            (43) 
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Abies nordmanniana 
subsp. 
bornmulleriana 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o o  o o o o o o            
Abies nordmanniana 
subsp. equitrajani 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o o  o o o o o o            
Abies nordmanniana 
subsp. 
nordmanniana 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o o  o o o o o o            
Cedrus libani Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o o  o o o o o o            
Picea orientalis Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o o  o o o o o o            
Cichorium intybus 
L. 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o o  o o o o o o     o o o    o 
(44) 
Daphne oleoides Turkey Asia Rat 
Incision / 
Excision   o  o o o o o o  o    o o    o 
Ranunculus pedatus Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o o          o 
(45) 
Ranunculus 
constantinapolitanu
s 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o o          o 
Michauxia 
campanuloides: 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o       o   
Anti-
inflamma
tory 
o 
 
 
(46)  
 
 
 
 
(46) 
Michauxia laevigata Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o       o   
Anti-
inflamma
tory 
o 
Michauxia 
tchihatchewii 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o       o   
Anti-
inflamma
tory 
o 
Michauxia 
thyrsoidea 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o       o   
Anti-
inflamma
tory 
o 
Michauxia nuda Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o       o   
Anti-
inflamma
tory 
o 
 
 
8 
    Model Gross Histological Biochemical 
 
 
 
 
Plant 
 
 
Area 
 
 
Continent 
 
 
Animal 
M
a
in
 
A
d
d
it
io
n
a
l 
W
o
u
n
d
 C
o
n
tr
a
c
ti
o
n
 
T
e
n
s
il
e
 S
tr
e
n
g
th
 
E
p
it
h
e
li
a
li
s
a
ti
o
n
 
E
p
id
e
rm
a
l 
R
e
m
o
d
e
ll
in
g
 
D
e
rm
a
l 
R
e
m
o
d
e
ll
in
g
 
F
ib
ro
b
la
s
t 
p
ro
li
fe
ra
ti
o
n
 
In
fl
a
m
m
a
to
ry
 i
n
fi
lt
ra
te
 
N
e
o
-v
a
s
c
u
la
ri
s
a
ti
o
n
 
C
o
ll
a
g
e
n
 d
e
p
o
s
it
io
n
 
H
y
d
ro
x
y
p
ro
li
n
e
 
H
e
x
o
s
a
m
in
e
 
D
N
A
 
P
ro
te
in
 
U
ro
n
ic
 A
c
id
 
E
la
s
ta
s
e
/C
o
ll
a
g
e
n
a
s
e
 
A
n
ti
-o
x
id
a
n
t 
C
y
to
k
in
e
s
 
G
ro
w
th
 F
a
c
to
rs
 
O
th
e
r 
C
o
m
p
o
u
n
d
 
D
e
te
c
ti
o
n
 
R
e
fe
re
n
c
e
 
Pinus halepensis 
Mill 
Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o o           
(47) 
Pinus pinea L Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o o           
Pinus sylvestris L Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o o           
Pinus nigra Arn Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o o           
Pinus brutia Ten Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o  o o o o o o o o           
Salvia cryptantha Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o     o o o o       o   
Tyrosina
se 
activity 
 
(48) 
Salvia cyanescens Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision  o     o o o o   
    o   
Tyrosina
se 
activity  
Multiple Plants Turkey Asia 
Rat and 
Mouse 
Incision / 
Excision                      (49) 
Anglo Saxon Britain Europe NA Culture Anti-microbial                     (50) 
Phyllanthus 
muellerianus 
(Kuntze) Exell. 
German
y 
Europe NA Culture                      (51) 
Calendula officinalis 
and more 
German
y 
Europe NA Culture                      (52) 
Compound R America 
North 
America 
Guinea 
Pig 
Burns  o                    (53) 
Croton zehntneri Brazil 
South 
America 
Mouse Excision  o     o o o o           o (54) 
Vernonia 
scorpioides 
Brazil 
South 
America 
Guinea 
Pig 
Excision  o                    (55) 
Multiple plants Brazil 
South 
America 
NA Culture                  TNF - α  
Cell 
signallin
g 
 (56) 
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Arrabidaea chica Brazil 
South 
America 
Rat 
Excision 
and 
Culture 
 o o        o           (57) 
Peperomia galioides Peru 
South 
America 
Mouse 
and 
Culture 
Incision / 
Excision 
Proliferation  o                   
(58) 
Mentzelia cordifolia Peru 
South 
America 
Mouse 
and 
Culture 
Incision / 
Excision 
Proliferation  o                   
Mutisia acuminata Peru 
South 
America 
Mouse 
and 
Culture 
Incision / 
Excision 
Proliferation  o                   
Himatanthus 
sucuuba 
Peru 
South 
America 
Mouse 
and 
Culture 
Incision / 
Excision 
Proliferation  o  
 
                
Spondias mombin Peru 
South 
America 
Mouse 
and 
Culture 
Incision / 
Excision 
Proliferation  o                   
Eleutherine bulbosa Peru 
South 
America 
Mouse 
and 
Culture 
Incision / 
Excision 
Proliferation  o                   
Muehlenbeckia 
tamnifolia 
Peru 
South 
America 
Mouse 
and 
Culture 
Incision / 
Excision 
Proliferation  o                   
Anredera diffusa Peru 
South 
America 
Mouse 
and 
Culture 
Incision / 
Excision 
Proliferation  o                   
Jatropha curcas Peru 
South 
America 
Mouse 
and 
Culture 
Incision / 
Excision 
Proliferation  o                   
Anredera diffusa Peru 
South 
America 
Rat Incision   o                  o (59) 
Hamelia patens 
El 
Salvador 
South 
America 
Rat Incision   o                   (60) 
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A more comparable animal model is porcine skin with Sullivan, et al. (13) highlighting the 
similarities between the human and porcine skin from both an anatomical and functional 
perspective, as well as the similarities in wound healing. Important similarities highlighted by 
the authors include firstly from a gross anatomical perspective a similar pattern of hair 
distribution. Secondly, at a micro-anatomical level, the comparison between the porcine and 
human dermis shows similarities in dermal thickness, number and distribution of blood vessels 
and the presence of rete-ridges and dermal papillary bodies. Furthermore the epidermal layers 
in both species have a similar keratinocyte turnover time and expression of native proteins. 
With regards to wound healing while both human and porcine skin heal by similar processes, 
the response to treatment modalities correlates only 78% of the time. This however is greater 
than that of smaller rodent based models and in-vitro culture assays which correlate with the 
human response 53% and 57% of the time respectively. Porcine models have previously been 
used in wound healing studies, but quite infrequently to evaluate plant based therapies. 
Recently, two studies from the University of the Witwatersrand utilised the porcine model to 
evaluate the effects of Bulbine natalensis and Bulbine frutensis and followed a similar protocol 
to that used for rodent models of wound healing (9, 10). 
 
It is evident that the model animal chosen will dictate the type of wound which can be created 
experimentally and how the resultant wound can be analysed. Most studies have employed 
incisional and excisional wounds created on the dorsum of the rodents. Incisional wounds 
usually produced using a scalpel, extended from the epidermis to the fascial planes and may 
be allowed to close by either primary intention, that is with sutures, or by secondary intention, 
that is, without sutures. In the majority of studies, sutures were removed up to one week later, 
and often used in tensiometer assays to measure wound breaking strength. The excisional 
wounds were usually created with punch biopsies, and harvested at various timepoints 
allowing for gross anatomical, histochemical and biochemical analyses of these samples. 
Other models used in wound healing experiments include burn models and deep partial 
thickness wounds. Deadspace models have been used to evaluate Semecarpus anacardium 
(24), Glycosmis arborea (28), Sesamum indicum (L.) (33), Aristolochia bracteolata Lam. (38). 
In these models, an artificially created subcutaneous space was made with an implant made 
from various materials and was allowed to be infiltrated by the cellular and connective tissue 
components which can be analysed thereafter (61). This technique is best suited to rodents 
as the skin of these animals is loose and easily manipulated for this purpose. 
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1.2.3 Gross Assessment 
Billingham and Russell (62) stated that contraction of wounds was the generally accepted 
method by which tissue continuity and functionality could be restored. They based their 
findings on a rabbit model which included a full thickness excisional wound coupled with 
sequential planimetric measurements of the wound area. Although this study did not evaluate 
any traditional remedy, it identified important determinants of wound contracture. These 
included the depth of the wound, shape of the wound, age of the animal, species of the animal 
and type of skin (loose or fixed). The driving mechanism behind wound contraction was not 
proposed in this study.  
 
Subsequently a wound healing sequence was proposed that included 1) a raised marginal 
tissue pressure due to inflammation, 2) migrating embryonal fibroblasts carrying the wound 
margins, 3) circumferential collagen fibres acting as a sphincter and the 4) contractibility of 
regenerating tissue opposing wound margins. More recent consensus, from publications in 
1995 and 2007, is that fibroblast populations infiltrate the wounded area, where some deposit 
collagen and some differentiate into myofibroblasts which are contractile in nature, thus 
explaining the contractile nature of the wound healing process (63, 64).  
 
Wound tensiometry or determination of the tensile strength is a technique that was proposed 
as a surrogate marker of wound healing and was originally described in 1929 by Howes, et al. 
(65). It has been shown to correlate with collagen content and is also related to structural 
orientation (66). However, White, et al. (66) showed that although maximal collagen formation 
was measured 17-20 days after injury, maximal tensile strength was only reached months 
after wounding. Tensile strength is therefore not entirely related to collagen production, but 
rather a multitude of additional factors including non-collagenous skin constituents, such as 
the epidermis, fibroblasts, endothelia, inflammatory cells, keratins and mucopolysaccharides 
(67). Despite these findings, this approach has been sensitive enough to detect differences 
between different treatment modalities and has become a widely utilised technique in many of 
the studies seen in Table 1.1 and include Hypericum patulum (29), Achillea biebersteinii Afan. 
(68), and in herbal formulations containing extracts of Terminalia arjuna (69).  
 
1.2.4 Process of Wound Healing 
Wound healing is required to effectively stabilize and repair injury (2, 70). In an optimal system, 
the process of wound healing occurs in an orderly and controlled series of overlapping phases, 
including, haemostasis, inflammation, proliferation, and remodelling (71, 72). To understand 
the rationale behind measuring other possible parameters in models of wound healing, it is 
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important to comprehend the sequence of events and factors regulating the process of wound 
healing.  
 
Cutaneous wound healing is a highly dynamic and complex process and in an optimal system, 
is orchestrated to not only effectively and timeously re-establish the homeostatic properties of 
the integument but also to be functionally similar to intact (non-wounded) tissues (8). However, 
when the normal process or aspects of the process are altered either by the body’s own 
system or by external factors (73), aberrations occur that may be detrimental to wound healing 
and in extreme cases lead to complete degradation of the skin and progression to non-healing 
wounds. On the other hand, careful manipulation of the right biochemical pathways could lead 
to accelerated healing with the eventual aim of attaining the formation of an aesthetically and 
physiologically normal epithelium. This poses a challenge as biochemical pathways in the 
healing wound have been shown to be highly variable with synergistic, agonistic and 
antagonist effects of many key constituents.  
 
Multiple reviews summarise the physiology of wound healing describing four distinct phases 
of haemostasis, inflammation, proliferation and remodelling (64, 71, 74, 75). These phases 
are classically described as overlapping and are depicted by Figure 1.1. Additionally multiple 
factors seen in Table 1.2 adapted from Baum and Arpey (76) summarise the soluble factors 
affecting wound healing which are also important targets for investigation. Each of these 
phases, together with key associated growth factors are described below. 
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Figure 1.1. Phases of wound healing. 
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Table 1.2. Components active in the various stages of wound healing (adapted from Baum 
and Arpey, (76). 
 
Phase Timing Cellular 
Components 
Non-Cellular 
Components 
Regulators 
a) Haemostasis 
  
Injury to 
15-30 
minutes 
  
Endothelial Cells Fibrin Prostagalandins  
Platelets Fibronectin Thromboxanes 
    Thrombin 
b) Inflammatory  
  
15-30 
minutes 
to 1 week 
  
Endothelial Cells Fibrin provisional 
matrix 
Cytokines: TNF-α, IL-1α and β, IL-6, 
IL-8   
Neutrophils  Growth Factors: TGF-β, PDGF 
Macrophages  Others: Histamine, Leukotrines, 
Complement 
Lymphocytes     
c) Proliferative  
  
2 days to 
a few 
weeks 
  
Endothelial Cells Provisional matrix Growth Factors: FGF-2, FGF-7, FGF-
10, VEGF, EGF, TGF-β, PDGF 
Macrophages Collagen 
Fibroblasts Proteoglycans Others: MMP/TIMP, Nitric Oxide, 
Angiopoietin 
Keratinocytes     
d) Remodelling  
  
Weeks to 
months 
  
Myofibroblasts Collagen Growth Factors: TGF-β, PDGF 
Fibroblasts Proteoglycans Cytokines: IL-1, IL-10 
Macrophages  Others: MMP/TIMP 
Lymphocytes     
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a) Haemostatic Phase: Restoring homeostasis must occur rapidly and occurs directly 
after a traumatic or intentional surgical insult. Blood vessels respond by contracting 
and activating the clotting cascade. The resultant fibrin plug forms from fibronectin and 
fibrinogen and associated platelet aggregation. Platelets are an important component 
of this process as they contain growth factors, cytokines, coagulation factors and 
protease inhibitors in their α-granules (77). Importantly, the fibrin plug forms the 
provisional matrix necessary to promote and support cell infiltration into the wounded 
area (78). It further, serves as a temporary repair mechanism before the following 
repair phases can come into effect (79). It is this early infiltration of cells that, through 
their production of appropriate cytokines, regulate the subsequent phases of wound 
healing.  
 
b) Inflammatory Phase: In response to cytokine, chemokine and other signals, 
inflammatory cells migrate into the wounded area. The predominant cell types are 
initially the short-lived polymorphonuclear leukocytes or neutrophils which are slowly 
replaced by the macrophage population (64). During this phase there is a release of 
soluble factors of multiple origins and functions and has been extensively reviewed by 
Werner and Grose (80). As is listed inTable 1.1, several soluble factors were 
investigated with regards to plant based therapies. These factors include the growth 
factors, transforming growth factor–β (TGF–β), basic fibroblast growth factor (bFGF), 
vasoendothethial growth factor (VEGF); and the cytokines, tumor necrosis factor–α 
(TNF-α) and interleukin 10 (IL–10). The factors listed here are by no means 
comprehensive in terms of the overall number of factors described by Werner and 
Grose (80), but rather represent the factors analysed when considering plant based 
therapies and will be further discussed at a later stage.   
 
c) Proliferative Phase: In an extensive review by Baum and Arpey (76), two important 
components of this phase were identified as 1) the formation of granulation tissue 
following the migration and proliferation of fibroblasts, with the subsequent production 
of collagen, 2) re-epithelialisation where the granulation tissue is covered by migrating 
keratinocytes. The migration and proliferation of these various cellular components is 
due to chemotactic signals generated within the wound.    
 
The source of these fibroblasts is from neighbouring unwounded tissue and from 
undifferentiated mesenchymal cells (76) and respond to signals by TGF-β, bFGF and 
PDGF (80). In culture based experiments, within the first 24 hours, these factors have 
similar effects on the migration of fibroblasts within the first 24 hours but thereafter 
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differential effects are seen with PDGF having the greatest effect and TGF- β the least 
(81). Additional factors have been linked to the migration and proliferation of fibroblasts 
namely epidermal growth factor (EGF), FGF and Insulin like growth factor (IGF) (80). 
The role of EGF to some degree is that of a modulating one as reported by Ware, Wells 
and Lauffenburger (82). Together with a matrix ground substance as a migratory 
surface, the speed and direction of fibroblast migration is manipulated by various 
concentrations of EGF (82). 
 
Re-epithelialisation is achieved by the migration, proliferation and differentiation of 
keratinocytes (83). Keratinocytes are derived from the adjacent non-wounded sites 
and if the hair follicles are intact, cells from these appendages are also mobilised. 
Keratinocytes migrate as sheets of cells and cease migrating on contact with opposing 
migratory keratinocytes. These migratory sheets of keratinocytes are fed by 
proliferating cells immediately posterior to the leading edge (84).  
 
To analyse these specific features of re-epithelialisation various markers present in the 
skin can be analysed using histochemical staining techniques of epidermal keratins. 
Migratory keratinocytes express and show a reorganisation of keratins 6 and 16 in 
response to wounding (83), proliferating cells express keratins 5 and 14 (85) and the 
differentiating suprabasal cells express keratins 1, 10 and K2 (83). Re-epithelialising 
tissue shows variation in differentiation state but evaluation of the keratin sub-types 
does not feature in the studies seen in Table 1.1. 
 
Various key factors regulate keratinocyte migration, proliferation and differentiation. In 
addition to calcium, magnesium, pH and hypoxia, growth factors involved in migration 
include neuronal growth factor (NGF) and hepatocyte growth factor (HGF), both of 
which are linked to tyrosine kinases and tyrosine phosphorylation (86, 87). Additionally 
(Table 1.2) factors affecting keratinocytes can be viewed as migratory stimulators and 
include FGF-2, 7, 10 and TGF-β, as well as those stimulating proliferation including 
NGF, HGF, IL-6, nitric oxide, leptin, and others (76). Although analysis of many of 
these factors is mostly absent from studies focussing on plant based therapies, it is 
clear that their roles are important in wound healing. 
 
d) Remodelling Phase: The remodelling phase is the synthesis and remodelling of the 
extracellular matrix which starts early with the deposition of granulation tissue and 
continues for months after the wound has been closed (70). Key to this phase is the 
synthesis and enzymatic breakdown of collagen fibres (88) by matrix 
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metalloproteinases (MMP’s) (64). However the activity of MMP’s is not only limited to 
the remodelling phase as they are directly involved with cell migration, cytokine and 
growth factor release from the cells producing them, in concert with the degradation of 
these factors (64). This phase is under the control of factors such as IL-1β and TNF-α 
which up-regulate expression and down-regulate their natural antagonists, the tissue 
inhibitors of metalloproteinases (TIMP) (74). 
  
Few studies, utilising either plant based therapies or commercially available products, 
have followed the wound healing process in its entirety. Limited data suggests that the 
final strength of the wounds is only about 80% of non-injured skin several months post-
treatment (70). It would appear that this phase is not well documented in the literature 
and neither has it been well investigated as opposed to the prior phases.   
 
1.2.5 Soluble Growth Factors 
The following factors described are those analysed by the authors in Table 1.1. Although by 
no means an extensive list, the factors presented here are those reported when considering 
the roles or mechanisms of plant based products in wound healing.  
 
Transforming growth factor–β (TGF- β). TGF- β is a ligand superfamily that is further divided 
into five sub-families designated TGF- β 1-5 (89). The membrane receptors of these ligands 
are linked to serine and threonine kinases that phosphorylate to transduce the ligand signal 
(89). Whereas the Epidermal Growth Factor (EGF) family ligand transmembrane receptors 
are coupled to tyrosine kinase activity a link between the TGF and EGF families exist where 
the former enhances the mitogenic effects of the later (80). The significance of these signalling 
mechanisms within the context of the present study is further reviewed in Chapter 3.  
 
TGF-β acts throughout all the wound healing phases by exerting mostly chemotactic and 
proliferative signals on monocytes, endothelial cells, fibroblasts and keratinocytes (89). Faler, 
et al. (89) emphasized that the role of this factor differs in some instances, where it could be 
anti-proliferative when endothelial cells and keratinocytes are involved, possibly due to the 
wound models used. However, with regards to experimentally assessing the efficacy of  
traditional medicines, TGF-β was found to be beneficial in wound healing studies reported by  
Zhao, et al. (20), Ganeshkumar, et al. (23), and Pather and Kramer (10) and are described 
below. 
 
The study by Zhao, et al. (20) was conducted using rabbit full thickness wounds to assess the 
effects of Shibao powder on soft tissue healing, where the authors evaluated the expression 
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of bFGF and TGF-β in the granulation tissue of these wounds. In response to the treatments 
there was an increased expression of bFGF at 6 days post operatively and increased levels 
of TGF-β at days 10 and 14, all of which were significant.  
 
Similarly, Ganeshkumar, et al. (23) showed elevated levels of  TGF- β at day 7 post-operatively 
when  the effects of ethanolic extracts of the plant Acalypha indica were assessed on full 
thickness excisional rat wounds. In association with raised TGF- β levels were increased rates 
of wound contraction, epithelialisation and tensile strength (23).  As the approach taken here 
was to quantify ribonucleic acid (RNA) expression levels from harvested wound tissue, no 
distinction was made as to the specific cellular localisation of the expression of TGF- β. 
 
Conversely, Pather and Kramer (10), assessed the expression of TGF- β by utilising 
immunohistochemical staining of the tissues harvested from porcine full-thickness models, 
where extracts of Bulbine natalensis  and Bulbine frutensis were used. Compared to the 
controls Bulbine natalensis and Bulbine frutensis treated wounds showed an increase in TGF- 
β expression which was linked to earlier epithelialisation of the wounds compared within the 
different treatment groups.  
 
Basic fibroblast growth factor (bFGF). bFGF is a member of the fibroblast growth factor 
family, whose signal is similarly transduced via transmembrane receptors coupled to tyrosine 
kinases, producing proliferative signals in endothelial, fibroblastic and keratinocyte cell lines 
(80, 90). McGee, et al. (91) reported that recombinant bFGF increased tensile strength and 
breaking energy but not collagen content in a full thickness incisional rat wound model. It was 
suggested that its effects may be more related to increased numbers of fibroblasts or their 
contractile counterparts, myofibroblasts. There is a paucity of data  regarding plant based 
therapies and their potential effects on bFGF expression.  Zhao, et al. (20) however reported 
significantly increased levels of bFGF expression, altered composition of the granulation 
tissue with regards to collagen content and organisation in response to Shibao powder in a 
rabbit tendon incisional wound model.   
 
Vasoendothethial growth factor (VEGF). VEGF is a growth factor whose receptors are also 
linked to transmembrane tyrosine receptor kinases (80). VEGF has been shown to be 
produced by multiple cells active in the wound healing process, including neutrophils, 
macrophages, endothelial cells, fibroblasts, myofibroblasts and keratinocytes (92) and exerts 
effects throughout the entire wound healing process. Additionally VEGF has also been 
implicated in scarless wound healing (93), an attractive aesthetic variable in wound healing. 
From the articles documented in Table 1.1, the expression and localisation of VEGF was 
demonstrated with the use of Bulbine natalensis and Bulbine frutescens full thickness wounds 
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in a pig model (10). Here, increased VEGF expression in the basal layers of the regenerating 
epidermis as well as scattered expression through the granulation tissue was established. 
Further, this increased expression correlated with an elevated break strength and 
angiogenesis.  
 
Interleukin-10. IL-10 has been shown to be a prominent anti-inflammatory cytokine active in 
the skin. Berg, et al. (94) demonstrated the role of IL-10 in Croton oil irritated skin in a mouse 
model. The effects of IL-10 were assessed based on its potential to reduce the inflammatory 
induced necrosis of skin tissue in wild type mice as well as IL-10 knockout mice. It was seen 
here that the inflammatory response based on macrophage infiltration, oedema and ulcer 
formation. Furthermore, the extent of damage was greater, with an increased inflammatory 
response in the knockout mice. In addition levels of other inflammatory cytokines, specifically 
IL-1β and IL-6, were also shown to decrease in response to IL-10. Other responses included 
an inhibition of chemotaxis of neutrophils and macrophages to the affected site (95). 
 
Nualkaew, et al. (42) investigated the anti-inflammatory effects of Memecylon edule Roxb. 
showed various fractions of the plant, in a macrophage culture model combined with a rabbit 
ear oedema model, produced an elevation of the IL-10 with a corresponding decrease in 
oedema suggesting a beneficial effect. In contrast, Eming, et al. (72) found that in IL-10 
knockout mice decreased levels of IL-10 accelerated wound closure in a mouse model where 
accelerated epithelialisation and wound contraction was observed. This suggests that 
cytokines inhibited by IL-10 may have a beneficial contribution to the wound healing process 
and these pro-inflammatory agents but quite possibly act as chemotactic agents for cells active 
in the wound healing process.  
 
Tumour necrosis factor-α (TNF-α). In contrast to the anti-inflammatory effects of IL-10, TNF-
α has more of a detrimental role and has indeed been linked to non-healing chronic wounds 
(96). TNF- α is a cytokine that is primarily produced by activated macrophages (97) but has 
also been shown to be produced by neutrophils (98). Its role in wound healing is a complex 
one, as its beneficial effects may be dose dependent, with roles in inflammation, mitogenicity 
and angiogenesis. Its role is however better explained as a synergistic molecule with regards 
to platelet derived growth factor (PDGF), but shows antagonistic effects with respect to TGF-
β (99).  
 
In utilising both a rat dead space and in-vitro cell culture wound models, Rapala (97) assessed 
the effects of TNF-α. In the dead space model, TNF-α decreased wound associated collagen 
production, but only with the continual addition of the cytokine and more specifically, only at 
days 4-7. In fibroblast cultures, TNF-α also reduced the production of collagen. While in culture 
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the effects of TNF-α are easily seen, the impact in animal models is not as great. Added to 
this, evidence from TNF-α null mice show that without the cytokine, expression of TGF-β 
expression is uncontrolled leading to excessive granulation tissue production and ineffective 
epithelialization (100). In light of this, the Brazilian study by Schmidt, et al. (56) where a 
multitude of plants were examined only Xanthium cavanillesii was capable of reducing the 
expression of TNF- α significantly (up to 70%) in fibrolast cultures after lipopolysacharide 
stimulation. 
 
1.2.6 Histological and Biochemical Analysis 
Determining the mechanism whereby a plant based therapeutic agent enhances healing 
requires the simultaneous measurement of a number of parameters. Interpreting 
concentrations of chemokine, cytokines and other parameters which orchestrate optimal 
wound healing has been made in the context of the wound healing phases. However such 
inferences may not be valid as measures may not be specific to one phase and may overlap 
with other phases. What is apparent is that the histological and biochemical variables that are 
commonly measured are in essence the outcomes of multiple underlying processes which are 
never fully evaluated when investigating a potential plant based therapy. They describe the 
wound in general terms but may not be adequate for mechanistic descriptions of the 
investigated plants. In light of this, histological and biochemical investigations are relatively 
cheap, remain the basis of wound healing investigations and therefore require further 
elaboration. 
 
Histological measures in wound healing including inflammatory infiltration, neovascularisation, 
fibroblast infiltration, epithelialisation, collagen deposition and remodelling are common 
variables determined when evaluating the efficacy of plant based therapies. Although these 
measures provide qualitative assessment of wound healing, the assays are mostly operator 
dependent. While there was a correlation between experienced observers and histological 
measurements, automated tissue processing was proven superior since it removes both 
inter/intra observer error and was more reproducible (101).  
 
In contrast, biochemical assays reduce the subjectivity associated with the histological 
analyses. An example is the reproducible colorimetric determination of hydroxyproline 
concentrations, which have been widely used to determine collagen content in connective 
tissues (102). Correct sampling appears to be a drawback of the assay. Additional biochemical 
parameters assessed when evaluating traditional medicines are DNA concentrations, elastase 
and collagenase activity, total protein and the frequently measured assessment of anti-
oxidants in plants.  
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Free radicals (i.e. superoxide’s and hydroxyls) are produced in healing wounds and have 
potent antimicrobial activity (103). They are also involved in signalling mechanisms within the 
wound environment (104). Excessive release of free radicals result in an elevated pain 
response and are responsible for excessive viable tissue damage (105). Concentrations of 
free radicals at micromolar concentrations enhance the wound healing process, whereas 
millimolar concentrations result in uncontrolled damage, to cause prolonged wound healing 
and possible formation of a chronic wound (106). Elevated free radical concentrations have 
been demonstrated in vascular insufficiency, diabetes and advanced age, conditions wherein 
chronic wounds are more common (107). Therefore anti-oxidants in traditional medicines may 
be important variables in the context of chronic wounds rather than in acute wound healing. 
 
Few studies have determined the toxicity of plant derived compounds. While, for example, the 
toxicity of orally administered extracts of Glycosmis arborea (28) and Aristolochia bracteolate 
Lam (38) have been determined,  there is a lack of information relating to toxicities of topically 
administered natural plant products to wounds. 
 
1.2.7 Plant Compound Detection and Isolation 
Given the complexity of the wound healing process, measuring panels of variables and 
determining interactions between these variables, should lead to a more complete 
understanding of wound healing and allow for the elucidation of some mechanisms of action 
of plant based therapies. In this regard, the isolation of the individual active compounds would 
better disclose the mechanism and the potential effects of concentration variability. Beneficial 
synergistic and antagonistic interactions between such compounds could also be elucidated 
(108). Indeed most beneficial outcomes may be from individual compounds isolated from 
different plants or even polyherbal pharmacy (109).  
 
The studies listed in Table 1.1 indicate the wound healing potential of  many relevant plants 
although the underlying mechanisms remain largely unknown. This may be due to the the 
limited number of variables that can be measured in a single experiment in the highly complex 
setting. If an outcome can be identified from the variables easily assessed such as wound 
closure, high throughput assays can be employed to identify the active fractions, component 
or components which affect the measured variable. 
 
From the studies reviewed in Table 1.1, it can be seen that a number of authors have 
documented potential components of the plants based on previously documented protocols 
seen in Trease and Evans (110), and here the majority of the authors employed the 
phytochemical screen. Furthermore chromatographic techniques including high performance 
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liquid chromataography (HPLC) and gas chromatography coupled with mass spectrometry 
(GCMS) have been used to identify potential compounds. Nagappan, et al. (31), for example, 
identified essential oils from Murraya koenigii by GCMS and isolated a carbazole alkaloid, 
mahanimbicine with potential anti-inflammatory properties. This was shown to increase both 
collagen depositon and organisation. β-Sitosterol from Cichorium intybus (L.) was firstly 
isolated by column chromatography and then identified by nuclear magnetic resonance (NMR) 
It’s benefit in wound healing was due to its anti-oxidant and anti-inflammatory properties (47). 
 
1.2.8 Current State of Wound Healing Investigations  
The complexity of the wound healing process has led investigators to determine general 
screening outcomes such as the wound tensile strength and contracture, as well as qualitative 
histological measures, including inflammatory cell infiltrate and epithelialisation of the wounds. 
Relatively few studies have continued to further determine molecular mechanisms of action of 
these plant remedies. Such molecular studies may allow for the development of rapid 
screening techniques of potential extracts, ultimately identifying  lead compounds of benefit in 
wound healing (6). 
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1.2.9 Senecio serratuloides 
Senecio serratuloides, a plant widely used for wound healing. It is referred to by the traditional 
healers of South Africa as “umsukumbili” or the “2 day cure” and belongs to the family 
Asteraceae/ Compositae. Although the plant is widespread throughout South Africa, 
information available on Senecio serratuloides is recent and mainly derived from books 
published on the various plants utilized in South African traditional medicine settings. The 
indications for this plant are for cutaneous cuts, sores, and burns (111, 112). The plant is 
simply prepared for use as dried leaves which are then burnt, crushed and applied directly to 
the affected areas. 
 
 
Figure 1.2. Senecio serratuloides. Leaves that are routinely used for wound healing are 
clearly defined from the stem. (Image taken from iSpot web page: 
http://www.ispot.org.za/node/195582). 
 
Although little information is available as to the efficacy of the plant some beneficial effects 
have been described by Fawole, et al. (113) including anti-inflammatory properties (COX-1/2 
assays), anti-cholinesterase, and anti-oxidant activity. These attributes were determined 
directly from plant preparations including 50% methanol, dichloromethane, petroleum ether 
and ethanolic extracts.  
 
A major limitation with this plant is that the genus is known to contain pyrrolizidine alkaloids 
(114, 115). Although these have not been specifically identified in this particular plant, there 
are reports of hepatic and pulmonary disorders observed with pyrrolizidine alkaloid poisoning 
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(116, 117). Senecio serratuloides was included in a screen of South African medicinal plants 
for genotoxicity using the AMES and VITOTOX® test where toxicity was only seen at high 
concentrations in the VITOTOX® assay (118). Since these in-vitro assays do not take into 
account the hepatic and pulmonary toxicity secondary to pyrrolizidine alkaloid poisoning, it 
would be an expansive leap to infer toxicity of the plant this warranting further investigation.    
 
Importantly, in most reports of pyrrolizidine alkaloid poisoning, the route of entry into the body 
is through the accidental contamination and consumption of food (119). In contrast as a wound 
healing remedy, this plant is applied topically on the wounded areas of the skin and there 
appear to be no reports of toxicity following this application. Thus the route of administration 
of the plant appears to have toxicological implications. 
 
The practice of charring the plant introduces the question of delivery and availability of the 
active ingredients. Traditional healers gently char this plant during preparation and this 
produces a slow release system known as biochar (120). Mawera, et al. (19) report an 
“ashened” local plant used for wound healing in Zimbabwe. Although the name of the plant 
was not disclosed, it is the first report of plant material prepared in this way.  
 
In summary, inappropriate wound healing and the development of a chronic wound can be a 
costly complication of simple surgical procedures. Interventions which accelerate the process 
are continually being sought and investigated. Although the efficacies of traditional wound 
healing remedies have been reported anecdotally, few have been subjected to any rigorous 
scientific investigation. Senecio serratuloides is one such local South African remedy which 
will be the subject of the present investigation. As accidental ingestion of this plant has resulted 
in hepatic failure, the question whether this plant is safe to use topically requires thorough 
testing. Moreover, the molecular mechanism whereby this plant accelerates the healing 
process has not been investigated.  
 
It is clear that multiple issues are present. Firstly the wound healing process that is described 
as being complex allows for multiple targets to be manipulated in order to accelerate the 
process and so assaying one particular target loses the sensitivity needed to identify lead 
compounds. Secondly very little is known about Senecio serratuloides with regards to efficacy, 
mechanism by which the plant works, and toxicity. It can therefore be seen that there is no 
indication as to how the plant works and if it is safe. There is additionally little indication as to 
what compounds in the plant could be active.   
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1.3 Aims 
In this investigation, the aim was to develop an objective set of parameters to assess wound 
healing that: 
a) Could be reproducibly measured to describe the overall effect of the plant in question; 
b) May identify suitable end-point parameters to elucidate the mode of action of the active 
compounds in the healing process; 
c) Identify a suitable in-vitro assay that could be used in high throughput screening 
assays when screening for active substances in the plant material. 
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Chapter 2 - Efficacy and Safety of Senecio serratuloides in treating Deep Partial 
Thickness and Full Thickness Wounds; Macroscopic and Histological Assessment 
 
2.1 Introduction 
Treating and caring for wounds places an enormous, and escalating burden on hospital and 
health care resources, with an estimated cost in 2010 of $15.3 billion in the USA alone (2). 
Sophisticated care is often unaffordable and unavailable in developing countries, where many 
patients rely on familiar, readily accessible and inexpensive traditional wound healing 
remedies.  
In South Africa, the plant, Senecio serratuloides (DC; Asteraceae/ Compositae), the “2 day 
cure”, has been anecdotally reported by traditional healers to promote the healing of cuts, 
sores, and burns (112). Traditional healers apply fresh, dried or even charred leaves directly 
onto the wound, that may then be covered with pig or zebra fat. Despite being used widely, its 
wound healing efficacy has yet to be fully evaluated particularly as there are reports of 
deliberate or accidental oral consumption of this plant causing hepatic, renal and pulmonary 
dysfunction and death in stock animals.  
This toxicity has been attributed to the presence of pyrrolizidine alkaloids (116) found within 
plants of the genus Senecio, although these have not specifically been reported from Senecio 
serratuloides. However, we are unaware of reports of cases of pyrrolizidine alkaloid poisoning 
following the topical application of Senecio serratuloides to cutaneous wounds. AMES and 
VITOTOX® assays of solvent extracts of this plant have shown no signs of mutagenicity, 
except at concentrations exceeding 2000 μg/ml (118). Despite these reports, Fawole, et al. 
(113) have demonstrated anti-oxidant and other beneficial properties in the plant to partly 
explain the beneficial wound healing properties. As the plant is widely used by traditional 
healers, a more detailed investigation of the wound healing potential and safety of Senecio 
serratuloides is required.  
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2.2 Aims 
Therefore the aims of this Chapter where to: 
a) Establish the efficacy of Senecio serratuloides in the healing of deep partial and full 
thickness cutaneous wounds in a porcine model, by assessing the effect of the 
treatment on wound closure, contraction and collagen infiltration; 
b) Determine changes in the pH, epidermal thickness and collagen infiltration of the 
recovering wound to provide potential mechanisms responsible for accelerating the 
healing process; 
c) Determine the toxicity and safety of topically applied Senecio serratuloides preparation 
in the porcine model. 
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2.3 Materials and Methods 
 
2.3.1 Collection and Preparation of Plant Material  
The plant material was purchased between 2008 and 2010 from the Mooi Street Traditional 
Market, Johannesburg, and was identified and deposited at the C.E. Moss Herbarium of the 
School of Animal, Plant and Environmental Sciences, University of the Witwatersrand. 
Specimen voucher numbers include 08/05/2009, 09/08/2009, 09/05/2009, and 27/02/2010. 
For simplicity Senecio serratuloides will be referred to as Senecio from this point forward. 
 
The material was air dried and stored at -20 oC until used. The preparation and application of 
the plant material was according to the traditional healer’s instructions. Leaves were dried in 
an oven at 40 oC overnight, after which they were crushed to a fine powder using a pestle and 
mortar and heated on a hot plate until charred to a black “ash”. The material was ground again, 
and the resultant powder placed directly on the wounds (described below). 
 
2.3.2 Animal Model and Test Groups 
Large white pigs (Sus scrofa domesticus) were selected for experimentation due to the 
similarities to human skin (13). Ethical clearance was obtained from the Animal Ethics 
Committee (Clearance number: 2008/15/04) of the University of the Witwatersrand. 
 
Surgery and Wound Generation: Nine (n = 9) female pigs (±30 kg) were anaesthetized using 
injectable midazolam (0.3 mg/kg) (Dormicum, Roche) and ketamine (11 mg/kg) (AnaketV; 
Bayer HealthCare). Anaesthesia was maintained by Isofor (Bayer HealthCare) as a volatile 
agent. Dr. Patel performed the surgery at the Central Animal Unit within the Faculty of Health 
Sciences. Deep partial thickness wounds were created with an electric dermatome, set to 
800μm (Aesculap HH Dermatome Ga 630) to remove six square sections of skin (2.5 cm by 
2.5 cm) spaced 4 cm apart, and either side of the midline of the dorsum of each pig. Additional 
to the deep partial thickness wounds, full thickness punch biopsies were created adjacent to 
the partial thickness wounds (Figure 2.1 and Figure 2.2). 
 
Treatment and Dressing: Wounds were treated with one of the following: 1) prepared Senecio 
material (0.2 g); 2) activated carbon (0.2 g, Merck South Africa; Cat. No. 102186), as the 
positive control; or 3) left untreated as the negative control. Each treated wound was also 
dressed with separate standard occlusive dressing, with an integrated absorptive pad (3M 
Tegaderm® Cat. No. 3584) (Figure 2.3). The test area of each pig was wrapped in a stocking 
to hold the dressings in place. Each pig was housed separately in the Central Animal Unit and 
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buprenorphine (0.3 - 0.6 ml) (Temgesic, Reckitt Benckiser Pharmaceuticals) was administered 
as post-operative analgesia. 
 
2.3.3 Wound sample Collection and Analysis 
The dressings were changed on days: 2, 5, 7, 8, 9, 12, and day 16, based on the schedule of 
the Central Animal Unit. At each dressing change photographs of the wounds were taken to 
record the overall healing pattern. Wound surface pH was measured, the wound fluid was 
collected from the absorptive pads and jugular venous blood was taken. Wound and control 
biopsies were taken as has been described in a later chapters. Liver biopsies were collected 
one month post-completion of the experiments. 
 
2.3.4 pH Measurement 
On the days of sample collection, the wound pH was measured using a surface electrode 
(Separations Scientific ST P17-BNC) and the average of three measurements plotted against 
the post-operative time in days. Before measuring the pH the wounds were cleaned with de-
ionised water and the electrode was rinsed in de-ionised water between measurements to 
negate any potential effects on the pH that could be ascribed to the treatments or cleasing 
regimen. 
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Figure 2.1. Preparation of the dorsum of the pigs. Left: the animals were shaved and the demarcated areas outlined with a permanent marker. 
Right: a schematic diagram of the 2.5 cm by 2.5 cm deep partial thickness wounds with adjacent full thickness wounds created with a 6 mm 
core biopsy. Wounds 1, 4, 7, 10 were treated as the negative control. Wounds 2, 5, 8, 11 were treated with activated carbon. Wounds 3, 6, 9, 
12 were treated with the test plant, Senecio. 
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Figure 2.2. A schematic diagram of one of the 2.5 cm by 2.5 cm deep partial thickness experimental wounds, 800 µm in depth, created on the 
back of the pig. The location of the core biopsy sites, relative to the wound area are illustrated. A biopsy of normal uninjured skin, outside the 
wound area, was taken as the control external reference tissue. B. Schematic diagram of samples taken from a full thickness wound. 
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Figure 2.3. Dressings used to hold the treatments in place. The image above shows the animal’s dorsum once all the wounds were treated as 
per protocol. The wounds were dressed with the occlusive dressings which were held in place with zinc-oxide tape and a surgical stocking (not 
shown). 
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2.3.5 Skin Biopsy Collection 
The remaining wounds were dressed and covered as described above and biopsied on 
subsequent days according to the schedule. This process was repeated for the three treatment 
groups on these days. Full thickness wounds (Figure 2.2) were completely excised with a 8 
mm punch biopsy. 
 
2.3.6 Histological Analysis 
The skin biopsies obtained for histological analysis were immediately placed in 10% buffered 
formalin. The biopsies were subsequently dehydrated through a graded ethanol series, 
followed by clearing in Xylene and embedded in paraffin wax; and sections were cut at a 
thickness of 5µm on a sledge microtome. Sections were floated on a water bath pre-heated 
to 50 oC, containing premixed Sta-On (Leica Biosystems, Cat. No.3803105). Sections 
retrieved on alcohol washed microscopy slides were heat adhered to the slides at 60 oC 
overnight in preparation for subsequent histological analyses.  
All basic histology, including tissue processing, sectioning and staining was conducted in the 
School of Anatomical Sciences, situated within the Faculty of Health Sciences at the University 
of the Witwatersrand. The staining procedures included routine haematoxylin and eosin (H 
and E) staining of biopsy material for morphometric analysis and Picrosirius red staining for 
evaluating collagen deposition. The same biopsy specimens provided source material for the 
immunofluorescence studies, as described in Chapter 3.   
Sections were imaged at 100x magnification on a Zeiss Axioskop 2 microscope and images 
captured with a Sony 3CCD camera. For each wound, 2 representative sections were chosen 
with further morphometric analysis being performed with the planimetric software package 
IMAGE J (version 1.4.3.67).  
 
2.3.7 Deep Partial Thickness Wound Morphometric Analysis 
To account for the variability of the epidermal thickness along the dorsum of the pigs (13) 
control biopsies were made immediately adjacent to the wounds. Ten measurements of the 
newly forming epidermis were taken along both sections (five measurements per slide) for 
each wound and adjacent control samples. A ratio was then determined from the 
measurements inside the wound to that for the adjacent control epidermal thickness. To avoid 
bias that could arise from determining the ratio from highly variable tissues, the measurements 
for each section were ranked from largest to smallest and from this series the ratios were 
calculated. The largest measurement in the wound was equated with the largest measurement 
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in the control samples. An average of the ten measurements per wound was determined and 
plotted against time. The approach was summarised as: 
 
Step 1: 10 measurements from inside wound and ranked from largest to smallest. 
Step 2: 10 measurements from adjacent skin considered “normal” and ranked from largest to 
smallest. 
Step 3: Ratio determined by the equation: 
 
Epidermal Thickness Ratio (ETR) = 
 
Wound Skin Thickness (μm) 
  
Adjacent Normal Skin Thickness (μm) 
 
Corresponding ranked measurements where used at this point to determine the ratio, i.e. rank number 
1 of the wounded skin thickness and rank number 1 of adjacent normal skin thickness. 
 Step 4: Average epidermal thickness ratio was calculated for each wound. 
Step 5: Calculated epidermal ratio was used as the final descriptive parameter for each wound. 
 
The results were reported as the epidermal thickness (ET) of the epidermis and the calculated 
epidermal thickness ratio (ETR).  
 
2.3.8 Full Thickness Wound Morphometric Analysis 
Full thickness wounds were analysed using the measurements illustrated in Figure 2.4 below. 
Measurements include; 1) Epidermal Tongue Length, 2) Inter-Epidermal deficit as a proxy of 
wound epithelialisation and 3) Mid-Dermal Deficit. Full thickness wounds were analysed on 
days 8 and 16 post-operative and results plotted against time (days post-operative). 
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Figure 2.4. Representative full thickness wound with the measurements labelled. Black 
arrows indicate the epidermal tongues that migrate into the wounded area. Inter-epidermal 
deficit was used as an indication of whether or not the wounds were epithelialized. (Original 
H & E image at 100x magnification) 
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2.3.9 Collagen Analysis 
Picrosirius Red (PSR) Staining Procedure 
To determine the effect of the treatments on collagen infiltration, a Picrosirius red (PSR) stain 
was employed to stain for collagen in an in-situ form of analysis. Prepared histological sections 
were immersed in 500 ml of saturated picric acid containing 0.5 g of Sirius or Direct red dye 
(SIGMA, St Louis, Mo) for an hour. Sections were then washed in 2 changes of 1% glacial 
acetic acid for 10 minutes at each interval. After the 2 washes in 1% glacial acetic acid 
(AnalaR, BDH; UK) the sections were dehydrated through a graded series of alcohols, 
infiltrated with Xylene and mounted using Entellen (SIGMA). 
PSR Section Imaging and Image Analysis 
The prepared sections were imaged on an Olympus IX71 fluorescence microscope fitted with 
the appropriate filters. The images were processed using the analysis LifeScience® software 
package in the Oncology Research Laboratory, Department of Internal Medicine. A composite 
red-green-blue image was produced by capturing the images using red, green and blue filters 
fitted to the microscope. The deep partial thickness wounds were imaged at 20x magnification 
to incorporate the epidermis and underlying granulation tissue. The regions of interest (ROI’s) 
were created as 200 pixels wide and 300 pixels high immediately below the epidermis (Figure 
2.5). This measure was repeated three times across the entire length of the captured image. 
The ROI’s were analysed as described below. The full thickness wounds were imaged in the 
middle of the wound site midway of the dermis. The entire image was considered as the region 
of interest and was analysed as described below. 
The image analysis performed was based on the method of McMullen, et al. (121). Briefly, the 
image was analysed on the grey scale luminosity and the resulting image histogram. The 
image histogram quantifies the number of pixels per shade of 256 shades of grey. Each shade 
was referred to as a “bin” and from the image histogram the number of pixels per bin (shade 
of grey) was determined. In this case the images were desaturated using the GIMP software 
package (version 2.6.8). Following desaturation, each image was saved as a high quality 
JPEG and re-opened in IMAGE J (version 1.4.3.67) and the histogram generated. The pixel 
count for each bin was calculated by the software and the copied into Microsoft’s Office 2013 
EXCEL package.  
The specimens that were analysed included control sections that were used to optimise the 
analysis of the histogram pixel distributions. Due to the nature of the histogram distributions 
being skewed the 1st, 2nd, and 3rd quartiles were calculated for each of the control sections. 
The positions of each of the quartiles within the series of 256 bins were determined and this 
served as the parameters around which the experimental sections could be analysed. From 
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the control section distributions, the average bin position for each of the quartiles provided a 
gate within which the total sum of the pixels was calculated. The following gates were used 
and further referred to as; Area 1 = Bin 0 – 1st Quartile Bin position, Area 2 = 1st Quartile Bin 
position – 2nd Quartile Bin position, Area 3 = 2nd Quartile Bin position – 3rd Quartile Bin position, 
Area 4 = 3rd Quartile Bin position – Bin 256.  
From the control sections it was seen that the majority of the mature collagen occurred in Area 
4. In the deep partial thickness wounds 81% and 72% of pixels occurred in the deep partial 
thickness and full thickness control sections respectively. As the majority of the pixels occurred 
in Area 4, only this area was considered for statistical analysis. A ratio was calculated for the 
experimental sections by taking the pixel count in area 4 of the experimental sections over the 
pixel count of area 4 of the control sections (as is seen in the equation below). The resultant 
collagen infiltrations were plotted against time (days post-operative). 
  
Collagen Content = 
Experimental Area 4 Pixel Count
Control Area 4 Pixel Count
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Figure 2.5. Picrosirius red analysis algorithm. The image A, represents the original PSR 
stained section imaged under fluorescence light as described above. Image B represents the 
desaturated image that is generated for further analysis. The yellow areas represent the 
ROI’s that were considered for the analysis. The pixel distributions for each ROI were 
averaged and the gating system applied to describe the distributions. 
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2.3.10 Safety Analysis of Liver Hepato-toxicity 
Jugular venous blood was collected on the sample collection days for liver function tests in 
8.5ml yellow top SST gel tubes (BD Biosciences) and sent to Contract Lab Services (CLS) at 
the National Institute for Occupational Health (NIOH), Braamfontein for analysis. In addition to 
the experimental pigs that were exposed to the Senecio based therapy, blood was taken for 
comparison purposes from 3 other pigs involved in another similar study with the same wound 
model. These pigs were exposed to the same anaesthetic agents, wounding mechanism, diet 
and sample collection days.  
A month post completion of the experiments, seven of the animals were euthanized and liver 
biopsies were taken from 2 lobes of the liver and placed in 10% buffered formalin. The samples 
were sent to Golden Vet Pathologists (Onderstepoort, Pretoria) for analysis of acute and 
chronic pyrrolizidine alkaloid poisoning.  
 
2.3.11 Statistical Analysis 
Statistical significance was determined using Statistica (Version 9). Analysis between the 
treatment groups was determined using the Kruskal-Wallis test, coupled with a post-hoc 
analysis. Significance was accepted at p < 0.05. 
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2.4 Results 
 
2.4.1 Deep Partial Thickness Wound pH 
Measured wound surface pH over the course of the experiment can be seen in Figure 2.6, 
with the corresponding data and statistical analysis was tabulated in Table 2.1. The pH of 
fresh wounds at day 0 post-operative, increased from between 7.93 and 7.97, then spiked to 
around 8.02 for the Senecio treated wounds, 8.37 for the activated carbon wound group (p = 
0.001 compared to the plant treated group), and 8.41 for the negative control treated group (p 
= 0.013 compared to the plant treated group) on day 2 post-operatively. 
From day 2 post-operatively, the pH in all treatment groups decreased to reach a similar end 
point by day 16 post-operatively. Additionally, throughout the observational period, the rates 
of decline differed. Day 5 post-operative marked a point where the initial rapid decrease 
changed to a more gradual decrease in all treatment groups. Thereafter, the rate of decline in 
pH reduced further and from day 12 post-operative onwards stabilised in the Senecio treated 
wounds. In contrast, the pH of the other two treatment groups continued to decline, without 
statistically significant differences compared to the Senecio treated wounds. 
 
Table 2.1. Wound pH at specific post-operative days. Data are presented as mean ± SEM 
(n). Underlined p – values are significant at p < 0.05. 
 
 
Days Post-
operative 
Negative Control 
Activated 
Carbon 
Senecio 
Group 
wise p - 
value 
Senecio vs. 
Negative 
Control p - 
value 
Senecio vs. 
Activated 
Carbon p - 
value 
Negative Control 
vs. Activated 
Carbon p - value 
0 7.93 ± 0.07 (12) 7.97 ± 0.08 (12) 7.95 ± 0.08 (12) 0.928 0.596 0.259 0.895 
2 8.39 ± 0.05 (11) 8.47 ± 0.04 (11) 8.02 ± 0.09 (9) 0.001 0.001 0.013 0.658 
5 7.17 ± 0.08 (10) 7.29 ± 0.12 (10) 7.02 ± 0.06 (11) 0.107 0.480 0.064 0.724 
7 6.62 ± 0.14 (6) 6.82 ± 0.16 (6) 6.87 ± 0.13 (8) 0.470 0.220 0.358 0.897 
8 6.70 ± 0.08 (9) 6.75 ± 0.08 (6) 6.73 ± 0.09 (9) 0.932 0.665 0.508 0.149 
9 6.67 ± 0.09 (7) 6.43 ± 0.09 (6) 6.56 ± 0.08 (7) 0.165 0.418 0.284 0.156 
12 6.23 ± 0.12 (9) 6.24 ± 0.12 (7) 6.22 ± 0.12 (9) 0.996 0.962 0.916 0.563 
16 5.75 ± 0.16 (6) 5.83 ± 0.14 (6) 6.20 ± 0.20 (6) 0.138 0.284 0.452 0.949 
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Figure 2.6. Wound pH plotted against time (Days post-operative). Error bars represent the SEM.
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2.4.2 Deep Partial Thickness Wound Gross and Histological Analysis  
Sequential photographs of the deep partial thickness wounds recorded the overall wound 
healing pattern. On day 2 post-operatively, all wounds appeared the same, with the fresh 
wound beds easily seen after the residual Senecio material and activated carbon was removed 
(Figure 2.7 - A, B and C). No epidermis was observed on histology in any of the treatment 
groups (Figure 2.7 - D, E and F). There also appear to be no differences between treatments 
as to whether debriding the residual material from the wound bed had affected the wounds.  
At day 5 post-operatively, histological sections demonstrated a newly formed epidermis in all 
three treatment groups which appeared similar in thickness (Figure 2.8 - D, E and F) and at 
this point the wounds were regarded as being ‘re-epithelialised’. At day 7 post-operative, the 
epidermis in the Senecio treated wounds appeared thicker when compared to the controls 
(Figure 2.9 - D, E and F). On debriding, the integrity of the newly formed epidermis in the 
Senecio group and in the activated carbon treated wounds differed. The epidermis in the 
Senecio group appeared to be more resilient to debriding and less prone to rupture compared 
to the activated carbon treated wound where the epidermis was easily ruptured with 
associated haemorrhaging. 
Figure 2.10, Figure 2.11 and Figure 2.12 were representive of the remainder of the 
observational days. The epidermis is seen to become thinner from days 7/9 post-operative 
where a similar thickness is seen in all three treatment groups at day 16 post-operative 
(Figures 2.9 to Figure 2.11 - D, E and F). 
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Figure 2.7. Wounds viewed on day 2 post-operative with the negative control (A), activated carbon (B), and Senecio (C). Corresponding 
histological sections are represented in D, E, and F being negative control (D), activated carbon (E), and Senecio (F). In the gross pictures (A, 
B and C) the initial wound edges are still evident with minimal contraction noted. The black arrows indicate the remaining dermis 2 days after 
the wounds were created. Histological sections were imaged at 100x magnification. 
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Figure 2.8. Wounds viewed on day 5 post-operative with the negative control (A), activated carbon (B), and Senecio (C). Corresponding 
histological sections are seen in D, E, and F being negative control (D), activated carbon (E), and Senecio (F). In the gross images (A, B and C) 
a prominent epithelial layer is present in the Senecio treated wounds, which was not evident in the control. In the histological sections, the 
arrows that are not filled indicate the regenerating epidermis, which was not evident in the corresponding gross images of the control wounds. 
The solid arrows indicate the granulation tissue deep to the epidermis. Histological sections were imaged at 100x magnification. 
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Figure 2.9. Wounds viewed on day 7 post-operative with the negative control (A), activated carbon (B), and Senecio (C). Corresponding 
histological sections are seen in D, E, and F being negative control (D), activated carbon (E), and Senecio (F). In the gross images (A, B and C) 
a prominent eschar was seen in the control wounds (A and B) but was not seen in the Senecio treated wounds. In the histological sections, the 
arrows that are not filled indicate the regenerating epidermis, which was thicker in the Senecio treated wounds. The solid arrows indicate the 
granulation tissue deep to the epidermis. Histological sections were imaged at 100x magnification. 
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Figure 2.10. Wounds viewed on day 9 post-operative with the negative control (A), activated carbon (B), and Senecio (C). Corresponding 
histological sections are seen in D, E, and F being negative control (D), activated carbon (E), and Senecio (F). In the gross images (A, B and C) 
the Senecio treated wounds have a more prominent epithelial layer but the control also has a more established epithelial layer. In the 
histological sections, the arrows that are not filled indicate the regenerating epidermis, which was thicker in the control treated wounds. The 
solid arrows indicate the granulation tissue deep to the epidermis. Histological sections were imaged at 100x magnification. 
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Figure 2.11. Wounds viewed on day 12 post-operative with the negative control (A), activated carbon (B), and Senecio (C). Corresponding 
histological sections are seen in D, E, and F being negative control (D), activated carbon (E), and Senecio (F). In the gross images (A, B and C) 
the eschar on the control treated wounds is still evident but is absent in the Senecio treated wounds. In the histological sections, the arrows that 
are not filled indicate the regenerating epidermis, which was equal in all treatment groups. The solid arrows indicate the granulation tissue deep 
to the epidermis. Histological sections were imaged at 100x magnification. 
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Figure 2.12. Wounds viewed on day 16 post-operative with the negative control (A), activated carbon (B), and Senecio (C). Corresponding 
histological sections are seen in D, E, and F being negative control (D), activated carbon (E), and Senecio (F). In the gross images (A, B and C) 
minimal eschar is present in all treatment groups. The original wound area is no longer present in the Senecio treated wounds but can still be 
seen in the controls. In the histological sections, the arrows that are not filled indicate the regenerating epidermis, which was equal in all 
treatment groups. The presence of desquamating keratinised epidermal layers is evident in all treatment groups. The solid arrows indicate the 
granulation tissue deep to the epidermis. Histological sections were imaged at 100x magnification. 
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2.4.3 Morphometric Analysis 
 
Deep Partial Thickness Wound Morphometric Analysis 
 
Epidermal Thickness 
Significant differences in the thickness of the epidermis was seen at all days except at day 16 
(Table 2.2). Compared to the negative control, the Senecio treated group had a significantly 
thicker epidermis at days 5 (p = 0.0001), 7 (p = 0.0002) and 9 (p = 0.031) but not at days 12 
(p = 0.121) and 16 (p = 0.623). When comparing the Senecio treated group to the activated 
carbon treated group there was a significantly thicker epidermis in the Senecio group at days 
5 (p = 0.017) and 7 (p = 0.002) but not at days 9 (p = 0.231), 12 (p = 0.241) and 16 (p = 0.212). 
The comparison between the vehicle and negative control shows that the vehicle had a 
significantly thicker epidermis at days 7 (p = 0.005), 9 (p = 0.009), and 12 (p = 0.011) but not 
at day 5 (p = 0.140) and 16 (p = 0.427). 
These data above are represented graphically (Figure 2.13) and showed a rapid increase in 
the epidermal thickness to a maximum value followed by a progressive decline to similar 
values at day 16. Compared to the other groups, the initial thickness of the Senecio treated 
group was greater, with an earlier maximum thickness at day 7, followed by the decline (Figure 
2.13). The other two treatments followed a similar pattern, with the maximum value later at 
day 9 with for the negative control and vehicle groups.  
 
Epidermal Thickness Ratio 
The epidermal thickness ratio of the Senecio treated group was significantly greater than the 
negative control (opsite only) at post-operative days 7 (p = 0.005) and 12 (p = 0.026) but not 
at other times (Table 2.3). The ratio of Senecio treated group was also significantly greater 
than the vehicle treated group (actvated carbon) at post-operative days 5 (p = 0.0002) and 7 
(p = 0.004). Finally, compared to the vehicle, the negative control had a statistically 
significantly greater ratio at post-operative days 5 (p = 0.004), 9 (p = 0.009), whereas the ratio 
of the vehicle was only greater than the negative control at day 12 (p = 0.010). The graphical 
representation (Figure 2.14) of the ratio follows a similar pattern as before with the peak in the 
Senecio being 2 days before that of the controls.
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Table 2.2. Epidermal thickness measurements (μm) at specific post-operative days. Data are presented as mean ± SEM (n). Underlined p – 
values are significant. 
 
Days Post-
operative Negative Control Activated Carbon Senecio 
Group wise 
p - value 
Senecio vs. 
Negative Control 
p - value 
Senecio vs. 
Activated Carbon p 
- value 
Negative Control 
vs. Activated 
Carbon p - value 
5 122.30 ± 2.30 (10) 125.74 ± 19.20 (10) 186.51 ± 9.81 (10) 0.001 0.000 0.017 0.141 
7 116.14 ± 10.34 (10) 161.51 ± 13.54 (10) 263.30 ± 21.20 (10) 0.000 0.000 0.002 0.005 
9 148.27 ± 14.58 (10) 247.76 ± 21.70 (10) 217.98 ± 20.83 (10) 0.012 0.031 0.241 0.009 
12 116.59 ± 8.28 (10) 153.75 ± 10.38 (10) 137.68 ± 8.48 (10) 0.028 0.121 0.241 0.011 
16 134.35 ± 9.00 (10) 147.99 ± 12.40 (10) 124.55 ± 3.95 (10) 0.412 0.623 0.212 0.427 
 
Table 2.3. Epidermal thickness ratio at specific post-operative days. Data are presented as mean ± SEM (n). Underlined p – values are 
significant. 
 
Days Post-
operative Negative Control Activated Carbon Senecio 
Group 
wise p - 
value 
Senecio vs. 
Negative Control 
p - value 
Senecio vs. 
Activated Carbon p 
- value 
Negative Control 
vs. Activated 
Carbon p - value 
5 2.32 ± 0.15 (10) 1.80 ± 0.09 (10) 2.39 ± 0.07 (10) 0.000 0.325 0.000 0.005 
7 2.02 ± 0.21 (10) 2.15 ± 0.15 (10) 3.54 ± 0.43 (10) 0.003 0.005 0.004 0.791 
9 2.79 ± 0.26 (10) 3.21 ± 0.18 (10) 3.04 ± 0.25 (10) 0.328 0.121 0.650 0.473 
12 1.70 ± 0.14 (10) 2.24 ± 0.08 (10) 2.36 ± 0.19 (10) 0.013 0.026 0.521 0.007 
16 2.03 ± 0.14 (10) 2.33 ± 0.12 (10) 2.29 ± 0.11 (10) 0.157 0.141 0.880 0.082 
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Figure 2.13. The mean epidermal thickness (μm) of the deep partial thickness wounds plotted against time (Days Post-operative). Error bars 
represent the SEM.  
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Figure 2.14. Epidermal thickness ratio (mean) of the deep partial thickness wounds plotted against time (Days Post-operative). Error bars 
represent the SEM. 
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Full Thickness Wound Morphometric Analysis 
By day 8 post-operatively, 44% of the Senecio treated wounds had closed compared to the 
activated carbon treated wounds where only 33% of the wounds had closed. In the negative 
control treated wounds, 100% of wounds had closed by day 8 post-operatively. By day 16 all 
the wounds in all 3 treatment groups had closed.  
The average tongue length at day 8 post-operative was not significantly different between the 
Senecio and activated carbon treatment groups (p = 0.566). No other comparisons could be 
drawn between the negative control group treated wounds and the other two treatment groups. 
By day 16 post-operative all the wounds had closed and it was not possible to measure the 
tongue lengths. 
The mid-dermal deficit at day 8 and day 16 post-operative was not significantly different 
between any of the treatment groups.  
The data represented graphically (Figure 2.15) shows a steep decline in the mid-dermal deficit 
in all treatment groups from day 0 to day 8 post-operatively. From day 8 to day 16 post-
operative the decline is not as marked, however the decline in the Senecio treated wounds 
was greater compared to the negative control and activated carbon treated wound groups.  
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Table 2.4. Full thickness wound morphological analysis at specific post-operative days. Data are presented as mean ± SEM (n). Underlined p – 
values are significant. 
Treatment 
Days Post-
Operative 
Percentage Wounds Closed (%) 
   
Negative Control 8 100    
Activated Carbon 8 33    
Senecio 8 44    
Negative Control 16 100    
Activated Carbon 16 100    
Senecio 16 100    
      
Treatment 
Days Post-
Operative 
Average Tongue Length 
Group wise p 
- value 
Post-hoc Analysis 
Negative Control 8 Wound Closed 
0.054 
Senecio vs. Negative Control NA 
Activated Carbon 8 741.88 ± 190.38 (9) Senecio vs. Activated Carbon 0.566 
Senecio 8 558.39 ± 231.37 (9) Negative Control vs. Activated Carbon NA 
Negative Control 16 Wound Closed       
Activated Carbon 16 Wound Closed NA     
Senecio 16 Wound Closed       
      
Treatment 
Days Post-
Operative 
Mid-Dermal Deficit 
Group wise p 
- value 
Post-hoc Analysis 
Negative Control 8 2159.33 ± 116.29 (9) 
0.759 
Senecio vs. Negative Control 0.810 
Activated Carbon 8 2237.08 ± 82.68 (9) Senecio vs. Activated Carbon 0.885 
Senecio 8 2214.19 ± 435.51 (8) Negative Control vs. Activated Carbon 0.427 
Negative Control 16 1936.26 ± 256.02 (6) 
0.365 
Senecio vs. Negative Control 0.575 
Activated Carbon 16 2251.18 ± 254.77 (6) Senecio vs. Activated Carbon 0.230 
Senecio 16 1726.27 ± 193.49 (6) Negative Control vs. Activated Carbon 0.379 
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Figure 2.15. Mid-dermal deficit plotted against time (Days Post-operative). Error bars represent the SEM.
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2.4.4 Collagen Analysis 
Deep Partial Thickness Wound Collagen Analysis 
Representative Picrosirius red stained sections of collagen deposition can be seen in Figure 
2.16. For the analysis purposes, desaturated images that were generated have been shown 
immediately below each of the original stained sections. More mature collagen appears 
brighter in the desaturated images. This however is minimal at day 8 post-operative in all 3 
treatment groups (Figure 2.16 - B, D, and F).  At day 16, brighter collagen fibres can be seen 
in the Senecio and negative control treated wounds (Figure 2.16 - H and L) when compared 
to the activated carbon treated group (Figure 2.16 - J). The collagen fibres in the Senecio and 
negative control treated groups differ with the Senecio treated wounds showing a finer 
distribution of collagen fibres when compared to the negative control where fibres are 
generally thicker.  
 
Table 2.5. Collagen content of the deep partial thickness wounds at specific post-operative 
days. Data are presented as mean ± SEM (n). Underlined p – values are significant at p < 
0.05. 
 
Days Post-
operative Negative Control Activated Carbon Senecio 
Group 
wise p - 
value 
Senecio 
vs. 
Negative 
Control p - 
value 
Senecio 
vs. 
Activated 
Carbon p - 
value 
Negative 
Control vs. 
Activated 
Carbon p - 
value 
8 35.95 ± 2.42 (10) 67.60 ± 3.12 (10) 52.59 ± 2.78 (10) 0.001 0.002 0.003 0.045 
16 79.82 ± 4.88 (10) 59.43 ± 8.88 (10) 77.99 ± 8.04 (10) 0.129 0.970 0.090 0.089 
 
The analysis of the collagen content immediately deep to the epidermis of the DPT wounds 
(Table 2.5) shows a significant difference at day 8 only (p = 0.001). The Senecio and negative 
control treated groups, had a significantly lower collagen content compared to the activated 
carbon treated group (p = 0.003 and 0.045 respectively). The Senecio group had a significantly 
greater collagen content than the negative control treated group (p = 0.002). At day 16 there 
was no significant differences between any of the groups (p = 0.129).    
The data represented graphically (Figure 2.17) shows that from wounding at day 0 to day 8 
post-operatively, there is an increase in collagen content in all treatment groups. From day 8 
to 16 there is a continued increase in the Senecio and negative control groups. The activated 
carbon treated wounds show a change in trend with a subsequent decrease in the collagen 
content from day 8 to day 16 post-operatively.  
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Figure 2.16. Deep partial thickness wounds post Picrosirius red staining. Images are shown 
as the original colour image with the later desaturation process shown immediately below as 
described in the materials and methods section. Senecio treated wounds are seen by A and 
B (Day 8) and G and H (day 16). The activated carbon treated wounds are seen in images C 
and D (day 8) and I and J (day 16). The negative control treated wounds are seen in images 
E and F (day 8) and K and L (day 16). At day 8 post-operative the collagen content in the 
Senecio and negative control treated wounds is less than that of the activated carbon treated 
wounds which is seen in the luminosity of the granulation tissue. From day 8 to day 16 post-
operative it can be seen that collagen fibres are being laid down at an equal rate in all 
treatment groups. 
 
 
  
 
 
58 
 
 
Figure 2.17. Collagen content of the deep partial thickness wounds plotted against time (Days Post-operative). Error bars represent the SEM. 
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Full Thickness Wound Collagen Analysis 
 
 
 
Figure 2.18. Full thickness wounds seen as the entire section above with the corresponding 
area analysed for collagen deposition below. The wound areas or dermal deficits are 
outlined in green in each of the sections. The same desaturation process and analysis was 
followed as described in the text before. The original stained images are not shown. Senecio 
treated wounds are seen by A and B (Day 8) and G and H (day 16). The activated carbon 
treated wounds are seen in images C and D (day 8) and I and J (day 16).  The negative 
control treated wounds are seen in images E and F (day 8) and K and L (day 16). No 
difference in collagen content can be seen in any of the treatment groups at any of the 
observational days. 
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Table 2.6. Full thickness wound collagen analysis at specific post-operative days. Data are 
presented as mean ± SEM (n). Underlined p – values are significant. 
 
Days Post-
operative Negative Control Activated Carbon Senecio 
Group 
wise p - 
value 
Senecio 
vs. 
Negative 
Control p - 
value 
Senecio 
vs. 
Activated 
Carbon p - 
value 
Negative 
Control vs. 
Activated 
Carbon p - 
value 
8 85.48 ± 4.96 (7) 73.58 ± 9.00 (6) 77.44 ± 11.85 (7) 0.639 0.617 0.898 0.353 
16 88.46 ± 6.01 (6) 96.17 ± 10.37 (6) 89.52 ± 6.08 (6) 0.796 0.936 0.575 0.689 
 
 
Desaturated images show brighter collagen fibres in the Senecio (Figure 2.18 - B) and 
negative control (Figure 2.18 - F) treated wound groups at day 8 post-operative compared to 
the activated carbon treated wounds (Figure 2.18 - D). At day 16, brighter collagen fibres can 
be seen in the Senecio and negative control treated wounds (Figure 2.18 – H and L) when 
compared to the activated carbon treated group (Figure 2.18 - J).  
There was no significant difference in collagen content on day 8 and 16 post-operative (Table 
2.6) with p = 0.639 and 0.796 respectively. Graphical representation of the data (Figure 2.19) 
shows a marked increase from day 0 to 8 after which the rise in the collagen content of all 3 
treatment groups decreases.  
   
 
 
 
 
61 
 
 
Figure 2.19. Full thickness wound collagen content plotted against time (Days Post-operative). Error bars represent the SEM.
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2.4.5 Safety and Toxicity 
With regards to the toxicity studies, LFTs were raised in all pigs with the majority of the 
elevations seen in the alanine aminotransferase (ALT) enzymes. There was no difference 
between the elevations seen in the pigs exposed to the plant and those that were not. 
Additionally, the liver samples that were sent to Golden Vet Pathologists for analysis, showed 
no signs of acute or chronic pyrrolizidine alkaloid poisoning. 
 
Table 2.7. Screen for potential pyrrolizidine alkaloid toxicity.  
 
Pig Identification Raised LFT's 
Acute Pyrrolizidine 
Alkaloid Poisoning 
Chronic Pyrrolizidine 
Alkaloid Poisoning 
Experimental Pig 1 + - - 
Experimental Pig 2 + - - 
Experimental Pig 3 + - - 
Experimental Pig 4 + - - 
Experimental Pig 5 + - - 
Experimental Pig 6 + - - 
Experimental Pig 7 + - - 
    
Control Pig 1 + NA NA 
Control Pig 2 + NA NA 
Control Pig 3 + NA 
NA 
 
LFT – liver function tests from jugular venous blood. Normal range as dictated by the Merck 
Veterinary guidelines, Reference Serum Biochemical Markers, Table 7 
(http://www.merckvetmanual.com/mvm/htm/bc/tref7.htm). 
 
 
 
 
63 
 
 2.5 Discussion 
The majority of poisonings associated with the Senecio genus was due to consumption of the 
plants by livestock and humans in the various preparations (114). Despite the known toxicity, 
whether topical administration of the plant material causes toxicity has not been determined. This 
study evaluated the wound healing efficacy, morphological aspects of the healing process and 
carried out preliminary investigation of potential toxic effects of topically applied Senecio 
serratuloides. 
  
2.5.1 Experimental Wound Model 
To evaluate traditional wound healing remedies an appropriate animal model was required. Many 
studies have used readily available, easy to handle, affordable and versatile rodent models. 
Wounds created on rodents have been full thickness incisional or excisional wounds. Inert porous 
substrates (dead space models) can be embedded within these wounds to absorb fluids for 
determining important biochemical molecules within the wound space that may affect the healing 
process (Table 1.1 of Chapter 1). However, rodent skin has been regarded as a poor proxy for 
human skin as the panniculus carnosus contracts and closes the wounds rapidly, which does not 
allow the re-epithelialisation of the wound to be monitored (122).  
In contrast, pig skin is similar to human skin (13) and a porcine model has previously been 
established in the Central Animal Unit at the University of the Witwatersrand (9, 10).  Furthermore, 
according to Van Wyk, et al. (112) and Hutchings (111), the indications for the use of Senecio are 
abrasions and burns which are partial thickness wounds and therefore rodent models which can 
mostly accommodate full thickness wounds would not be appropriate. Furthermore for deep 
partial thickness wounds, rodent skin is not appplicable. Therefore a porcine deep partial 
thickness wound model was initially selected for these experiments. 
Due to the erratic nature of wounds that can present it was important to include a full thickness 
wound model in this investigation. Full thickness wound models allow for the rate of wound 
contraction to be assessed from morphometric analysis of histological sections of the wound. The 
extent and rate of epithelialisation, dermal remodelling, fibroblast proliferation, inflammatory 
infiltrates, neovascularisation and collagen deposition can additionally be determined (Table 1.1 
of Chapter 1). However, many such measures are often reported on subjective scoring scales. 
This has additional implications and is discussed further below. 
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2.5.2 Wound pH 
With other investigations into the use of plant based therapies for wound healing ‘broad’ variables 
can be used whose outcome depicts multiple processes that are ongoing within the wound. As a 
commonly encountered example of a “broad” variable the measurement of wound tensile strength 
is seen in many of the studies listed in Table 1.1. Tensile strength has been measured in 
determining the effects of Hypericum patulum (29), Achillea biebersteinii Afan. (68), and in herbal 
formulations containing extracts of Terminalia arjuna (69). As previously stated in Chapter 1, the 
strength of a wound in the initial period is not nearly that of a wound that has remodelled over 
months or even when compared to normal uninjured skin. What is seen is that other factors in the 
wound environment such as the epithelial layers add to the tensile strength (123). With deep 
partial thickness wound models, measuring the tensile strength variable would not be suitable as 
a certain amount of the uninjured dermis could potentially interfere with overall results. Measuring 
tensile strength of a wound is therefore suited mostly to full thickness wounds.  
In this case the alternative broad variable chosen was the pH of the wounds. Intact skin produces 
and maintains an acidic environment and is important for the barrier function ascribed to skin 
(124). What is also known is that a gradient exists from the neutral deeper skin layers to the more 
acidic mantle of the stratum corneum but the mechanism by which the epidermis is acidified is 
currently hypothetical (125). What is seen is that for the skin to produce a normal pH it needs to 
be intact and so makes an excellent “broad” variable to describe the overall integrity of the newly 
formed skin and specific to this investigation where deep partial thickness wounds were assessed. 
From the investigations seen here, the pH on day 2 post-operative was lower for the Senecio 
treated wounds after which no other differences were detected statistically. The pH decreased at 
a similar rate in all treatment groups with a change in the rate around day 5 post-operative. This 
change could be associated with development of the newly formed epidermis which was 
documented histologically here. With the presence of the newly formed epidermis, a modulatory 
effect on the pH may be developing. Moreover, at day 5 post-operative, the pH would reflect the 
state of the newly formed epidermis and not the state of the acute wound environment. On this 
premise there appears to be no difference from a functional perspective in that all rates of pH 
changes for the treatment groups were similar. But from a wound environment perspective, 
metabolic activity could be affected due to the differing pH in the Senecio treated wounds group 
on day 2 post-operatively where no epidermis is present.  
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2.5.3 Deep Partial Thickness Wound Morphometric Analysis 
Histological analyses of the wounds is mostly employed which includes the variables 
epithelialisation, dermal remodelling, fibroblast proliferation, inflammatory infiltrates, 
neovascularisation and collagen deposition. These variables are mostly assessed in full thickness 
wound models and an additional drawback of this approach is that in many instances these results 
were based on subjective scoring systems. In this investigation it was important to develop an 
objective parameter that could be easily reproducible with minimal intra and inter observer error. 
The major variable for assessment identified here was the epidermal thickness. Quantification of 
the thickness of the epidermis may identify a variable that could be used for in-vitro assays at a 
later stage.  
Previous studies measuring epidermal thickness examined only the actual epidermal thickness 
at one time point only (126, 127) and without expressing the thickness as a ratio relative to normal 
skin. Here the epidermal thickness was monitored over an extended period where it was apparent 
that the epidermis thickens substantially for a certain period of time after which it thins to resemble 
the thickness of normal skin. The process by which the epidermis thickens in these investigations 
is unknown at this point but multiple processes may be at play namely, epidermal proliferation, 
epidermal hypertrophy or migration from outer uninjured skin.  
With the documentation of the increase and subsequent decrease in epidermal thickness, there 
is no indication as to whether the skin is actually normal from a thickness perspective at the end 
of the observational period. In this event the use of an epidermal thickness ratio would indicate at 
which point the newly formed skin’s thickness is indeed that of un-injured skin. The premise can 
therefore be made that when the epidermal thickness ratio reaches 1, it may serve as an end-
point at which epidermal layers have completed a process of thickening and then subsequent 
thickening. 
The skin thickness and thickness ratio increased and then decreased and we postulate that the 
ratio followed sequential phases of proliferation/hypertrophy/migration followed by maturation. 
The peak in the epidermal ratio for the Senecio treated wounds was 2 days earlier than that of 
the other treatment groups with all 3 three treatment groups having a similar epidermal ratio on 
day 16. This may suggest that the Senecio plant accelerated the proliferation/hypertrophy/ 
migration of the epidermal layer which was then followed by an earlier maturation phase. 
However, the epidermal thickness and epidermal thickness ratio measurements are limited when 
determining treatment efficacy as they do not describe the functional state of the epidermis and 
therefore further analysis may be required to fully evaluate efficacy.  
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2.5.4 Full Thickness Wound Morphometric Analysis 
In previous studies the rate of contraction was measured macroscopically by visualizing the 
wound area and determining the change in the size of the wound over successive days. In this 
study, histological sections were examined and the change in mid-dermal deficit represented the 
contraction of the wound. The change in the dermal deficit size in this case is a product of the 
contraction due to myofibroblasts but this only accounts for roughly 40% of the decrease in wound 
size (63, 64), therefore the collagen content is responsible for the rest of the dermal regeneration.  
With the collagen content being a major component of wound contraction it is also vital for the 
migration of keratinocytes into wounds. In the case of the activated carbon treated wounds, the 
epidermis was seen to be delicate during debriding on sample collection days which may be 
accounted for by the lower collagen concentrations even though they were not significant. This 
point was also noted by Abercrombie, et al. (128).   
 
2.5.5 Collagen Deposition 
Investigations into collagen deposition in the wound are an important variables in the healing 
wound. Assessment of the collagen deposition is commonly achieved by tensiometry experiments 
or biochemical colorimetric assays to determine the concentration of hydroxyproline, a surrogate 
marker of collagen turnover (102). Tensile strength was shown to correlate with collagen content 
of wounds and became an early measured variable in wound healing investigations (129). It has 
also been measured in multiple studies regarding plant based therapies as was listed above. 
Colorimetric estimation of collagen has been used in studies on Catharanthus roseus (130), 
Calotropis procera (131), Terminalia chebula (132), and Mimosa pudica (133).  
A qualitative technique that has shown to be particularly useful is the Picrosirius red staining 
method of histological sections. Although, the highly specific Picrosirius red stain for thin and thick 
collagen fibres has an advantage over other more commonly used modalities but the use of this 
technique is limited to qualitative studies (134). This validated staining technique (135) has been 
used for formalin fixed, paraffin embedded tissue samples (136) and coupled with fluorescence 
microscopy, this approach allows for greater image resolution (137).  More commonly, polarised 
light has been used to view and image collagen subtypes (134). However in this case the 
fluorescent imaging allowed for the best resolution. It is therefore proposed that the image can be 
subjected to image analysis techniques to quantify the collagen content.   
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In this Chapter, an algorithm was developed to analyse and quantify collagen deposition in deep 
partial thickness and full thickness wounds. With the image analysis approach here, the change 
in luminosity from darker to lighter distributions is expected as more collagen is deposited within 
the wound. Additionally with the shift in luminosity it was clear that with the gating system 
proposed here, direct quantification of the more mature collagen could be performed and 
ultimately compared between treatment groups.  
In the deep partial thickness wounds at day 8 post-operative, using this technique, the Senecio 
group had more collagen than the negative control treated wounds but not as much as the 
activated carbon treatment wounds. Subsequently, the collagen content in the Senecio and 
negative control treated wounds continue to increase, whereas the activated carbon treated 
wounds decreased, and at the end of experiment the groups were similar. 
Importantly the described technique may allow quantification of collagen directly as compared to 
colorimetric techniques. The limitation of collagen colorimetric assays was (138) the requirement 
for accurate collection of wound samples, free of unwounded skin collagen which would be difficult 
to obtain. Furthermore, the method was based on the measurement of hydroxyproline which is 
not incorporated directly into the newly formed collagen but is rather a by-product of the synthetic 
process and its measurement may be more suited to collagen turnover (138). This technique may 
therefore be more suited to the deep partial thickness wounds as it represents an “in vitro” 
measurement where residual collagen from unwounded tissue could be excluded. 
In the full thickness wound model, a similar pattern was seen with collagen concentrations similar 
in the Senecio and negative control treated wounds, which were not significantly less than the 
activated carbon treated wounds. At day 16 there was a significant difference between the 
activated carbon treated wounds and both the Senecio and negative control treated wounds. 
 
2.5.6 Plant Toxicity 
Toxicity associated with plants within the genus Senecio, and specifically with Senecio 
serratuloides, has been demonstrated by Elgorashi, et al. (118) using the AMES and VITOTOX® 
assays. These assays are based on bacterial cultures that are susceptible to various toxins. 
Importantly the majority of poisonings associated with the Senecio genus are due to consumption 
of the plant and are so subjected to the acids and conditions in the gastrointestinal tract (114). In 
human subjects, and commonly in the paediatric patients, the oral administration of traditional 
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medicines containing species from the Senecio genus leads to hepatic veno-occlusive disease 
(139) and has also been associated with hepatic malignancies (140). This was demonstrated by 
Zuckerman, et al. (141) where traditional preparations containing Senecio latifolius lead to the 
rapid decompensation of a three year old infant. Additionally they isolated pyrrolizidine alkaloids 
from the traditional preparations and their demonstrated their toxic potential in an in-vitro assay.  
At present, little is known about the chemical composition of pyrrolizidine alkaloids and the 
relevant concentrations used in this and other studies. Senecio is classified as poisonous 
according to the South African National Biodiversity Institute (SANBI), with pyrrolizidine alkaloids 
existing as either the hepatotoxic free base form or the less toxic N-oxide form. However when 
the plants are ingested, the N-oxides are converted to the free base form in the gastro-intestinal 
tract resulting in the reported hepatotoxicity (142).  
The topical administration of application may result in direct action of any active substances, 
including toxic compounds directly within the wound site where they may or may not be absorbed 
systemically. In this study, to determine possible toxicity, liver function tests were performed, and 
livers of the test animals were biopsied one month after completion of the experiments. Here no 
toxicity was detected in liver samples sent to accredited pathologists.  
A possibility for the lack of toxicity may be due to observations made by Brauchli, et al. (143), who 
showed that the conversion to the toxic free base format was not as pronounced when 
administered percutaneously and could therefore explain why no toxicity was detected. In this 
model, the extent of the experimental wounds exposed to the potential toxic compounds was less 
than would be seen when ingested or in a clinical wound setting, especially in extensive burn 
injuries. Therefore the toxicity, if any, cannot be completely ruled out. In addition, the lack of 
knowledge with regards to the chemical composition of the plant investigated here is limited and 
more detailed investigations are warranted. 
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2.6 Conclusion  
The results suggest that the Senecio based therapy prepared according to traditional healer’s 
instructions and applied topically: 
a) Decreased the initial wound pH; 
b) Lead to an earlier increase and decrease of the thickness of the epidermis suggesting 
effects on cell proliferation or maturation; 
c) Did not appear to alter collagen content in the wounds; 
d) Preliminary data suggested signs of pyrrolizidine alkaloid toxicity were not present when 
the plant was applied topically. 
Further isolation and identification of the possible active compounds would need to be done in 
order develop the application of the Senecio based therapy and to further validate the safety of 
these preparations. 
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Chapter 3 – Mechanistic Investigation of Senecio serratuloides: Cytokine, Tyrosine 
Phosphorylation and Proliferating Cell Nuclear Antigen Quantification 
 
3.1 Introduction 
The importance of cellular signalling needs to be investigated as a possible mechanism by which 
the plant acts. The basis of this is due to a study by Toma, et al. (144) where extracts of the plant 
Senecio brasilliensis (known to contain pyrrolizidine alkaloids) was used to treat acute and chronic 
gastric ulcers in a shorter time period when compared to proton pump inhibitors and 0,9% saline. 
This mechanim by which this occurred was through the upregulation of epidermal growth factor 
(EGF). With minimal evidence available on the plant in question together with the complexity of 
the wound healing process, this provides a starting point for the investigation into the potential 
mechanism by which the plant acts. 
To further complicate the scenario proposed here, multiple additional factors are known to play 
important roles in wound healing. An extensive review by Werner and Grose, (80) focussed on 
the regulation of wound healing by growth factors and cytokines which have been shown to be 
key regulators in the wound healing process. Even though the effects and applications of these 
factors are well documented with extensive work gone into their application in wound healing, 
their success could be measured based on their routine application in the clinical setting. To date 
only recombinant PDGF (becaplermin, marketed as Regranex by OMJ Pharmaceuticals) has 
been registered with the United States Food and Drug Administration as a biological agent (a 
term used for cytokine/growth factor derived interventions) used for wound healing (145).  
More recent information from a search for wound healing products on the DrugBank website 
(http://www.drugbank.ca) shows that the only other product that has been investigated and 
approved is Oprelvekin (an active ingredient of Neumega, Genetic Institute Inc.), a recombinant 
IL-11 used for intestinal wound healing. With only two products approved for clinical use, it is clear 
that the application of growth factors has not been a success. A link between in-vitro discovery 
and clinical application has been missed, Robson and Mustoe, (146) postulate that this may 
possibly be due to the mode of delivery of these factors and synergistic effects seen between 
various factors. Quite possibly an additional cost related factor or legislation may come into play.   
Another possible reason for the lack of marketable products is the concept of synergism with 
many of the factors (146).  Multiple authors demonstrate this concept as can be seen in the 
application of platelet gels (containing a cocktail of factors namely TGF-α and β, PDGF, EGF, and 
VEGF) (77) or different combinations of growth factors (namely EGF, TGF-α and β, FGF, IGF-1 
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and PDGF) (127) with the observation that the individual components are not as effective 
compared to the combinations. 
It is therefore clear that analysing a couple of factors that are potentially applicable to wound 
healing may not be extensive enough in identifying a mechanism by which a plant based therapy 
may act. In light of this another approach may be to assay a common feature of these factors. 
The available literature describes phosphorylation of the receptor linked tyrosine residues as a 
potential target for analysis.  
 
3.1.2 The Role of Tyrosine Phosphorylation  
In the review by Werner and Grose (80), a significant proportion of factors bind to receptors that 
act via tyrosine residue phosphorylation thereby transmiting their signals down various cascades 
and are therefore known as the receptor linked tyrosine kinase (RLTK) receptors. It has been 
shown that while activation of the RTLK via their ligands does lead to improved wound healing, 
due to the complexity of the process and the known synergistic effects of the ligands, analysing 
single or at most two ligands has the potential to miss possible actions of wound care modalities 
(147). In the present study, it was therefore a logical assumption to focus on a common link 
between most of the ligands and their receptors, this being the phosphorylation of the tyrosine 
residues on the membrane bound receptors as well as the cytoplasmic response messenger 
proteins. Table 3.1 lists the recognised factors with the associated receptor phosphorylation. 
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Table 3.1. Tabulation of the recognised growth factors and associated receptor activity known to 
be beneficial in the wound healing process. 
 
Ligand Receptor Phosphorylation Reference 
Epidermal growth factor 
(EGF) 
Tyrosine 148, 149, 150 
Basic fibroblast growth 
factor (bFGF) 
Tyrosine 151, 152, 153, 154, 155 
Insulin-like growth factor 
(IGF) 
Tyrosine 156, 157 
Keratinocyte growth factor-1 
(KGF-1), platelet derived 
growth factor (PDGF) 
Tyrosine 158, 159, 160 
Transforming growth factor 
(TGF) - α 
Tyrosine 161, 162 
Interleukins 1β, 6, 8, 10, and 
TNF-α 
Tyrosine 95, 163, 164, 165, 166 
 
 
Cell membrane receptors that function through tyrosine phosphorylation contain 20 subfamilies, 
and these subfamilies are based on the ligands that bind to and activate them (167). The 
activation of these receptors is known to control cell survival, proliferation and differentiation, all 
of which are important to wound healing (168). The generic receptor format includes a 
glycosylated extra-cellular ligand binding domain, linked to the intra-cellular domains via a single 
transmembrane helix (169). It is the intracellular domain that contains the tyrosine residues that 
are phosphorylated resulting in the downstream activation of cytoplasmic messenger molecules 
that transduce signals to the cell nucleus, thus influencing gene transcription (170).  
Once the receptor has been activated, further signalling pathways are activated through the 
recruitment of regulatory proteins known as the adaptor and scaffolding proteins. On these 
adaptor and scaffolding proteins various amino acid domains are present that activate the 
respective pathways, importantly the Src homology 2 (SH2) and Phosphotyrosine-binding (PTB) 
domains are known act via tyrosine phosphorylation (171). Pathways that are generally activated 
by receptor tyrosine phosphorylation include the phosphoinositide 3-kinase (PI3k) pathway, the 
extracellular signal-related kinase (ERK) or mitogen-activated protein kinase (MAPK) pathway, 
the phospholipase C-γ (PLC- γ) pathway and the Janus kinase / signal transducer and activator 
 
 
73 
 
of transcription (Jak/STAT) pathway (172). Although these pathways have predominant actions 
via their associated signalling cascades, there exists a significant overlap between many of these 
pathways. This point is highlighted in review articles by Morrison (173) and by Bennasrourne, et 
al. (171). However, the scope and complexity of these pathways is beyond this investigation.  
Thus in this investigation, there is a broad focus on tyrosine phosphorylation without making a 
distinction between any one of the signalling pathways. The addition of an outcome response 
(and in this case, cellular proliferation) is important as it has been proposed that the amount of 
tyrosine phosphorylation does not necessarily correlate with the amount of response (174). 
 
3.1.3 Proliferating Cell Nuclear Antigen 
Proliferating cell nuclear antigen (PCNA) is a protein that is highly conserved from an evolutionary 
perspective and is up-regulated in the G1 and S phases of cellular proliferation and so correlates 
with the proliferative state seen in most eukaryotic cells (175). The information available on PCNA 
within the cutaneous wound healing context is few. Examination of the available literature 
concerning wound healing shows that PCNA is mostly used as a marker of proliferation with little 
consideration for the activity or function of the molecule. 
The importance of PCNA is as an outcome measure of cellular proliferation secondary to tyrosine 
phosphorylation, but a close relationship between these targets is also recognised. The PCNA 
molecule has been shown to be phosphorylated on the 211 tyrosine residue in response to 
activation of EGFR (176) additionally the phosphorylation of this residue is important to maintain 
the function of PCNA in proliferating cells (177) by protecting the PCNA molecule from 
ubiquitylation-mediated degradation but this is only of the chromatin bound moiety and not the 
free form (178). Furthermore proliferating cell nuclear antigen is expressed in migrating cells 
(179). 
 
3.1.4 Inflammatory Cytokines 
Even with extensive work on the role of the above mentioned growth factors, there is a clear 
failure in their clinical application. The role of inflammatory cytokines however, has been largely 
ignored when plant based therapies are concerned. However, it is of particular interest that select 
inflammatory cytokines also act through tyrosine phosphorylation. Table 3.1 tabulates the 
cytokines linked to tyrosine phosphorylation which includes the pro-inflammatory cytokines, 
interleukins-1β, 6, 8, TNF-α and the anti-inflammatory cytokine interleukin-10.  
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Interleukin - 1β (IL-1β): IL-1β is known to be an important mediator of inflammation in the wound 
milieu and has various synergistic effects with other mediators active in the wound healing 
process. IL-1β is however site and injury specific with regards to expression and activity (180). IL-
1β has a role in the induction of keratinocyte migration and proliferation together with the induction 
of fibroblast proliferation and synthetic functions (being mostly collagen synthesis) (181).  
Furthermore the activity of IL-1 is not only limited to the proliferative response of various cell 
populations but also important in their distribution within tissues which was demonstrated by 
Wilson, et al. (182) in a corneal tissue wound model. The authors found that keratinocytes and 
fibroblasts were redistributed and underwent apoptosis in response to IL-1 which was either a 
normal or pathological response to mechanical injury. Although these results were obtained in 
corneal tissues, the fundamental response of fibroblasts and keratinocytes is universal in the 
wound healing process.    
 
Interleukin – 12p70 (IL-12p70): Little is known regarding to the role of IL-12p70 in wound healing. 
However, IL-12p70 is a major contributor in the development of T-helper cells to mature into either 
TH1 (inflammatory) or TH2 (anti-inflammatory) mediators, with high IL-12p70 concentrations 
favouring the TH1 response (183). The various TH responses manipulate the functionality of 
macrophages and may determine wound healing outcomes (184). IL-12p70 induces Inducible 
Nitric Oxide Synthase (iNOS) due to the activation of the pro-inflammatory functionalities (185). 
The authors demonstrated this relationship in an allograft rat model, where the rate of rejection 
was decreased with an increase in iNOS when treated with IL-12p70.  
 
Interleukin – 6 (IL-6): IL-6 has a modulatory effect as it has roles in producing inflammatory 
responses and in the differentiation of lymphocyte populations (186). The IL-6 ligand is able to 
bind directly to the IL-6 receptor on cell surfaces and induce dimerization of the gp-130 molecule, 
however a soluble form (not membrane bound) of the receptor is expressed which bind the ligand 
thereafter activating the gp-130 molecule (187). This allows IL-6 to interact with cells that do not 
express the receptor and so increases the scope of the activity.  
The extent of IL-6’s role in inflammation has been demonstrated in inflammatory conditions such 
as Sjögren’s syndrome (188) and uveitis (189). These conditions are clearly more related to the 
eye, but in a study by Mc Farland-Mancini, et al. (186) the role of IL-6 was demonstrated in a 
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cutaneous wound model. Detrimental effects were shown in mice lacking a combination of IL-6 
and its receptor where a reduction in macrophage infiltration, fibrin clearance and wound 
contraction was seen. Interestingly this study showed that the effects were mediated through the 
phosphorylation of the tyrosine residues on the gp130 intracellular receptor domains.  
 
Interleukin – 8 (IL-8): IL-8 has a major role in chemotaxis of polymorphonuclear cells whose 
main function is to debride the wound of cellular debris and foreign materials (190). Although this 
is an important component of wound healing additional interest in IL-8 lies in its ability to modulate 
keratinocyte proliferation in a time dependent manner (191). Kleinbeck, et al. (191) describe an 
important concept in that the cytokines seem to operate to a satisfactory level at a narrow 
concentration range.  
 
Tumour Necrosis Factor – α (TNF-α): As an integral component of the inflammatory process 
during wound healing, excessive concentrations are associated with the formation of chronic 
wounds (192). Although it is known to be mostly derived from monocyte/macrophage populations 
(97) evidence has shown that it may also be produced by neutrophils (98). As the evidence 
suggests that TNF-α may be associated with chronic non-healing wounds, there is also a role for 
the cytokine in normal wounds, as it important for mitogenic and angiogenic events (99). Steenfos, 
et al. (99) showed that TNF-α has the potential to inhibit key growth factors specifically TGF-β, 
but in these rat studies the effect of this inhibition was not detrimental to the wound healing 
process. Similar to IL-1, TNF-α is able to induce cellular proliferation through the activation of 
fibroblastic growth factors but when acting alone the unwanted result of chronic wound formation 
predominates (193).  
 
Interleukin-10 (IL-10): As a prominent anti-inflammatory cytokine active in the skin, Berg, et al. 
(94) demonstrated the role of IL-10 in Croton oil irritated skin in a mouse model where the effects 
of IL-10 were assessed based on its potential to reduce the inflammatory induced necrosis of skin 
tissue. Results showed that IL10 was active in decreasing the expression of TNF-α which is a 
prominent pro-inflammatory cytokine, an observation also made by Sato, et al.  (95). In addition 
to this observation other cytokines were also shown to be decreased namely IL-1β and IL-6. In 
addition to the suppression of inflammatory cytokine expression, Sato, et al. (95) also 
demonstrated the inhibition of chemotaxis of neutrophils and macrophages to the affected site. 
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However evidence presented by Eming, et al. (72) shows that depression of IL-10 accelerates 
the closure of wounds in a mouse model. In the IL-10 knockout mice, they observed accelerated 
epithelialisation and wound contraction. This suggests that the role of other cytokines inhibited by 
the actions of IL-10 may have a positive contribution to the wound healing process and not only 
active as pro-inflammatory agents. 
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3.2 Aims 
The aims of this Chapter where to:  
a) Quantify the relative concentrations of IL-10, IL-12, IL-1β, IL-6, IL-8 and TNF-α; 
b) Quantify the extent of tyrosine phosphorylation in the epidermis; 
c) Quantify the outcome response of cellular proliferation by assessing the concentration of 
proliferating cell nuclear antigen.  
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3.3 Materials and Methods 
 
3.3.1 Animal Model and Test Groups 
The wound model, surgery, treatment groups, dressings, the timing of and taking of skin biopsies 
was as described in Chapter 2. The occlusive dressings contained an absorptive pad to trap the 
wound exudate for this part of the study. 
 
3.3.2 Wound Exudate Collection and Analysis 
On day 5 post-operative, the absorptive pads of the occlusive dressings were cut free and placed 
in sample collection tubes and placed immediately on ice. Once in the laboratory the absorptive 
pads were placed in syringe barrels and inserted into collection tubes. The dressings were spun 
down at 2000 rpm; the supernatant/exudate was collected, aliquoted into 500 µl Eppendorf tubes 
and frozen at -70 oC. The wound fluid from the treated and control wounds were analysed to 
quantify the concentrations of the inflammatory cytokines namely IL-10, IL-12, IL-1β, IL-6, IL-8, 
TNF-α.  
 
3.3.3 Cytokine Analysis 
The concentrations of the inflammatory cytokines in the wound exudates were analysed using the 
Multiplexed Human Inflammatory Cytokine Bead Array kit (BD Biosciences, Cat. No: 551811). 
The manufacturer’s instructions were followed with some modifications during the initial sample 
processing. EDTA was added due to the associated proteolytic activity associated with wounded 
tissue.  
Twelve standard concentrations for each interleukin were prepared by serial dilution ranging from 
0 pg/ml to 5000 pg/ml. Eighteen samples were analysed in duplicate therefore 36 samples with 
twelve standards resulted in 48 preparations all together. According to manufacturer’s instruction, 
25 µl per sample of each cytokine capture bead was combined to produce a stock solution 
amounting to 6 different cytokines x 48 samples x 25 µl capture beads = 7 200 µl combined 
capture beads. The combined reconstituted capture beads were centrifuged at 2000 rpm and the 
supernatant discarded. The capture beads were suspended in 7 200 µl serum enhancement 
buffer, vortexed and incubated at room temperature for 30 minutes. During this incubation period, 
150 µl of each wound fluid sample was placed separately in EDTA Vacutainers (BD Vacutainer) 
and incubated for 20 minutes.  
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Standard samples were reconstituted in 2 ml assay diluents and allowed to equilibrate for 15 
minutes. They were then mixed by pipette and a serial dilution prepared from 5000 pg/ml of protein 
to 0 pg/ml of protein. Standards were prepared in 15 ml BD Falcon tubes (Cat. No. 352008). 
Standards and experimental samples (100 µl) were placed into separate Eppendorf tubes and 
incubated for 2 hours with 25 µl of combined capture beads. All samples were centrifuged in 500 
µl wash buffer, supernatant discarded, 25 µl PE detection reagent added and incubated for a 
further 2 hours at room temperature. Samples were centrifuged with 500 µl wash buffer, 
reconstituted in a further 100µl wash buffer and transferred to a 96 well plate. The labelled beads 
were be analysed on a FACSArray Flow Cytometer (BD biosciences). Instrument settings can be 
seen in Table 3.2 below. Final cytokine concentrations were determined using the software 
supplied with the instrument. 
 
Table 3.2. Flow Cytometer Parameters as run on the FACSArray Flow Cytometer. 
 
 
Physical Properties 
 
Voltage (mV) 
Forward Scatter 249 
Side Scatter 270 
 
Laser Properties 
 
Far Red 578 
Yellow 480 
NIR 500 
Red 
 
395 
       
3.3.4 Immunofluorescence Staining and Analysis 
Solutions and buffers used were made up in the Department of Surgery and all staining was 
performed in the Oncology Research Laboratory, Department of Internal Medicine. On the days 
of incubation sections were dewaxed in two changes of Xylene and then rehydrated through a 
graded series of alcohols and then rinsed in distilled, de-ionised water. Following this, sections 
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were placed in a microwavable slide rack, immersed in tris-ethylenediamine tetra-acetic acid (Tris-
EDTA) buffer (pH 9.0) and microwaved at medium heat for 5 minutes and then allowed to cool for 
20 minutes on the bench top. Next, sections were placed in phosphate buffered saline (PBS) for 
5 minutes, after which they were permeabilised in 0.1% Triton-X100 in 0.1% Bovine Serum 
Albumin (BSA)/PBS for 10 minutes. Once permiabelised, sections were washed in 3 changes of 
0.1% BSA/PBS, then aspirated and marked with a DAKO pen around each section. 
Primary antibodies include Mouse anti-Proliferating Cell Nuclear Antigen (PCNA), clone 10, 
isotype IgG2a (Invitrogen, Cat. No. 13-3900) and anti-Phosphotyrosine (4G10), mouse 
monoclonal IgG2bk (Millipore, Cat. No. 05-321). The PCNA anti-body was detected when 
conjugated to the Alexa Fluor® 488 secondary antibody (Molecular Probes®, Cat. No. A 21131) 
that specifically targets the IgG2a isotype and fluoresces on a green fluorescent channel. The 
anti-phosphotyrosine antibody was detected when conjugated to the Alexa Fluor® 568 secondary 
antibody, (Molecular Probes®, Cat. No. A 21124) specifically targeted to the IgG2bk isotype that 
fluoresces on a red fluorescent channel. Both positive and negative controls were included in the 
immunofluorescence staining runs. The positive control used was paraffin embedded sections of 
rat kidney and the negative control was skin sections obtained from this study wherein the primary 
antibody mixture was omitted and substituted with an equivalent volume of 0.1 % BSA/PBS.  
For dual immunofluorescence labelling of the sections, dilutions were determined prior to 
complete analysis on separate sections at a dilution of 1:150 for each of the primary antibodies. 
For dual labelling purposes the dilutions were maintained at 1:150 diluted in 0.1% BSA/PBS. 
Sections were incubated overnight with 25 µl of the primary antibody mixture at 4 oC in an airtight 
container lined with moistened blotting paper. 
The slides were washed in three changes of 0.1% BSA/PBS for 5 minutes at each wash. The 
secondary antibodies used were prepared with a dilution ratio of 1:200 diluted in 0.1% BSA/PBS. 
Sections were incubated with 25 µl of the secondary antibody mixture for an hour at room 
temperature in the dark. After incubation with the secondary antibodies, sections were washed in 
3 changes of PBS after which they were mounted with 100 µl of Fluoro-mount (Sigma, RSA). 
 
3.3.5 Section Imaging and Image Analysis 
Sections were imaged on an Olympus IX71 fluorescent microscope and processed using the 
analysis LifeScience® software package in the Oncology Research Laboratory, Department of 
Internal Medicine. Images were captured at a 40x magnification and exposure time of 1000 
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milliseconds (ms). At this magnification, three images were taken for analysis, laterally at either 
side of the section and in the midline to supply an evenly distributed representation of the sections. 
The images generated were a RGB composite which were then decomposed into the separate 
channels for further analysis (Figure 3.1). The blue channel was omitted as no signal was 
expected there and only the red (denoting tyrosine phosphorylation positivity) and green (denoting 
proliferating cell nuclear antigen) channels were analysed. 
Each channel was further analysed by importing the image into the planimetric software package 
IMAGE J (version 1.4.3.67) where the regions of interest were isolated and the mean fluorescence 
intensity (MFI) calculated. This was done in all the images on each of the sampling days. An 
average MFI of each treatment on each day was calculated and represented graphically. 
 
3.3.6 Statistical Analysis 
Statistical Analysis was done using the software package Statistica (ver. 9). All data was tested 
for normality using the Shapiro-Wilk Normality test accepting non-parametric data at p < 0.05. 
Data was found to be non-parametric; therefore the Kruskal-Wallis test was used for significance 
testing. 
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Initial Fluorescence Image with the ROI 
indicated by the yellow outline. 
Initial fluorescence Image decomposed into the green (PCNA) and red (4G10) Channels. At this 
point the mean intensity of the ROI is calculated which is denoted by the yellow lines. 
Figure 3.1. Immunofluorescence analysis algorithm. 
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3.4 Results 
 
3.4.1 Cytokine Analysis 
The results from the cytokine analysis at day 5 post-operative are shown in Table 3.3. The 
Senecio treatment group had a significantly greater IL - 1β when compared to the negative 
control (p = 0.017) but not when compared to the activated carbon treated wounds (p = 0.566). 
The activated carbon treated wounds had a significantly greater concentrations of IL - 1β than 
the negative control (p = 0.005). There were no significant differences in the other cytokines 
analysed. 
 
Table 3.3. Cytokine concentrations (pg. protein/ml wound fluid) at day 5 post-operative. Data 
are presented as mean ± SEM (n). Underlined p – values are significant. 
 
Cytokine 
Negative 
Control 
Activated 
Carbon Senecio 
Group 
wise p - 
value 
Senecio 
vs. 
Negative 
Control p - 
value 
Senecio 
vs. 
Activated 
Carbon p - 
value 
Negative 
Control vs. 
Activated 
Carbon p - 
value 
IL - 8 13.50 ± 2.78 (9) 20.50 ± 2.69 (9) 20.30 ± 4.84 (9) 0.325 0.158 0.724 0.331 
IL - 1β 8.02 ± 1.05 (9) 17.91 ± 2.66 (9) 25.52 ± 5.79 (9) 0.009 0.005 0.566 0.017 
IL - 6 8.93 ± 2.19 (9) 13.03 ± 2.29 (9) 15.43 ± 3.80 (9) 0.163 0.112 0.930 0.112 
IL - 10 9.09 ± 2.23 (9) 16.87 ± 3.39 (9) 11.93 ± 3.21 (9) 0.095 0.058 0.133 0.377 
TNF - α 18.09 ± 3.56 (9) 19.86 ± 3.14 (9) 18.63 ± 4.19 (9) 0.797 0.627 0.566 0.965 
IL - 12p70 18.40 ± 2.62 (9) 22.88 ± 2.93 (9) 25.32 ± 8.11 (9) 0.505 0.270 0.427 0.724 
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3.4.2 Tyrosine Phosphorylation and Cellular Proliferation 
Results for the tyrosine phosphorylation of the healing epidermis are shown in Table 3.4. 
Tyrosine phosphorylation in the healing epidermis for the Senecio and negative control treated 
wounds were similar throughout the duration of the experiment with no difference detected 
statistically throughout the observation period.  
The Senecio treated wounds had significantly greater tyrosine phosphorylation than the 
activated carbon treated wounds on days 9 (p = 0.042) and day 12 (p = 0.034) post-operative 
but was significantly lower at day 16 (p = 0.017). The negative control treated wounds were 
only significantly greater than the activated carbon treated wounds (p = 0.015) on day 7 post-
operative.   
 
Table 3.4. Epidermal tyrosine phosphorylation (4G10 MFI) at specific post-operative days. 
Data are presented as mean ± SEM (n). Underlined p – values are significant.  
 
Days 
Post-
operative Negative Control Activated Carbon Senecio 
Group 
wise p - 
value 
Senecio 
vs. 
Negative 
Control p 
- value 
Senecio 
vs. 
Activated 
Carbon p 
- value 
Negative 
Control vs. 
Activated 
Carbon p - 
value 
5 107.10 ± 2.13 (9) 98.06 ± 10.57 (9) 99.59 ± 6.53 (9) 0.377 0.537 0.4799 0.185 
7 113.67 ± 3.19 (9) 100.89 ± 5.77 (9) 120.84 ± 6.46 (9) 0.038 0.251 0.077 0.015 
9 116.25 ± 11.62 (9) 99.54 ± 6.78 (9) 119.55 ± 3.04 (9) 0.180 0.659 0.042 0.289 
12 114.91 ± 9.17 (9) 100.76 ± 9.54 (9) 126.43 ± 4.74 (9) 0.107 0.427 0.034 0.289 
16 118.40 ± 6.61 (9) 131.92 ± 5.55 (9) 113.01 ± 4.08 (9) 0.075 0.659 0.017 0.216 
 
Shown graphically the levels of tyrosine phosphorylation (Figure 3.2) increased rapidly for the 
Senecio treated wounds from day 5 to day 7, and remained elevated to day 12 post-operative 
and decreased after day 12. The negative control treated wounds showed a moderate 
elevation in tyrosine phosphorylation from day 5 to day 9 post-operative, after which it 
remained constant until day 16 post-operative. The activated carbon treated wounds remained 
constant at lower levels compared to the other treatments until day 12 when it increased to 
day 16 post-operative. 
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Figure 3.2.  Epidermal tyrosine phosphorylation (4G10 MFI) plotted against time (Days Post-operative). Error bars represent the SEM.
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Results for epidermal proliferation seen in the healing epidermis are shown in Table 3.5. The 
Senecio treated wounds had significantly less proliferation at day 5 post-operative when 
compared to both the negative control negative control treated wounds (p = 0.001) and 
activated carbon treated wounds (p = 0.003). From day 7 to day 16 post-operative, no other 
differences were noted when the Senecio treated wounds were compared to the negative 
control treated wounds. The Senecio treated wounds had significantly greater levels of 
proliferation than the activated carbon treated wounds at days 9 (p = 0.013) and 12 (p = 0.017). 
At day 16, the activated carbon treated wounds had significantly more proliferation than the 
negative control treated wounds (p = 0.042).  
 
Table 3.5. Epidermal proliferation (PCNA MFI) at specific post-operative days. Data are 
presented as mean ± SEM (n). Underlined p – values are significant. 
 
Days Post-
operative 
Negative 
Control 
Activated 
Carbon Senecio 
Group 
wise p 
- value 
Senecio 
vs. 
Negative 
Control p 
- value 
Senecio vs. 
Activated 
Carbon p - 
value 
Negative 
Control vs. 
Activated 
Carbon p - 
value 
5 86.91 ± 3.51 (9) 84.03 ± 3.87 (9) 66.71 ± 2.47 (9) 0.001 0.001 0.003 0.595 
7 69.47 ± 6.05 (9) 75.21 ± 6.27 (9) 70.49 ± 5.58 (9) 0.783 0.930 0.427 0.957 
9 53.87 ± 4.53 (9) 49.92 ± 4.46 (9) 71.17 ± 7.29 (9) 0.052 0.157 0.013 0.596 
12 83.77 ± 9.56 (9) 66.23 ± 8.85 (9) 95.78 ± 7.06 (9) 0.030 0.185 0.017 0.112 
16 70.88 ± 6.61 (9) 84.87 ± 4.30 (9) 73.68 ± 7.83 (9) 0.080 0.589 0.093 0.042 
 
Shown graphically in Figure 3.3, the level of proliferation in the Senecio treated wounds was 
maintained from day 5 to day 9 post-operative, whereas the level of proliferation in the 
negative control and activated carbon treated wounds decrease in the same time period. From 
day 9 to day 12 post-operative, all treatments show an increase in levels of proliferation. At 
day 12 post-operative, the Senecio and negative control treated wounds show a decline in 
levels of proliferation to day 16 post-operative, whereas the activated carbon treated wounds 
continue to increase. 
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Figure 3.3. Epidermal Proliferation (PCNA MFI) plotted against time (Days Post-operative). Error bars represent the SEM.
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3.5 Discussion 
The main finding from the cytokine assays shows that on day 5 post-operative, the IL-
1β concentration was significantly higher in the Senecio and activated carbon treated 
wounds. At the same time point, although the Senecio treated wounds had a 
significantly lower level of proliferation, the level of tyrosine phosphorylation was the 
same for all treatment groups. From day 5 post-operative, the level of proliferation in 
the Senecio treated wounds is maintained at a steady state. This was not seen in the 
activated carbon or negative control treated wounds where a rapid decline is seen at 
the same point in time which recovers later. From day 5 post-operative there is an 
increase in tyrosine phosphorylation in the Senecio treated wounds which was not 
evident in the controls. 
The specific mechanisms by which a wound is re-epithelialized is proliferation and 
migration of keratinocytes from the wound edges and remaining hair follicles. It is quite 
possible that the cells in all treatment groups are migrating into the wound which would 
account for the thickening of the epidermal layers. In addition to the migratory input in 
the Senecio treated wounds, there was an added proliferative response (from days 5 
to 9 post-operative) as was shown by the sustained levels of the proliferating cell 
nuclear antigen which may also account for the epidermal thickness.  
Reasons for why the proliferative response was sustained in the Senecio treated 
wounds may be related to the tyrosine phosphorylation. Tyrosine phosphorylation has 
a role in cellular signalling mechanisms which are important in cell migration, 
proliferation and differentiation (168). Although, significant at day 7 post-operative the 
Senecio treated wounds maintained greater and sustained levels of tyrosine 
phosphorylation. These findings were similar to those of Murphy and Blenis (194) 
where the sustained and elevated levels of cellular signalling may be account for the 
differences observed in outcomes such as cellular proliferation and not neccesarily the 
actual amount of signal or tyrosine phosphorylation.  
The cell signalling pathways that are activated by tyrosine phosphorylation, although 
distinct are seen to overlap, and multiple ligands may bind to the same receptor linked 
pathway but with different effects. For example, MAPK pathways can be triggered by 
growth factors as well as inflammatory cytokines (194). Murphy and Blenis (194) 
reviewed the hypothesis that the same pathway could be manipulated to produce 
specific effects via different control mechanisms. Signal transduction could be 
manipulated by the density of membrane receptors and the duration of the tyrosine 
phosphorylation or the half-life of the specific phosphorylated protein.  
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The idea that ligand concentration is not the only factor driving cell responses and may 
be reason for the previously noted complexity of cell responses to stimulation. This 
contributing factor in the differential results of various growth factors brings into 
question the biochemical properties and kinetics of tyrosine phosphoryation, a topic 
that is highly complex and not yet fully elucidated.  
Responses to tyrosine phosphorylation is also determined by cell type and locality. 
The concept of signal transduction as a regulatory factor was initially proposed by 
Marshall (172) due to Fibroblast Growth Factor induces proliferation in fibroblasts but 
in PC12 cells the same growth factor induces differentiation. Signalling pathways in 
keratinocytes and fibroblasts (key cell populations in wound healing), a “proliferative” 
signal in keratinocytes has the opposite effect on fibroblasts where a “differentiation” 
signal is expected (195). An important pathway that is linked to keratinocyte 
differentiation is the activation of protein kinase C (intially activated by PLC- γ) with the 
concurrent influx of calcium, a potent mediator of this process (196). In keeping with 
the observation of Miteva (195) where the converse occures in fibroblasts who 
proliferate when the protein kinase C pathway is activated. 
PCNA is both a marker for cellular proliferation and has a key role in maintaining the 
proliferative response. Specifically PCNA assists with the tethering of DNA polymerase 
epsilon, a key enzyme involved in DNA synthesis and repair, to its DNA targets (197). 
Once bound to chromatin, its function is dependent on the tyrosine kinase activity of 
the EGF receptor (EGFR) within the nucleus (198) which leads to the phosphorylation 
of Tyrosine 211 residue of chromatin bound PCNA molecule to stabilize it. 
Furthermore, consistently raised PCNA Tyrosine 211 residue phosphorylation is 
correlated with pronounced cell proliferation (198). Thus the sustained expression of 
PCNA, possibly due to elevated or sustained levels of tyrosine phosphorylation, may 
have contributed to the significantly thicker epidermis measured on day 7 post-
operative, as described in the previous Chapter. 
As simple as this explanation might be, prior to the increase in the epidermal thickness 
there are lower levels of PCNA in all treatment groups which requires explanation. In 
the negative control and activated carbon treated wounds the lowest concentrations of 
PCNA are noted at day 9 post-operative coinciding with the point at which the 
epidermal thickness is maximal for these treatment groups. In the Senecio treated 
wounds the lowest concentrations of PCNA are seen around day 5 and 7 post-
operative, again coinciding with the time point at which the epidermal thickness is 
maximal. At day 5 post-operative where the Senecio treated group had significantly 
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lower concentration of PCNA compared to the controls, it had a significantly thicker 
epidermis than both the controls but, with the sustained levels of PCNA the epidermis 
continued to thicken until day 7 post-operative.  
In summary, the Senecio treated group’s initial low levels of PCNA coincide with a 
significantly thicker epidermis and sustained levels of PCNA coincided with an earlier 
maximum in epidermal thickness. In the control groups, a lower level of PCNA also 
coincided with an increase in epidermal thickness. These data may suggest that the 
role of PCNA was to maintain a proliferative response and, with greater sustained 
levels of tyrosine phosphorylation may have resulted in the greater epidermal 
thickness between days 5 to 7 after creating the wounds. Of note within the Senecio 
treated wounds, data was absent prior to day 5 post-operative and the trend of PCNA 
expression before the thickening of the epidermis could not be determined. 
Importantly in this study, IL – 1β was the only cytokine which was shown to be 
significantly higher in the Senecio group and only on day 5 post-operative. With the 
related functions being keratinocyte migration, keratinocyte and fibroblast proliferation 
and fibroblast synthetic function (181) the responses observed in the Senecio treated 
wounds may well be linked to the raised levels of this cytokine. 
Even though there were no observed differences in the other cytokines their roles are 
vital in wound healing and even though a significant elevation of IL – 1β was detected 
it would be naïve to consider this the important distinguishing feature because not all 
the potentially implicated ligands were measured here. The reason for this is that it 
was not financially possible to do so and again the importance of measuring the 
tyrosine phosphorylation is emphasised as it is a common link between many of the 
ligands (80).      
Although significant differences between the groups were determined, the specific 
proteins that were phosphorylated were not analysed. It is thus not currently known 
whether different signalling cascades were activated by diffferent ligands which was a 
limitation of this study. Furthermore as overlap between the signalling cascades (173) 
would further complicate determining the specific pathways involved, the approach of 
measuring overall tyrosine phosphoryation and proliferation was probably correct. 
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3.6 Conclusion 
Tyrosine phosphorylation and PCNA was elevated in Senecio treated wounds. The 
sustained elevated levels of tyrosine phosphorylation seen in these wounds may 
maintain and stabilise the function of PCNA, a factor known to be important in DNA 
synthesis and cellular proliferation. It is feasible that the raised levels of tyrosine 
phosphorylation in the Senecio treated wounds more than the controls was associated 
with the significantly greater concentrations of IL-1β. This cytokine is known to be 
important in keratinocyte proliferation and is also associated with receptor linked 
tyrosine kinases. Given the morphometric analysis showing that the epidermal 
thickness and cellular proliferation were significantly increased when the wounds were 
treated with the Senecio preparation, suggests that an assay determining keratinocyte 
proliferation could be used to measure accelerated wound healing by Senecio 
serratuloides var. Such an in-vitro assay could be used in a high throughput assay to 
identify possible lead compounds from plant extractions and isolates.  
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Chapter 4 - Plant Extraction, Isolation and Partial Identification through Culture 
Based Proliferation Assays 
 
4.1 Introduction 
In Chapters 2 and 3 it was shown that treating deep partial thickness wounds in a 
porcine model with Senecio preparations lead to the formation of a significantly thicker 
epidermis associated with increased tyrosine phosphorylation and sustained 
proliferation of the epidermal layers. The data therefore suggests that active 
compounds in the plant increase cellular proliferation in the epidermal layers. 
In the epidermal layer, 95% of the cell population are keratinocytes (199). In-vitro 
keratinocyte cultures can be used in a cell proliferation assay to screen for active 
fractions of the plant to isolate and characterise lead molecules. These molecules and 
their derivatives could potentially be patented to protect the indigenous knowledge and 
possibly secure an income for the owners of such knowledge.  
To identify lead compounds, active fractions needed to be assayed for wound healing 
activity. This requires the simultaneous extraction and fractionation of the plant 
together with the development of a simple and rapid screening in-vitro assay. 
Furthermore the development of the in-vitro assay needs to be compatible with the 
high-throughput assay format, for reasons that will be discussed further.  
 
4.1.2 Previous Plant Based Studies 
Studies focussing on plants described with wound healing activity have been reviewed 
in Chapter 1 and highlighted again in Table 4.1. Colorimetric tests were used to identify 
the chemical class of active components in Semecarpus anacardium (24), 
Zantboxylum chalybeum and Warbugiaugandensis (18), Ranunculus pedatus (45), 
Euphorbia caducifolia (26), Trichosanthes dioica Roxb (27), Glycosmis arborea (28), 
Hypericum patulum (29), Terminalia arjuna (35), Dendrophthoe falcata (L.f) Ettingsh 
(36). Such approaches identified tannins, saponins, steroids, flavonoids, phenols, 
glycosides and alkaloids all of which react to specific staining agents that can 
visualised under normal light, UV light or spectrophotometrically. Following these 
phytochemical screens, the “whole” extracts were tested on various wound models to 
prove efficacy but few studies continued to isolate and identify active components. An 
example was the study of the Michauxia species (46) that specifically determined 
polyphenols spectrophotometrically (200). These were then tested on rodent incisional 
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and excisional wound models and demonstrated efficacy but no further attempt was 
made to separate or identify specific phenolic compounds.  
In contrast, studies on Murraya koenigii (31), Croton zehntneri (54), Holoptelea 
integrifolia (37) and Cichorium intybus L. (47) used HPLC/MS. This approached 
identified carbazole alkaloids (important pro-apoptotic agents in leukaemia’s, 
lymphomas, and prostatic malignancies) and sesquiterpine phenolic compounds from 
essential oils from Murraya koenigii (31). Several alkaloids fractions and the essential 
oils as a whole, showed significantly enhanced epithelialisation at the midpoint of the 
observational period in rodent wound model experiments but not at the end of the 
experiment, an observation also made in this study (please see Chapters 2 and 3). 
Furthermore the activities of the separated alkaloids were compared and identified as 
previously described compounds.  
Suntar, et al. (201) investigated and characterised the active fractions from Cichorium 
intybus L. using a rodent model, solvent extractions, thin layer chromatography (TLC) 
and spectrophotometric techniques (mass spectrometry, UV spectrometry, 1H-13C and 
nuclear magnetic resonance) and determined β-sitosterol as the active compound.  
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Table 4.1. Selected studies where plants used for wound healing have been assessed for 
potential active compounds. 
Plant Name Extraction Solvent 
Further 
Evaluation 
Compounds Reference 
Jatyadi Taila 100% Methanol HPTLC 
Flavonoids, Essential oils, Tannins, 
Glycosides, Alkaloids, Resins, Steroids 
(22) 
Cichorium intybus L 
85% Methanol and 
sub fractionation 
Nil Phenolics (201) 
Semecarpus anacardium 100% Methanol Nil 
Flavonoids, Phenolics, Glycosides, 
Tannins 
(24) 
Zanthoxylum chalybeum 
and Warbugia ugandensis 
Ethanol Nil 
Polyurinides, Reducing Compounds, 
Saponins, Tannins, Alkaloids, Glycosides, 
Anthracenisides, Coumarin Derivatives, 
Flavonoids 
(18) 
Murraya koenigii Ethanol GCMS Alkaloids, Essential oils (31) 
Ranunculus pedatus and 
Ranunculus 
constantipolitanus 
Diethyl ether, n-
hexane, Ethyl 
acetate, Methanol, 
Water 
Nil 
Steroids, Triterpenes, Alkaloids, Saponins, 
Tannin, Anthraquinones, Flavonoids, 
Flavonoids, Sugars, Starch, Coumarins, 
Starch 
(45) 
Michauxia L'Herit Methanol Nil Polyphenols (46) 
Pinus species 
Water - Hydro 
distillation 
Nil Essential oils (47) 
Euphorbia caducifolia Latex resin Nil 
Carbohydrates, Amino acids, Phytosterols, 
Saponins, Glycosides, Fatty acids 
(26) 
Croton zehntneri Steam distillation GCMS Essential oils (54) 
Trichosanthes dioca Roxb Methanol Nil Alkaloids, Flavonoids (27) 
Glycomis arborea 50 % Ethanol Nil 
Flavonoids, Triterpinoids, Alkaloids, 
Phenols 
(28) 
Hypericum patulum Methanol Nil Steroids, Flavonoids (29) 
Plagiochasma 
appendiculatum Lehm. Et 
Lind 
Petroleum Ether, 
acetone, chloroform, 
ethanol, water, 
hydro alcoholic acid 
Nil 
Alkaloids, Anthraquinones, Saponins, 
Flavonoids, Sesquiterpenes, Terpines 
(32) 
Sesamum indicum No active extraction Nil Constituent Sesamol used (33) 
Terminalia arjuna 50% Ethanol Nil Tannins, Saponins, Reducing Sugars (35) 
Dendrophthoe falcata Ethanol Nil 
Alkaloids, Saponins, Flavonoids, Terpines, 
Steroids, Glycosides, Tannins 
(36) 
Holoptelea integrifolia Methanol HPTLC 
Alkaloids, Saponins, Flavonoids, Terpines, 
Steroids, Glycosides, Tannins, 
Anthraquinolones 
(37) 
Anredera diffusa 90% Ethanol NMR, HPLC Oleonolic Acid (59) 
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When determining and identifying active components, experimental controls are 
critical and should be based on previously established treatments with proven efficacy 
and market related success. For example, Reddy, et al. (37) investigated the chemical 
constituents in Holoptelea integrifolia using high performance thin layer 
chromatography (HPTLC) and assessed both wound healing efficacy and anti-
microbial effects of the extract. Comparison was made between the plant and 
Nitrofurazone, a common topical anti-microbial. In contrast, Malveira Cavalcanti, et al. 
(54) separated and identified essential oils from Croton zehntneri by gas 
chromatography and mass spectrometry (GC/MS) and tested these tested for wound 
healing effect. The most abundant essential oil was trans-anethole. To determine 
whether trans-anethole was the compound of interest, its efficacy was compared to 
the whole essential oil extract, with corticosteroids and fibrinolysin controls in a rodent 
model. Such controls are not commonly used in clinical practice and therefore may not 
be appropriate. 
 
4.1.3 Approach to Identifying Potential Compounds of Interest 
A number of protocols have been used to isolate active substances in plants. Neutral, 
acidic or basic water or solvent extracts of plant material provide a convenient means 
of extracting active substances from large amounts of plant material in sufficient 
quantities to undertake further isolation, assay and analysis of the active substances. 
The initial extract will indicate whether the substances are polar or non-polar and 
simple screening by thin layer chromatography (TLC) with colorimetric spray reagents 
can indicate the class of potential substances with activity. Further separation including 
high performance liquid chromatography (HPLC) and gas chromatography (GC), 
coupled with mass spectrometry (MS) allows for elucidation of chemical structures. 
Scale-up and fractionation from nano- or microgram scale to the gram scale may 
involve large and expensive preparative columns. Once purified, the isolated 
compound’s structure can be confirmed using techniques including infra-red 
spectroscopy, nuclear magnetic resonance and X-ray crystallography. 
 
4.1.4 Alkaloid Detection and Characterisation – Gas Chromatography and Mass 
Spectrometry 
Available literature suggests a potential compound class of interest in wound healing 
are the pyrrolizidine alkaloids with their role in gastric ulcer healing (144) and 
furthermore, many useful drugs in use today are alkaloid based. 
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The alkaloid group of plant compounds is generally described as being nitrogen 
containing cyclic compounds often synthesized from an amino acid precursor.  The 
class of alkaloids is known to contain many compounds and with more sophisticated 
investigations being routinely employed, the isolation and characterization of these 
compounds has accelerated. Currently known alkaloids have been classified (110). 
Four classification criteria are used: 
a) Chemical Classification – the most widely used classification based on the 
chemical nucleus. 
b) Biosynthetic Classification – based on the amino acid precursor being 
tryptophan, lysine, ornithine, tyrosine and histidine. 
c) Pharmacological Classification – based on the therapeutic outcome which is a 
broad classification and somewhat simplistic for novel agent identification. 
d) Taxonomic Classification – based on the plant taxonomy, again being an 
extremely broad classification. 
 
Chemical classification has an additional sub-classification based on the cyclic nucleus 
common to those alkaloids (Figure 4.1) and are either non-heterocyclic (one element 
– usually carbon) or heterocyclic with more than one element in the nucleus (carbon 
and nitrogen). In alkaloids with non-heterocyclic nuclei nitrogen resides within the side 
chains or functional groups. Additionally a distinction can be made on the number of 
rings present within each of these nuclei. Our investigation used GC/MS and mass 
spectra data from the nuclei is readily available from the National Institute of Standards 
and Technology (NIST) (202). If possible once a potential nucleus was identified 
further investigation of functional groups was made.  
Alkaloids are derived from amino acid precursors such as ornithine, lysine, tyrosine 
and tryptophan derived classes, and similar fragmentation patterns are observable 
within each of the amino acid sub-groups. Pyrrolizidine and tropane type alkaloids 
have base ions of 80-82 m/z for the pyrrolizidine alkaloids and the ion at 82 m/z as the 
base ion with a second peak 20% of the base ion at 83 m/z is commonly seen in the 
tropane alkaloids (203). Distinguishing ions for these 2 compounds are based on triplet 
fragments of 93-95, 119-121 and 136-138 m/z for the pyrrolizidine alkaloids (204) and 
an additional fragment at 94 m/z is common for the tropane alkaloids (203). 
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Figure 4.1. Common alkaloid nuclei making up a major classification system. Taken 
from Trease and Evans Pharmacognosy (110). 
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4.1.5 Approach to Identifying Potential Compounds 
Mass spectral fragmentation patterns allow for the identification of the common 
alkaloid nuclei which are represented in Figure 4.1 and with the corresponding 
fragmentation patterns seen in Table 4.2. Such data provides a starting point for 
identification of the possible class of compounds of interest. In general the fragments 
less than 100 m/z are fairly non-specific and are present in most cases. However, 
fragments around 40 m/z (± 5 m/z), specifically less than 40 m/z, are seen in the 
glycine, tyrosine, tryptophan, and pyridine type alkaloids. Those more than 40 m/z are 
common in the ornithine, lysine and histidine type alkaloids. Additional fragments 
greater than 55 m/z but less than 60 m/z are common in the ornithine and lysine type 
alkaloids and less than 55 m/z are common in the tyrosine, tryptophan and pyridine 
type alkaloids. Fragments greater than 60 m/z but less than 65 m/z are more common 
in the tyrosine and tryptophan classes. Identification of the alkaloid nuclei in the smaller 
fragments can lead to identification of the functional groups that are attached to the 
alkaloid nuclei and would be represented in the larger fragments. 
These ions and the fragmentation pattern are matched to similar fragmentation 
patterns in databases and in most cases this is an automated process and multiple 
computational algorithms have been developed for this purpose. When comparing 
unknown molecules, comparisons to spectral libraries will lead to non- or miss 
identifications and therefore additional algorithms have been developed to analyse the 
generated spectra of unknown compounds (205). These include 1) searching for 
similar spectra in a database and generating a percentage similarity, 2) rule based 
spectrum prediction using fragmentation principles, 3) combinational fragmentation 
using fragments to describe the compounds structure, 4) fragmentation trees and 5) 
mass spectral classifiers (205). 
Fragmentation patterns generated by electron impact ionization have been useful for 
identification of alkaloids using the mass spectral classifiers approach. Electron impact 
ionization gives rise to abundant molecular or parent masses, and complex 
fragmentation patterns to provide mass spectral classifiers (206).  
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Table 4.2. GCMS data for the relevant alkaloid bases. Data is presented as compounds occurring within an amino acid group with examples 
included. The formula and mass ion are shown with the mass ion represented as a range with the most common ion bolded. The fragmentation 
pattern depicted here is based on those from the NIST database with the prominent ions represented as a range and most common ion being 
bolded and in brackets. Key or base ions of each compound are underlined. 
 
Amino Acid 
Precursor Alkaloid Base Important Example Formula 
M m/z           (range 
of M) Fragmentation Pattern (m/z) 
Glycine Pyrrole Basic Building Block C4H5N 67.01 (66-68) 50-53 (52) , 36-42 (39) , 25-28 (28) 
Ornithine 
Pyrrolidine Nicotine C4H9N 71.12 (68-71) 37-44 (43) , 26-30 (28) 
Pyrrolizidine Senecionine/Retrosine C7H13N 111.18 (109-112) 93-98 , 80-85 (83) , 67-70 , 52-58 (55) , 39-44 (42) , 27-30 (28) 
Tropane Cocaine C8H15N 125.21 (122-126) 112-113 (113) , 91-98 (96) , 77-84 (82) , 66-71 (67) , 51-58 (57) , 39-44 (42) , 27-31 (27) 
Lysine 
Piperidine Basic Building Block C5H11N 85.15 (84-86) 67-70 (70) , 51-58 (56/57) , 39-44 (44) , 26-30 (29) 
Quinolizidine Sparteine C7H17N 139.24 (138-140) 110 , 96-97 (96) , 81-83 (82) , 67-68 , 53-55 , 39-41 
Indolizidine Swanisionine C8H15N 125.21 (120-126) 108-110 (110) , 93-98 (97) , 81-84 (83) , 67-71 (69) , 52-57 (55) , 39-43(41), 26-30 (27) 
Tyrosine 
Isoquinoline Morphine C9H7N 129.16 (128-130) 100-103 (102) , 74-78 (76) , 61-64 (63) , 50-52 (51) , 38-39 
Mescaline Mescaline C11H17NO3 211.26 (209-211) 
179-183 (182) , 165-168 (166) , 151-152 , 133-139 (136) , 120-124 (121) , 105-109 (105) , 89-95 
(91) , 77-81 (80) , 63-67 (65) , 50-54 (52) , 38-45 (39), 29-31 (30) 
Tryptophan 
Indole Ergotamine C8H7N 117.15 (116-118) 89-91 (90) , 61-64 (63) , 50-52 (51) , 37-39 (39) 
Quinoline Quinine C9H7N 129.16 (128-130) 100-103 (102) , 74-78 (76) , 61-64 (63) , 50-52 (51) , 38-39 
Histidine Imidazole Pilocarpine C3H4N2 68.08 ( 67-69) 38-42 (41) , 26-28 (28) 
Pyridine Pyridine Basic Building Block C5H5N 79.10 (75-80) 49-53 (52) , 37-40 (39) , 26-27 
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4.1.6 In-vitro Wound Healing Assays 
Scratch assays are widely used cell culture based bioassays where a cell monolayer is grown 
on a coverslip and the monolayer is “scratched” to create a wound or disruption. The cells can 
be treated with the substance being assessed and the migration of the cells back into the 
wounded area can be quantified (207). 
Previous Chapters demonstrated that in the in-vivo porcine wound model, cell migration was 
not significantly affected when comparing the various treatment modalities. In the deep partial 
thickness wounds, all wounds, regardless of treatment, were re-epithelialised to some degree 
by day 5 post-operative and in the full thickness wounds there was no difference in the extent 
of the migrating epidermal tongues. Although the process of wound healing requires cell 
migration into the wound space, this was not seen to be affected by the treatment modalities. 
From the immunofluorescence investigations, it was evident that cellular proliferation was the 
key variable and simple and inexpensive assays were required to assess this parameter when 
determining potential active constituents that affect wounds in the Senecio plant preparation.  
Cellular proliferation assays using tetrazolium salt and bromodeoxyuridine (BrdU) have been 
widely used to assess the potential of novel compounds for therapeutic use. However, despite 
their widespread use the tetrazolium salts are known to be toxic as the formazin dye that is 
produced has been shown to be carcinogenic. Furthermore these assays require the lysis of 
the cells to release and quantify the dye to determine cell proliferation. These assays cannot 
be used in on-going real time assays and would be difficult to adapt to high-throughput assays. 
An alternative to the tetrazolium salt and BrdU based assays is the use of resazurin based 
detection reagents. The resazurin based dyes have been used in cell proliferation assays for 
over 50 years and may offer significant advantages over the tetrazolium and BrdU approaches 
(208). Firstly the resultant fluorescent resorufin and is non-toxic to the cells and operator, 
making it a safer option (209). Secondly and importantly for our purposes, the cells do not 
need to be lysed to release the fluorescent metabolite for spectrophotometric quatification and 
therefore allow for a real time assessment of cellular proliferation.  
With the known complexity of the wound healing process single time point assays have the 
potential to miss important prior or subsequent events or effects. In-vivo monitoring and 
sampling of the wounds at multiple time points as opposed to a single time point has led to 
the detection of when the plant based therapy differs from controls and when it exerts specific 
effects. The development of a real time assay would be particularly useful to gain further 
insight into the wound healing effects.  
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Figure 4.2. Reduction of the Resazurin dye (accessed from www.pharmacelsus.de.). 
 
Past studies where resazurin assays have been employed in traditional or plant based 
therapies focus on the anti-proliferative aspects of potential lead compounds and so were 
mostly utilised in oncological investigations. The study of the antiproliferative properties of 
citrus flavonoids by Kawaii, et al. (210), using human lung carcinoma, mouse melanoma, 
human T-cell leukaemia and human gastric cancer cells emphasises this point. Studies on 
plant based therapeutics (Table 1.1) for wound healing made use of the tetrazolium salt and 
BrdU based assays and include Bulbine natalensis and Bulbine frutescens (9), the Astragalus 
genus (211) and multiple Brazilian derived plants (56). A PubMed search for the use of 
resazurin based assays in wound healing was unable to detect any previous publications in 
this regard and therefore makes our approach here a novel one.  
 
4.1.7 High-Throughput Assay Platform 
After identifying an in-vitro assay which could be used to identify potential lead compounds, 
the development of a high-throughput assay platform was explored. Such platforms have 
become the current pharmaceutical gold standard (212) and allow the screening of numerous 
compounds obtained from databases and in our case plant based therapies for a particular 
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desired response. These assays have often been automated to reduce the investigators input 
required to identify and develop therapeutic agents. Furthermore high throughput assays allow 
for screening of known compounds in established databases and identification of compound 
classes from preliminary investigations when testing synthetic molecules. Furthermore such 
assays avoid expensive and time-consuming in-vivo models. However unlike in-vivo models, 
in vitro assays do not fully account for the complexity of the healing wound. 
Scratch assays have been the standard protocol for many investigations into wound healing 
and lead molecule identification, but it does not lend itself entirely to the high-throughput assay 
platform as its application to automated systems using multiwell plates is complex. Attempts 
have been made to adapt cell migration assays to high-throughput screening modalities (213). 
These authors were able to apply scratch based assays to multiwell plates (96 and 384) which 
were monitored using time lapse microscopy and then further quantified. Although this format 
fulfils the requirements for a high throughput assay, factors pertinent to wound healing appear 
to have been neglected and for our purposes would not suffice. Importantly cell proliferation 
could not be taken into account unless further staining techniques were employed thereby 
reducing the potential to automate the assay. As cellular proliferation was shown to be key to 
the present investigations, scratch assays would be difficult to adapt to high through assays 
for determining cellular proliferation. 
In development of the high throughput assays, a suitable target needs to be identified that 
responds in such a way that a therapeutic effect can be measured and compared (214).  
Suitable targets are mostly in the format of membrane receptors, enzymatic activity, ion 
channels and DNA responses (215). Additional general cellular responses could be measured 
but would require additional cell culture steps with longer preparation and assay times. The 
goal in the present experiments was to rapidly measure cellular proliferation. The format of 
these assays could be in 96 up to 384 multi-well plates.  
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4.2 Aims 
The aims of this study are therefore to:  
a) Develop an easily reproducible plant extraction protocol that can be adapted to scaling 
up isolation of lead fractions; 
b) Develop an in-vitro assay, which has high throughput assay applications, to identify 
possible lead fractions; 
c) Determine the constituents of the possible lead fractions.  
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4.3 Materials and Methods 
 
4.3.1 Plant Extraction and Analysis 
Whole Plant Extract 
The plant material was prepared as previously described in Chapter 2. A whole plant extract 
was prepared by extracting 5 g of previously prepared plant material in 100ml of deionised 
water. The extraction was continued for 24 hours after which it was sonicated for 90 minutes 
in a 200ml flat bottomed flask. The extract was filtered through a Number 1 Whattman filter 
paper and then filtered through a 0.22 µm syringe filter (Millex, Millipore). The extract was 
aliquoted into 5ml aliquots and stored at -70oC until use. Prior to experimentation the whole 
extract was prepared by serial dilution ranging from a 1:40 dilution to a 1:10 240 dilution. 
 
Plant Fractionation 
A water based solvent was used with the aim of extracting basic, neutral and acidic 
compounds. Therefore 5g of previously prepared plant material was extracted in either pure 
de-ionised water, 0.05M sulphuric acid in deionised water or 5% (v/v) ammonia in deionised 
water. The extraction volumes were each at 100 ml and the extraction continued for 24 hours. 
The extracts were sonicated for 90 minutes in 200 ml flat bottomed flasks. Following 
sonication, the extracts were filtered through no, 1 Whattman filter papers and then through a 
0.22 µm syringe filter (Millex, Millipore).   
For further extraction, 3 preconditioned 35cc/6g hydrophobic lipophilic (HLB) solid phase 
extraction cartridges (Oasis, Waters) were used. The solvents that were used were allowed to 
pass through the columns by gravitational force and each extraction took place over 6 hours. 
As per the manufacturers protocol, the cartridges were pre-conditioned with 100% methanol 
and equilibrated with deionised water. The sample was loaded and the resultant effluent was 
retained after which the cartridges were washed with 5% methanol in deionised water (wash 
1).  
For elution of the acidic compounds the acidic extract was subjected to a 2nd wash of 2% 
formic acid in methanol after which the cartridge was eluted firstly with 5% ammonia and 
secondly in 0.05M sulphuric acid in deionised water. The procedure for the neutral and basic 
compounds was the same up to the first wash after which the second wash was 5% ammonia 
in methanol; and eluted firstly with 2% formic acid in methanol, followed by the second elution 
of 0.05 M sulphuric acid.  
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Once all the extracts had been passed through the cartridges, the presence of alkaloids in 
each of the various fractions was detected by spotting the fractions on thin layer 
chromatography plates, and spraying the plates with Dragendorff’s reagent followed by 
heating the plates in an oven set to 150oC for 20 minutes. The first wash and the subsequent 
elutions were retained for the cell culture based assays with a resultant twelve fractions in total 
being tested. Prior to the in-vitro proliferation assay, the various fractions were evaporated to 
dryness after which they were reconstituted in phosphate buffered saline (PBS) at a 
concentration of 1:40 of the original extraction volume. The fractions were sterile filtered using 
a 0.22 µm syringe filter (Millex, Millipore) and then serial dilutions were prepared for use for 
the proliferation assays. All serial dilutions were stored at -70 oC until use. 
 
Table 4.3. Description of the various extractions and resultant fractions. 
 
Solvent Step Acidic Extract Neutral Extract Basic Extract 
Water Extract Whole plant Extract 
5% MeOH Acidic Extract Wash 1 Neutral Extract Wash 1 Basic Extract Wash 1 
2% formic acid / 5% ammonia Acidic Extract Wash 2 Neutral Extract Wash 2 Basic Extract Wash 2 
2% formic acid / 5% ammonia Acidic Extract Elution 1 Neutral Extract Elution 1 Basic Extract Elution 1 
0,05 M sulphuric acid Acidic Extract Elution 2 Neutral Extract Elution 2 Basic Extract Elution 2 
 
 
4.3.2 Proliferation Assays 
Cell Culture Conditions  
Based on the animal work described above, keratinocytes were identified as cells which are 
potentially the target of the active fractions of Senecio. Immortalised keratinocytes (HaCat) 
were obtained from Dr Nalini Pather from the School of Anatomy, University of the 
Witwatersrand. The protocol for in-vitro analysis was based on work by Hsu, et al. (216). Cells 
for the analysis were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) (Highveld 
Biological, South Africa, P02) supplemented with 5% Foetal Bovine Serum (FBS) (Gibco – 
Invitrogen, South Africa, 41F5180F). The cells were grown in 25 cm3 Corning culture flasks 
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(Sigma, South Africa) with 5 ml of cultured media. Subculture of the cells was done when the 
flasks were 80-90% confluent. The used media was discarded and the cells were washed with 
phosphate buffered saline (PBS) after which the flasks were trypsinised with 2 ml Trypsin-
EDTA for 5 minutes after which it was neutralised with a further 2 ml of culture media. Once 
detached the cells were centrifuged at 1500 rpm in 15ml culture tubes for 2 minutes. The 
supernatant was discarded and the pellet re-suspended in 10 ml of culture media. Once re-
suspended, the final volume was split into two flasks each containing 5ml of culture media and 
cells. The flasks were incubated in 5% carbon dioxide at 37 oC. 
 
Resazurin Based Proliferation Assay 
In order to conduct the proliferation assays, the cells were harvested from the culture flasks 
and counted using a haemocytometer. Cells for analysis were seeded into 96-well plates at a 
concentration of 0.5 X 104 cells/ml. Plates where further incubated for a further 24 hours after 
which they were treated with either the extracts as described above or the controls.  
 
Proliferation Assay Optimisation 
To assess the validity of the resazurin based assay multiple controls were employed. To 
negate any possible effects of the plant fractions as possible reducing agents, wells were left 
unseeded with cells and then treated with concentrated fractions (1:80). To negate any 
possible effects of the media, wells were seeded with cells, and left un-treated and the 
resazurin dye was omitted from these wells. 
 
Control and Resazurin Dye Preparation 
Controls included the vehicle (PBS only) acting as a negative control and epidermal growth 
factor (EGF) as the positive control. Lyophilised murine submandibular EGF (Sigma, South 
Africa) was reconstituted in 1% FBS in PBS to produce a stock solution of 340 ng/ml. From 
this stock solution, aliquots were prepared to adjust the concentration of EGF to 6.5 ng/20µl.   
For the quantification of proliferation, resazurin sodium salt (Sigma, South Africa) was made 
up to a standard 10% solution in DMEM and sterile filtered through a 0.22 µm syringe filter 
(Millex, Millipore) prior to use.   
 
Whole Plant Extract and Plant Fraction Proliferation Assays 
After the intial 24 hour incubation period and with the cells nearing confluence, they were 
treated with the various plant extract fractions and controls. A volume of 20 µl of either plant 
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fraction or control was added to the wells. Thereafter 10 µl of the Resazurin solution per 100 
µl culture media was added to each of the wells at the time of treatment.  
 
All treatments can therefore be summarised as: 
a) Negative control – 20 µl PBS 
b) EGF – 6.5 ng/20µl 
c) Whole plant extract – 20 µl of each serial dilution ranging from 1:40 to 1:5120 
d) Acidic extract fractions – 20 µl of each serial dilution ranging from 1:80 to 1:10240 
e) Neutral extract fractions – 20 µl of each serial dilution ranging from 1:80 to 1:10240  
f) Basic extract fractions – 20 µl of each serial dilution ranging from 1:80 to 1:10240 
 
After 4 hours of incubation of the cells the plates were read on a Biotek PowerWave HT UV – 
vis microplate spectrophotometer at a wavelength of 570 nm and 600 nm. All treatment 
modalities and controls were run in quadruplicate. According to Al-Nasiry, et al. (208) the 
percentage reduction can be extrapolated from the absorbance measurements using the 
following equation: 
 
% Resozurin reduction =  
(εoxλ2)(𝐴 λ1)  −  (εoxλ1)(𝐴 λ2) 
(εredλ1)(ᾈλ2)  − (εredλ2)(ᾈλ1)
 x 100 
Key: εox x1 = extinction co-efficient of Resazurin at 570 nm wavelength in the oxidised state, 
εox x2 = extinction co-efficient of Resazurin at 600 nm wavelength in the oxidised state, εred λ
1 
= extinction co-efficient of Resazurin at 570 nm wavelength in the reduced state, εred λ2 = 
extinction co-efficient of Resazurin at 630 nm wavelength in the reduced state, ᾈλ1 =  
Absorbance of negative control wells at 540 nm wavelength , ᾈλ2 = Absorbance of negative 
control wells at 630 nm wavelength, Aλ1 =  Absorbance of the test wells at 540 nm wavelength, 
Aλ2 = Absorbance of the test wells at 630 nm wavelength. 
 
Real Time Proliferation Assays 
To produce a real time assay the fractions at that specific dilution showing the best activity 
were repeated and monitored over 12 hours. The rate of proliferation was determined by 
generating linear equations for the first 4 hours of the experiments where the wells were 
treated with the identified fractions. Once the formulae’s were generated the gradient was 
determined for all test wells and the fractions and was compared to each of the controls. The 
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rate of proliferation for each fraction was expressed as a percentage of the controls, namely 
the negative control and EGF controls.   
 
4.3.3 Statistical Analysis 
All results were presented as percentage (%) reduction of resazurin dye. Statistical Analysis 
was done using the software package Statistica (ver. 9). The one-way ANOVA test with the 
Tukey post-hoc analysis was used and significance was accepted at p < 0.05. 
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Identification of potential lead fractions 
Gas Chromatography and Mass Spectrometry to 
identify potential lead compounds 
Figure 4.3. Schematic representation of the fractionation of the plant and subsequent steps thereafter. 
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4.3.4 Extract Analysis 
The fractions that showed significant activity were further analysed using gas chromatography 
coupled with electron ionisation mass spectrometry namely a 7890A GC system coupled with 
a 5975C inert XL EI/CI MSD triple axis detector (Agilent Technologies) fitted with a DB5 gas 
chromatography column (30m x 250 µm x 25 µm) (Agilent Technologies). The instrument used 
was based in the Department of Chemical Pathology, School of Pathology, University of the 
Witwatersrand.  
Samples for analysis were evaporated and reconstituted in 5 ml of HPLC grade methanol. The 
operation conditions for the analysis were as follows: samples were injected at a volume of 2 
µl with an initial starting temperature of 100 oC for 5 minutes thereafter an incremental increase 
of 5 oC to 310 oC which was maintained for a further 15 minutes. The entire run time was 62 
minutes. Nitrogen was used as the inert carrier gas with a pressure of 184.22 kPa at a flow 
rate of 1.0034 ml/min with an average velocity of 32.447 cm/sec.  
The resultant chromatograms were further analysed for significant peaks. In each 
chromatogram the peaks were noted and the retention times, molecular ion (M), base ion and 
absolute abundance and fragmentation pattern recorded. To account for potential background 
noise, pure methanol was run in between the sample runs and background peaks identified 
here were subtracted from the plant fraction spectra to obtain an accurate mass spectrum. To 
compare the two fractions, the retention times for the major peaks previously recorded were 
analysed for similarities in the two fractions i.e., retention time A in the neutral extract was 
identified in the basic extract and the data recorded as before. Mass spectra obtained were 
also compared to common fragmentation patterns for alkaloid bases obtained from the NIST 
database.  
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4.4 Results 
 
4.4.1 Cell Culture and Proliferation Assay  
 
Assay optimisation 
The results for the optimisation experiments are seen in Table 4.4. When the cells were not 
treated with either control or plant fraction, no resazurin reduction is seen until 2 hours after 
which they follow an incremental increase. The wells containing Cells + Resazurin dye and 
the wells without cells but with resazurin dye + 1:80 plant fraction show no reduction of the 
dye.   
Results were represented graphically in Figure 4.3. The wells that were seeded with cells 
showed minimal resazurin dye reduction up to 2 hours after which an incremental reduction of 
the resazurin dye is seen up to 12 hours. The wells containing no cells (Cell–less) but with 
either the resazurin dye only and with the resazurin dye + 1:80 plant fraction showed no 
reduction of the resazurin dye throughout the observational period as is seen as flat lines in 
the graphical representation of the optimisation experiments. 
 
Table 4.4. Percentage reductions of the optimisation of the resazurin based assays. Data are 
presented as mean ± SD (n).  
Time (hours) 
 
Negative Control 
 
Cell-less + Resazurin + 1:80 
 
Cells – Resazurin 
 
0 29.22 ± 4.74 (6) 22.39 ± 4.55 (9) 24.24 ± 5.18 (9) 
2 31.69 ± 2.11 (6) 22.43 ± 4.52 (9) 24.02 ± 4.82 (8) 
4 43.42 ± 7.20 (6) 22.35 ± 4.50 (9) 23.81 ± 4.77 (9) 
8 63.96 ± 13.84 (6) 21.71 ± 5.44 (6) 22.59 ± 5.39 (6) 
12 89.70 ± 10.46 (6) 22.28 ± 4.54 (6) 23.52 ± 4.67 (6) 
 
 
 
112 
 
 
 
Figure 4.3 Graphical representation of the optimisation experiments plotted against time (hours). Each marker represents mean % reduction 
and the error bars represent the SD.
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4.4.2 Whole Plant Extract Proliferation Assay 
Results for the whole plant proliferation assay were shown in Table 4.5. At a dilution of 1:160 
the whole plant extract had a significantly greater percentage reduction of the resazurin dye 
when compared to the negative control (p = 0.022) and EGF control (p = 0.008). No other 
significant differences were detected. The data is represented graphically in Figure 4.5. The 
whole plant extract shows increases in percentage reduction of the resazurin dye from a 
dilution of 1:160 to 1:1280 but was only significantly greater at the lower dilution. 
 
Table 4.5. Percentage reductions of the whole plant extract. Data are presented as mean ± 
SEM (n). Corresponding comparisons between the negative control and EGF control were 
shown with p –values. Underlined p – values are significant. 
  
 
Dilution % Reduction Negative Control 
Comparison p - 
value 
Epidermal Growth 
Factor Comparison 
p - value 
Negative Control 43.42 ± 7.09 (48)  
Epidermal Growth Factor 41.01 ± 6.52 (48) 
1:40 38.57 ± 1.24 (3) 0.485 0.825 
1:80 41.60 ± 3.81 (3) 0.903 0.989 
1:160 55.54 ± 3.74 (3) 0.022 0.008 
1:320 53.39 ± 9.40 (3) 0.139 0.060 
1:640 53.33 ± 9.39 (3) 0.142 0.061 
1:1280 49.12 ± 2.34 (3) 0.383 0.165 
1:2560 40.08 ± 5.67 (3) 0.732 0.976 
1:5120 40.38 ± 5.60 (3) 0.770 0.989 
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Figure 4.4. Graphical representation of the percentage reduction of the whole plant extract at 4 hours post treatment. Each bar represents 
mean % reduction and the error bars represent the SD. Significant differences were seen at the 1:160 dilution.
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4.4.3 Plant Fraction Proliferation Assay 
The generalised approach in this chapter is summarised in Figure 4.3. The results from the 
fraction’s proliferation assays were shown in Tables 4.7 to 4.10. There was no significant 
increases in the first three collected fractions, being Wash 1 (Table 4.7), Wash 2 (Table 4.8) 
and the Elution 1 fraction (Table 4.9). There were significant increases in proliferation relative 
to the controls in the Elution 2 fraction (Table 4.10). The differences seen were in the basic 
and neutral extraction at the dilutions of 1:160 to 1:640.  
At a dilution of 1:160, the basic extract had a significantly greater percentage reduction than 
the EGF control (p = 0.029) but not the negative control (p = 0.136). The neutral extract had a 
significantly greater percentage reduction than the EGF control (p = 0.000) and the negative 
control (p = 0.000).  
At the dilution of 1:320 the neutral extract had a significantly greater percentage reduction than 
the EGF control treatment (p = 0.001) and the negative control (p = 0.000). At the 1:640 dilution 
the neutral extract had a significantly greater percentage reduction than the EGF control (p = 
0.042) but not the negative control (p = 0.160).  
Graphical representation can be seen in Figures 4.6 to 4.9. The majority of the proliferative 
activity were seen in Figure 4.9, the Elution 2 fraction. The percentage reduction for this 
fraction show levels elevated above that of the controls but the significant differences were 
seen in the 1:160 to 1:640 concentrations as stated previously. 
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Table 4.6. Percentage reduction of Wash 1 fraction of the acidic, neutral and basic extracts. 
Data are presented as mean ± SD (n). Corresponding comparisons between the negative 
control and EGF control were shown with p –values. 
 
Extraction Dilution % Reduction 
Negative 
Control 
Comparison p 
- value 
Epidermal 
Growth Factor 
Comparison p 
- value 
 
Controls 
Negative Control 43.42 ± 7.09 (48) 
 
Epidermal Growth Factor 41.01 ± 6.52 (48) 
 
Acidic Extract 
1:80 33.87 ± 6.52 (4) 0.654 0.916 
1:160 33.70 ± 2.87 (4) 0.496 0.874 
1:320 32.04 ± 7.91 (4) 0.543 0.889 
1:640 34.49 ± 7.79 (4) 0.675 0.945 
1:1280 33.13 ± 7.52 (4) 0.358 0.747 
1:2560 34.98 ± 5.70 (4) 0.757 0.976 
1:5120 35.70 ± 0.46 (4) 0.999 1.000 
1:10240 34.63 ± 3.49 (4) 0.974 1.000 
 
Neutral Extract 
1:80 33.45 ± 3.82 (4) 0.703 0.939 
1:160 34.77 ± 5.50 (4) 0.450 0.842 
1:320 35.37 ± 2.41 (4) 0.657 0.944 
1:640 34.29 ± 2.58 (4) 0.437 0.803 
1:1280 34.21 ± 10.27 (4) 0.486 0.856 
1:2560 35.78 ± 6.83 (4) 0.560 0.902 
1:5120 37.81 ± 9.92 (4) 1.000 1.000 
1:10240 36.18 ± 5.73 (4) 0.922 0.998 
 
Basic Extract 
1:80 35.43 ± 4.72 (4) 0.970 0.999 
1:160 32.38 ± 4.13 (4) 0.114 0.382 
1:320 34.20 ± 8.31 (4) 0.178 0.491 
1:640 33.44 ± 5.31 (4) 0.424 0.792 
1:1280 33.83 ± 6.74 (4) 0.491 0.859 
1:2560 35.54 ± 9.27 (4) 0.449 0.829 
1:5120 36.41 ± 10.38 (4) 0.994 1.000 
1:10240 35.30 ± 7.93 (4) 0.951 0.999 
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Figure 4.5. Graphical representation of the percentage reduction of the Wash 1 fraction at 4 hours post treatment. Each bar represents mean % 
reduction and the error bars represent the SD. No significant differences were detected. Each bar represents mean % reduction and the error bars 
represent the standard deviation.
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Table 4.7. Percentage reduction of Wash 2 fraction of the acidic, neutral and basic extracts. 
Data are presented as mean ± SD (n). Corresponding comparisons between the negative 
control and EGF control were shown with p –values. 
 
Extraction Dilution % Reduction 
Negative 
Control 
Comparison p 
- value 
Epidermal 
Growth Factor 
Comparison p 
- value 
 
Controls 
Negative Control 43.42 ± 7.09 (48) 
 
Epidermal Growth Factor 41.01 ± 6.52 (48) 
 
Acidic 
Extract 
1:80 37.03 ± 10.20 (4) 0.991 1.000 
1:160 34.09 ± 6.44 (4) 0.540 0.900 
1:320 34.35 ± 9.13 (4) 0.670 0.949 
1:640 36.40 ± 8.45 (4) 0.942 0.999 
1:1280 34.90 ± 6.40 (4) 0.735 0.970 
1:2560 37.88 ± 5.39 (4) 0.987 1.000 
1:5120 36.48 ± 7.68 (4) 0.987 1.000 
1:10240 45.52 ± 6.80 (4) 1.000 0.998 
 
Neutral 
Extract 
1:80 40.03 ± 7.52 (4) 1.000 1.000 
1:160 35.98 ± 5.43 (4) 0.843 0.993 
1:320 33.89 ± 6.39 (4) 0.595 0.917 
1:640 36.10 ± 6.67 (4) 0.922 0.998 
1:1280 37.64 ± 5.93 (4) 0.982 1.000 
1:2560 39.99 ± 9.41 (4) 1.000 1.000 
1:5120 36.78 ± 11.44 (4) 0.991 1.000 
1:10240 35.63 ± 8.67 (4) 0.813 0.988 
 
Basic 
Extract 
1:80 37.82 ± 9.76 (4) 0.997 1.000 
1:160 34.18 ± 8.96 (4) 0.556 0.908 
1:320 31.09 ± 4.27 (4) 0.200 0.529 
1:640 31.91 ± 2.71 (4) 0.349 0.718 
1:1280 31.90 ± 3.90 (4) 0.270 0.642 
1:2560 36.12 ± 4.62 (4) 0.890 0.996 
1:5120 36.77 ± 5.18 (4) 0.991 1.000 
1:10240 34.97 ± 3.84 (4) 0.715 0.967 
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Figure 4.6. Graphical representation of the percentage reduction of the Wash 2 fraction at 4 hours post treatment. Each bar represents mean % 
reduction and the error bars represent the SD. No significant differences were detected. Each bar represents mean % reduction and the error bars 
represent the standard deviation.
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Table 4.8. Percentage reduction of Elution 1 fraction of the acidic, neutral and basic extracts. 
Data are presented as mean ± SD (n). Corresponding comparisons between the negative 
control and EGF control were shown with p –values. 
  
Extraction Dilution % Reduction 
Negative 
Control 
Comparison p 
- value 
Epidermal 
Growth Factor 
Comparison p - 
value 
 
Controls 
Negative Control 43.42 ± 7.09 (48) 
 
Epidermal Growth Factor 41.01 ± 6.52 (48) 
 
Acidic 
Extract 
1:80 37.85 ± 5.84 (4) 0.998 1.000 
1:160 35.02 ± 8.52 (4) 0.700 0.965 
1:320 36.11 ± 12.42 (4) 0.900 0.997 
1:640 35.35 ± 7.79 (4) 0.852 0.990 
1:1280 34.79 ± 4.86 (4) 0.718 0.966 
1:2560 34.62 ± 11.89 (4) 0.689 0.957 
1:5120 35.46 ± 3.58 (4) 0.957 0.998 
1:10240 38.59 ± 4.53 (4) 0.996 1.000 
 
Neutral 
Extract 
1:80 39.89 ± 6.58 (4) 1.000 1.000 
1:160 33.63 ± 5.96 (4) 0.461 0.850 
1:320 35.16 ± 5.42 (4) 0.792 0.982 
1:640 35.99 ± 9.27 (4) 0.913 0.997 
1:1280 34.89 ± 6.84 (4) 0.735 0.970 
1:2560 42.32 ± 11.98 (4) 1.000 1.000 
1:5120 35.73 ± 4.84 (4) 0.967 0.999 
1:10240 39.54 ± 3.96 (4) 1.000 1.000 
 
Basic Extract 
1:80 37.93 ± 7.08 (4) 0.998 1.000 
1:160 35.98 ± 4.09 (4) 0.842 0.992 
1:320 30.47 ± 9.30 (4) 0.145 0.430 
1:640 34.18 ± 2.49 (4) 0.697 0.953 
1:1280 36.46 ± 2.86 (4) 0.921 0.998 
1:2560 35.92 ± 14.94 (4) 0.869 0.994 
1:5120 33.69 ± 2.56 (4) 0.832 0.978 
1:10240 36.67 ± 10.14 (4) 0.925 0.999 
 
 
 
 
121 
 
 
Figure 4.7. Graphical representation of the percentage reduction of the Elution 1 fraction at 4 hours post treatment. Each bar represents mean 
% reduction and the error bars represent the SD. No significant differences were detected. Each bar represents mean % reduction and the 
error bars represent the standard deviation.
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Table 4.9. Percentage reduction of Elution 2 fraction of the acidic, neutral and basic extracts. 
Data are presented as mean ± SD (n). Corresponding comparisons between the negative 
control and EGF control were shown with p –values. Underlined p – values were significant. 
 
Extraction Dilution % Reduction 
Negative 
Control 
Comparison p 
- value 
Epidermal 
Growth Factor 
Comparison p 
- value 
 
Controls 
Negative Control 43.42 ± 7.09 (48) 
 
Epidermal Growth Factor 41.01 ± 6.52 (48) 
 
Acidic 
Extract 
1:80 36.73 ± 4.51 (4) 0.581 0.875 
1:160 31.50 ± 3.96 (4) 0.030 0.136 
1:320 32.70 ± 5.68 (4) 0.098 0.324 
1:640 34.08 ± 4.10 (4) 0.191 0.501 
1:1280 34.52 ± 3.69 (4) 0.263 0.632 
1:2560 32.73 ± 6.14 (4) 0.257 0.625 
1:5120 34.66 ± 3.57 (4) 0.752 0.954 
1:10240 33.46 ± 5.27 (4) 0.247 0.619 
 
Neutral 
Extract 
1:80 39.69 ± 4.12 (4) 1.000 1.000 
1:160 64.10 ± 3.98 (4) 0.000 0.000 
1:320 63.29 ± 4.48 (4) 0.001 0.000 
1:640 57.25 ± 4.94 (4) 0.160 0.042 
1:1280 52.15 ± 4.68 (4) 0.389 0.123 
1:2560 59.14 ± 6.12 (4) 0.999 0.944 
1:5120 62.14 ± 9.48 (4) 0.998 0.949 
1:10240 50.14 ± 5.23 (4) 0.980 0.766 
 
Basic 
Extract 
1:80 55.25 ± 6.02 (4) 0.539 0.244 
1:160 57.01 ± 5.86 (4) 0.136 0.029 
1:320 51.28 ± 5.06 (4) 0.585 0.235 
1:640 54.52 ± 6.66 (4) 0.560 0.228 
1:1280 47.03 ± 6.70 (4) 1.000 0.993 
1:2560 51.96 ± 3.33 (4) 0.962 0.705 
1:5120 50.43 ± 6.50 (4) 1.000 0.996 
1:10240 46.90 ± 5.11 (4) 1.000 0.997 
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Figure 4.8 Graphical representation of the percentage reduction of the Elution 2 fraction. Each bar represents mean % reduction and the error 
bars represent the SD. No significant differences were detected. Each bar represents mean % reduction and the error bars represent the 
standard deviation. Significant differences were seen at the dilutions 1: 160, 1:320 and 1:640.
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4.4.4 Real Time Proliferation Assay 
The real time assay results (Table 4.11 and Figure 4.10) shows that the two fractions identified 
as potential leads have a significantly greater percentage reduction when compared to the 
controls at 4 hours. From the point of treatment (0 hours) the controls exhibit a period of delay 
after which at 2 hours the percentage proliferation starts to increase. The lead fractions exhibit 
no delay period and immediately start to increase. The lead fractions show a change in the 
rate of percentage reduction at 4 hours to reach an eventual end point at 12 hours equal to 
that of the controls.  
When considering the first 4 hours and specifically the rate at which the cells are proliferating 
(Figure 4.11 and Table 4.12), the neutral and basic fractions have greater rates of proliferation 
when compared to the negative control (353% and 264% respectively) and the epidermal 
growth factor (383% and 286% respectively). 
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 Table 4.10. Real time assay with the two fractions where activity was shown at 4 hours. Data are presented as mean ± SD (n). Corresponding 
comparisons between the negative control and EGF control were shown with p –values. Underlined p – values were significant. 
Time 
 Basic Extract Elution 2 Neutral Extract Elution 2 
Negative Control % 
Reduction 
Epidermal Growth 
Factor % Reduction 
% Reduction 
Negative Control 
Comparison p = 
value 
Epidermal Growth 
Factor Comparison 
p = value 
% Reduction 
Negative Control 
Comparison p = 
value 
Epidermal Growth 
Factor Comparison 
p = value 
0 29.22 ± 4.74 (6) 27.93 ± 3.98 (6) 19.48 ± 7.02 (4) 0.990 0.539 13.87 ± 2.18 (4) 0.690 0.170 
2 31.69 ± 2.11 (6) 30.88 ± 2.82 (6) 35.68 ± 5.86 (4) 0.697 0.926 40.63 ± 2.42 (4) 0.689 0.930 
4 43.42 ± 7.20 (6) 41.01 ± 6.21 (6) 57.01 ± 10.80 (4) 0.001 0.001 64.10 ± 1.38 (4) 0.136 0.050 
8 63.96 ± 13.84 (6) 62.87 ± 13.24 (6) 74.07 ± 1.15 (4) 0.691 0.751 73.23 ± 3.20 (4) 0.750 0.493 
12 89.70 ± 10.46 (6) 88.49 ± 10.96 (6) 91.38 ± 1.70 (4) 0.615 0.822 91.76 ± 3.98 (4) 0.570 0.783 
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Figure 4.9. Real time assay of the two lead fractions compared to the controls. Means were plotted against hours post treatment. Markers 
represent the mean percentage reduction and the error bars represent the SD.  
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Figure 4.10. Analysis of the first 4 hours of the real time proliferation assay. Means were plotted against hours pot treatment. Markers represent 
the mean percentage reduction and the error bars represent them SD. Corresponding linear equations for each treatment are shown for further 
evaluation.
y = 3.5505x + 27.675
y = 3.2705x + 26.731
y = 9.3823x + 18.627
y = 12.556x + 14.42
10
20
30
40
50
60
70
80
0 1 2 3 4
%
 R
e
d
u
c
ti
o
n
 o
f 
R
e
s
a
z
u
ri
n
 
Hours Post Treatment
Negative Control
Epidermal Growth Factor
Basic Extract Elution 2
Neutral Extract Elution 2
 
 
128 
 
 
Table 4.11. Gradient and rate comparison of the fractions where activity was seen. The 
gradients shown here depict the rate of proliferation. Rates of proliferation were compared to 
both the negative control and epidermal growth factor and expressed as percentage of the 
relevant control.  
 
Treatment Equation Gradient 
Gradient Comparison of Extracts 
Compared to Controls (% of Control) 
   
Negative 
Control 
Epidermal Growth 
Factor 
Negative 
Control 
y = 3.5505x + 27.675 3.551 
 
Epidermal 
Growth Factor 
y = 3.2705x + 26.731 3.271 
Neutral Extract 
Elution 2 
y = 12.556x + 14.42 12.556 353.640 383.917 
Basic Extract 
Elution 2 
y = 9.3823x + 18.627 9.382 264.253 286.877 
 
 
4.4.5 Gas Chromatography and Mass Spectrometry  
The two fractions identified by the proliferation assays being the 2nd elution’s of the neutral 
and basic extractions were further analysed by gas chromatography coupled with mass 
spectrometry. Gas chromatograms are seen in Figure 4.11 and Figure 4.12. Fragmentation 
patterns are seen in Table 4.12.  
With the same GCMS run conditions, the neutral extract produced better peak separation and 
peak abundances when compared to the basic extract. In the neutral extract fraction, five 
peaks were identified as being significant and are labelled 1-5 in Figure 4.11. Corresponding 
peaks (based on retention time) of the basic extract fraction were labelled 6-8 in Figure 4.12 
but peaks 3 and 5 were not identifiable in the basic extract fraction. Significant peak 
abundances in the neutral extract fraction ranged from 2 x 106 to 9 x 106  units compared to 
the basic extract fraction which ranged from 4 x 105 to 8 x 105 units.   
The similarities between the 2 fractions were identified between the retention times of 18 and 
25 minutes. The data produced for the parent ions (M) shows masses of 534.9, 539.3, 537.1, 
538.9, 539.4, 493.0, 538.0 and 544.4 m/z for peaks 1 to 8 respectively. For simplification the 
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similar peaks were assessed based on base ions, similarities in the detected peaks, and 
parent ion indicated by the largest mass ion on the spectra.  
At the retention time of 18.821 minutes, both peaks 1 and 6 have base ions of 199 m/z. Further 
similarities in the peak abundance (relative to base ion) are seen at 230, 135, 104, 76, 50 m/z. 
An additional peak at 253 m/z was noted in the basic extract fraction. The parent masses for 
these peaks are at 534.9 and 493.0 m/z for the neutral and basic extracts respectively 
indicating a difference of 41.9 m/z. Important fragmentation patterns are seen in peaks 1 and 
6 with significant ions seen at 50, 76, 104 and 135 m/z with base ions at 199 m/z detected in 
both peaks. 
At the retention time of 19.522 minutes, in peaks 2 and 7 both have base ions of 253 m/z. 
Similar peaks in the mass spectra can be seen at the ions 191, 64, and 48 m/z although the 
relative abundances are greater in the basic extract fraction at the ions 64 and 48 m/z. 
Additional peaks were noted in the basic extract at the ions 493, 346.1, 331.1, 301.1 and 269 
m/z. The neutral extract had an additional ion at 207 m/z. The parent masses for these peaks 
are at 539.3 and 538.0 m/z for the neutral and basic extracts respectively indicating a 
difference of 1.3 m/z. 
At the retention time of 20.047 minutes, peak 3 was detected in the neutral extract fraction but 
not the basic extract fraction. The fragmentation pattern here was the same as that of peak 2 
with a base ion of 253 m/z. Differences were noted in the parent mass of 537.1 m/z and the 
abundance of the ion 207 m/z relative to the base ion was greater than that of peaks 2 and 7. 
Additional ions were detected here at 347.1 and 281 m/z. 
At the retention time of 22.325 minutes peaks 4 and 8 were detected but were different. The 
base ions of the neutral extract was detected at 405 m/z and the basic extract detected at 301 
m/z. The prominent ions in both fractions were detected at 405, 343.1, 64 and 48 m/z. In the 
neutral extract additional ions were detected at 373, 223, 131 and 119 m/z which were not 
present in the basic extract. The basic extract had additional ions detected at 389.1, 253, 191 
and 135 m/z. The basic extract fraction had additional ions at 301 (base peak) and 156 m/z. 
The parent masses for these peaks were 538.9 and 544.4 m/z for the neutral and basic 
extracts respectively with a difference of 5.5 m/z. 
At the retention time of  26.247 minutes peak 5 was seen in the neutral extract but not in the 
basic extract. Prominent base ions at 207 and 135.1 m/z were seen with a prominent ion at 
472 m/z. Other significant ions were detected at 417. 64 and 48 m/z. The total parent mass 
ion was at 539.4 m/z.
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Figure 4.11. Gas chromatogram of the 2nd elution of the neutral extract. Significant peaks are labelled 1 – 5 on the chromatogram. 
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Figure 4.12. Gas chromatogram of the 2nd elution of the basic extract. Peaks labelled 6 – 8 are those correspond with the peaks 
identified in neutral extract. Peak 6 correlates with peak 1, peak 7 correlates with peak 2 and peak 8 correlates with peak 4. Peak 3 
and 5 seen in the neutral extract were not detectable. 
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Table 4.12. GCMS results. Data presented – Extract either neutral or basic, Peak number corresponding to the labelled peaks in Figure 4.12 
and Figure 4.13, Retention Time, Absolute Abundance, M or parent ion, and fragmentation pattern with the base ion bolded and underlined. M 
and fragmentation masses reported correspond with m/z. The fragmentation pattern for the pyrrolizidine and Isoquinoline type alkaloids are 
taken from the NIST database. 
 
Extract 
Peak 
Number 
Retention 
Time 
(min) 
Absolute 
Abundance 
M Fragmentation Pattern (Base ion is bolded and underlined) (M+) - Base Ion 
Neutral 
Extraction 
1 18.821 9000000 534.9 534,9 , 230 , 199 , 135 , 104 , 76 , 50,1 335.9 
2 19.522 2200000 539.3 539,3 , 253 , 207 , 191 , 64 , 48 286.3 
3 20.047 1600000 537.1 537,1 , 347,1 , 331,1 , 281,1 , 253 , 165,1 , 64 , 48 284.1 
4 22.325 6300000 538.9 538,9 , 405,1 , 389,1 , 343,1 , 253 , 191 , 135,1 , 64 , 48 133.9 
5 26.247 2000000 539.4 539,4 , 417,2 , 207 , 135,1 , 64 , 48 332.4 / 404.4 
Basic 
Extraction 
6 18.821 800000 493.0 493 , 253 , 230 , 199 , 135 , 104 , 76,1 , 50,1 340.0 
7 19.522 500000 538.0 538 , 493 , 346,1 , 331,1 , 301,1 , 269 , 253 , 191 , 165,1 , 91 , 64 , 48 285.0 
 20.047 Not detected   
8 22.325 400000 544.4 544,4 , 405,1 , 343,1 , 301 , 156 , 64 , 48 243.4 
 26.247 Not detected   
Pyrrolizidine Alkaloid Base Comparison 93-98 , 80-85 (83) , 67-70 , 52-58 (55) , 39-44 (42) , 27-30 (28)  
Isoquinoline Alkaloids Base Comparison 100-103 (102) , 74-78 (76) , 61-64 (63) , 50-52 (51) , 38-39  
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4.5 Discussion 
4.5.1 Cell Proliferation Assay 
The extraction protocol followed here yielded multiple fractions based on the pH and relative 
solubilities of the wash and elution steps. Of the twelve fractions collected, two were seen to 
be efficacious based on the resazurin proliferation assay. The identified fractions were from 
the second elution steps of the neutral and basic extractions. Compared to the controls at 4 
hours after treatment of the culture wells, the neutral extracts showed significantly greater 
percentage reductions of 64.1 ± 3.98% and 63.29 ± 4.48% (dilutions of 1:160 and 1:320 
respectively) and the basic extracts showing percentage reductions of 57.01 ± 5.86%  and 
57.25 ± 4.94% (dilutions of 1:160 and 1:320 respectively) which was almost 20% greater than 
the controls. 
With further experimentation over an extended observational period interesting differences 
were seen. The controls show a delayed response in that the percentage reductions here only 
increased appreciably after 2 hours. Compared to the identified fractions, the delay was not 
present and the treated cells exhibited an immediate increase in the reduction of the dye 
thereby bypassing the “lag” phase. Additionally, when the rate of proliferation was calculated, 
it was noted that the plant fractions increased the rate of proliferation by up to 380% when 
compared to the controls.  
At the end of the observational period the percentage reductions were however equal but this 
is in keeping with the animal based assays where similar results were seen. Equal end points 
in experimental and controls was also seen in the work by Nagappan, et al. (31) which 
establishes the importance sequential measurements in a real time based assay which was 
achieved here.  
Development of this assay was conducted with multiple controls to account for possible 
confounding factors. To establish the optimal time point for observation in mass 
experimentation, the negative control was run separately over a 12 hour observational period 
with a sequential increase in the percentage reduction noted. From this an optimal time period 
was identified at 4 hours after the cells where treated with a percentage reduction of 43.42 ± 
7.2% close to 50% of the total amount of resazurin reduction that was possible.  
The possibility of the plant fractions acting as possible reducing agents of the dye was also 
considered. At this optimisation stage, the fractions were shown not to affect the reduction of 
the dye. With the wells not having been seeded with cells, the percentage reduction was 
maintained at 30%. As there were no cells in the wells it was expected that the reduction of 
the dye should be 0% but this was not the case as was stated before however all the wells 
regardless of treatment and cells started at roughly the same point of around 20-30% reduction 
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and therefore the plant fractions were assessed as not being the cause of the reduction of the 
dye but rather the response of the cells to the plant fractions. It is currently unclear why the 
percentage reductions all started at 30% could be found. 
With the confounding factors in mind, the assay results seen at 4 hours was sensitive enough 
to identify two lead fractions which were then followed up with further experimentation over a 
longer period of time converting the assay to a real time assay. With the evidence seen 
previously as being a good identification of the lead fractions, the real time assay revealed 
interesting trends which was seen with the loss of the lag phase. To our knowledge this has 
not been described before and is an interesting possibility when considering wound healing. 
It is also a possibility that the significant differences in percentage reduction seen at 4 hours 
was a product of the immediate proliferation induced by the plant fractions. 
Importantly to the aims of this Chapter, the process of extraction and fractionation described 
here was found to be reproducible with scaling up of the procedure with large quantities of 
isolates being the eventual goal. Additionally an important aim achieved here is that 2 similar 
fractions were identified with the only difference being the pH at which they were initially 
extracted, all conditions were otherwise the same. For reasons unknown the acidic extracts 
second elution step did not show any activity.  
Deductively any similar compounds identified between the active fractions should be the 
eventual molecules of interest. Here we have identified a number of similarities between the 
two fractions but the abundance obtained from each extraction differed and may be the reason 
for the differing proliferation assay results. It was shown that the neutral extract performed 
better compared to the basic extract but may be due to a concentration effect of the potential 
compounds. This is substantiated by a higher percentage reduction at the higher dilution of 
1:180 of the basic extract (however not significant) compared to the neutral extract at the same 
dilution (55.25 ± 6.02 compared to 39.69 ± 4.12 respectively).  At lower dilutions the neutral 
extract performed better (see dilutions 1:160 and 1:360) but at greater dilutions no effect was 
noted. This may be a toxic effect and further experimentation is warranted. 
The assay developed here is not routinely performed for investigations concerning wound 
healing. As was previously stated, the most widely used approach is scratch assays, which 
are labour intensive and characterise the cell migration aspect of wound healing. The assay 
developed here is simple to perform making it highly reproducible, allows for real time 
applications and importantly can be applied to automated platforms for further development 
into a high-throughput assay. 
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Multiple advantages of conversion to a high-throughput assay exist. Firstly, by virtue of the 
fact that plants contain numerous potential lead compounds, they may be assessed quickly 
and efficiently with quantification of the effect as opposed to subjective assessments 
commonly seen in wound healing investigations. Secondly, there exists a possibility that other 
previously documented compounds existing in extensive databases may produce a similar 
effect which could be assessed singularly, in combination with other known compounds or 
used to augment the effects of the plant compounds that have been identified here. 
 
4.5.2 Gas Chromatography and Mass Spectrometry  
It is well known that members of the Senecio genus are known to contain pyrrolizidine 
alkaloids which prompted the search for a possible lead compound of this class. Significantly 
the report by Toma, et al. (144) identified this class as having a potential to promote healing 
however this was shown in the gastric mucosa of a rodent ulcer model. Additionally throughout 
the extraction process, the fractions where activity was shown where assessed for the 
presence of alkaloid type compounds by the use of Dragendorff’s reagent. There is therefore 
a strong possibility that a pyrrolizidine-type alkaloid may be the reason for the beneficial effects 
noted in Senecio based therapy assessed here. The possibility that another compound type 
may also be of interest should not be ignored and therefore the extraction protocol followed 
here are not specifically aimed at isolating pyrrolizidine alkaloids but rather compounds with 
similar properties. 
The choice of extraction and chromatographic techniques has varied considerably when 
alkaloids are concerned and even vary as to the various plant components from which they 
are isolated. Early descriptions of generic protocols were based on extractions performed with 
a chosen solvent followed by evaporation and protonation of the extract. From here the 
extracts were made basic with an alkali solution rendering the compound of interest insoluble 
in water. From here liquid-liquid extractions could be performed dissolving the compounds into 
a solvent with differing densities and polarities to that of the original extract and 
dichloromethane was commonly used.  
Solid phase extraction protocols are now seen to be superior when isolating compounds from 
complex biological mixtures. Compared to the original liquid-liquid extraction techniques, solid 
phase extraction allows for faster processing times and higher isolate yields compared to the 
former but cost and extensive sorbent possibilities tend to be complicating factors (217). The 
use of this approach has mostly been seen in samples where the compound of interest was 
known and were used to identify and quantify the relevant compounds in samples. For 
 
 
136 
 
pyrrolizidine alkaloids specifically the packing sorbent material of the SPE cartridges is mostly 
strong cation exchange resins. This was used by Colgate, et al. (218) and Boppre, et al. (219) 
to identify pyrrolizidine alklaoids in food sources. Interestingly, Yoshimatsu, et al. (220) made 
use of the same cartridges that were used in this investigation, namely the hydrophobic-
lipophilic (HLB) reverse phase based sorbent.   
Ideally the sorbent material of the cartridges is selected based on the properties of the 
compounds of interest. An algorithm described by Zwir-Ference and Bizuik (221) shows that 
ideally water based extractions are best processed using cation or anion exchange resins 
once the extract is either acidified or alkalinised whereas neutral water and organic solvent 
extractions are mostly processed using phase dependent sorbent materials. Otherwisely 
described as separation based on polarity being more suited to phase dependent sorbent 
materials and charged based separations more suited ion exchange sorbent materials. The 
extractions of Senecio here, being either acidic, neutral or basic produced both of the 
previously mentioned scenarios. The acidic and basic extractions were most likely charged 
and therefore the ideal sorbent material should have been the relevant ion exchange resins. 
The neutral extract therefore performed better on the HLB reverse phase material and this 
may be a reason for the differing results obtained from the gas chromatography and mass 
spectrometry.    
In theory, selection of the appropriate sorbent material is based on prior knowledge of the 
analyte of interest making the use of solid phase extraction controversial when used in the 
context of this investigation. To counteract this problem the use of the HLB cartridges allowed 
for a wider range of polarities to be isolated. According to the manufacturers insert, protocols 
have been designed to accommodate acidic, neutral and basic extractions. Also important to 
these experiments was the ability of the packing materials to tolerate water as the mobile 
phase for loading the samples. As the initial extractions were water based, there was no 
necessity to evaporate the samples to suspend them in organic solvents thus minimising 
sample processing steps and losses. 
Literature concerning the chromatographic separation of plant extractions describe liquid 
chromatography as the technique of choice. This was seen in the study of Murraya koenigii 
(31) which is one of the few reports concerning alkaloid isolation for the use of wound healing. 
Again the work concerning Daphne oleoides (44) also employed the use of liquid 
chromatography to identify potential lead compounds. The use of chromatography with 
regards to wound healing has led to significant compound identification and so was considered 
ideal for the work described here.  
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This investigation included gas chromatography and mass spectrometry to characterise the 
compounds present in the extract fractions. Gas chromatography was preferred due to its 
advantages over liquid chromatography when analysing complex unknown mixtures but may 
not be the best option for pyrrolizidine alkaloids detection as further derivitisation techniques 
may be indicated (222). Nevertheless, reports of the use of gas chromatography for 
pyrrolizidine alkaloids have been reported in identification of toxic PA’s in Senecio cineraria 
(223) and selected Senecio species from Egypt (224). In these instances a crucial step was 
included which was the reduction of the extracts using zinc powder which results in the 
reduction of the N-oxide form (which cannot be analysed on GCMS) to the free base form. 
The importance of this step is seen in the relative concentrations of these forms being roughly 
90% of the N-oxide form and 10% of the free base form therefore allowing greater detection 
of pyrrolizidine alkaloids (225). As the fractions analysed here were largely unknown, omission 
of the derivitisation step was permissible.   
The identification of potential compounds present in the plant was a partial success. Firstly as 
it was theorised that if multiple fractions elicite a certain reaction (i.e. keratinocyte 
proliferation), then the compounds that are similar within those fractions should be the 
compounds of interest. In these experiments, the compounds that were most similar were 
those seen in peaks 1 and 6. The similarities recorded here was the retention time, base ion, 
and fragmentation patterns. No other similarities were noted between the other identified 
peaks and therefore the possibility that peaks 1 and 6 contained the compound/s of interest 
was greatly supported.  
Investigations of this nature typically aim to characterise the compounds with a molecular 
formula and structure as the end point. However mass spectrometry is not sufficient to achieve 
this and therefore further investigation such as nuclear magnetic resonance would be 
indicated. The goal of mass spectrometry would be to identify a compound based on reference 
spectra but as discussed previously this may be problematic when unknown samples are 
investigated. The mass spectra produced here were not identifiable on the NIST database, 
which may be advantageous as unknown compounds are promising for potential patents. 
Possibly the most important question here is whether the compounds/peaks identified here 
are in fact pyrrolizidine alkaloids. As was previously stated, the pyrrolizidine alkaloids have 
characteristic mass spectra with a characteristic ion at 80/82 m/z depending on the saturation 
of the necine base with additional features that include the triplet fragments of 93-95, 119-121 
and 136-138, none of which were evident in any of the identified peaks which suggests that 
the compound of interest may not be a pyrrolizidine alkaloids.  
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An important feature seen here was that the parent mass ions identified in the peaks where in 
the order 500 + m/z. The potential that the molecular mass of the compounds could be a 
general indicator as to the possibility that these compounds are not pyrrolizidine alkaloids was 
not substantiated as selected reports have shown a wide range in the parent masses of 
pyrrolizidine alkaloids. Witte, et al. (1993)  reported extensively on about 100 different 
pyrrolizidine alkaloids with a range in parent masses extending from 155 m/z up to 483 m/z. 
Colgate, et al. (218) identified pyrrolizidine alkaloids in Crotalaria juncea with mass ions of up 
to 360 m/z with the presence of the characterisitc fragmentation ions. Boppre, et al. (219) 
characterised multiple pyrrolizidine alkaloids from commerically available honey extracts and 
showed that the masses of these compounds ranged from 380 m/z up to 500 m/z.   
The work by Witte, et al. (226) documents of pyrrolizidine alkaloids extensively, based on 
separation by gas chromatography and identification by mass spectrometry, based on the 
retention time and mass ions. These important features provided adequate comparison here.  
Additionally they documented the use of a DB-5 column, which was used in the experiments 
reported here. In comparing retention times and mass ions, no similarities in any of the peaks 
were identified thereby reducing the possibility of the presence of pyrrolizidine alkaloids in the 
plant fractions analysed here.  
The fragmentation patterns obtained here do provided information as to the potential class of 
compounds. From the peaks identified here it was seen that peaks 2, 3, 4 and 8 did not show 
any similarities with the alkaloid base fragmentation paterns identified in the NIST database 
but their potential as compounds of interest cannot be excluded.  
Peaks 1 and 6 display similar fragmentation patterns with the potential that these are the same 
compounds. Additionally examination of the fragmentation patterns is not in keeping with any 
data consistent with pyrrolizidine alkaloids. The possibility therefore is that that the peaks 
identified here may be another type of alkaloid and comparrisons with the NIST data (table 1 
and again in table 8) shows similarities with the isoquinolone type alkaloid bases, an important 
class due to the examples here being morphine and codeine normally extracted from the 
Papaveraceae family (227). 
Although the bases show significant similarities between each other and with the bases 
identified in the NIST database, it was difficult to compare published data, as other mass 
spectrometric approaches were employed. Wu-Nan and Cheng-Hong (228) used ion spray 
tandem mass spectrometry to assess the various isoquinolone, benzylisoquinoline, aporphine 
and phenanthrene alkaloids. Schmidt, et al. (227) used tandem mass spectrometry to analyse 
these types of alkaloids but with atmospheric pressure photoionisation. Although the 
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experiments here did not use tandem mass spectrometry, similarities could be seen in the 
base peak ions occuring in the 180-200 ranges similar to what was seen in this investigation 
but the base ion of 199 m/z and mass ions could not be found in published reports concerning 
alkaloids. 
With the speculation as to the possible types of compounds that have been identified, it is not 
certain as to what class of alkaloid could be exerting the effects seen in the in-vitro assays. It 
is clear that further isolation of the identified peaks is necessary and from this point the in-vitro 
assays would need to be repeated to identifiy the compound/s of interest. Further 
characterisation of the compound can be done using other modalities such as nuclear 
magnetic resonance. 
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4.6 Conclusion 
The approach adopted here is different to that reported in the literature. In this investigation 
we used a porcine model to establish if efficacy indeed existed. In-vitro experiments were then 
used to further establish the efficacy and serve as an assay when fractionating the plant. The 
use of keratinocytes allowed for the development of an in-vitro assay that led to the 
identification of two potential active fractions. Furthermore the assay described here has the 
potential for high throughput applications. Analysis of these lead fractions by gas 
chromatography and mass spectrometry did not identify the pyrrolizidine alkaloids reported in 
the literature, but another class of alkaloids was identified which requires further 
characterisation.  
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Chapter 5 – Final Conclusion and Future Studies 
 
With the aims of this project defined in Chapter 1, it was clear that multiple questions needed 
to be answered in order to accomplish the aims. It was clear that minimal information was 
present regarding the plant and moreover the effect that it could potentially have on the 
process of wound healing was largely if not completely unknown. Additionally, the wound 
healing process is extremely complex with multiple variables present and important at different 
phases throughout the process. This makes it particularly challenging to identify a mechanism 
through which potential agents may work. The project was therefore divided into Chapters 
dealing with: 1) efficacy and safety, 2) mechanistic investigation and 3) plant fractionation and 
assay development. 
 
5.1 Efficacy and Safety 
It was therefore decided that the first phase in this project would establish efficacy and safety; 
key concepts that needed to be proven as motivation for subsequent experimentation. This 
phase required in-vivo experimentation, mostly due to the complexities of wound healing being 
poorly translated into in-vitro experimentation. A porcine model was used with deep partial 
thickness and full thickness wounds created on the animal’s dorsum. The reason for using 
deep partial thickness wounds lies in the traditional healer’s indication being for superficial 
cuts and abrasions. However the addition of full thickness wounds was to provide important 
information that could not be obtained from the deep partial thickness wounds.  
The information obtained from the deep partial thickness wounds included wound pH and 
epidermal thickness. The information obtained from the full thickness wounds included 
keratinocyte migration and wound contraction. An image analysis algorithm was also devised 
to assess the collagen production within both kinds of wounds, with a method which is believed 
to be novel, as opposed to the traditional colorimetric approaches.  
The plant under investigation here is known colloquially as the “2 day cure” but its potential 
was only seen at day 5 post-operative by gross inspection. With clear differences seen at this 
time point it was necessary to quantify these differences in the most objective approach 
possible hence the development of the algorithms employed to describe and quantitate the 
elements of the wounds. It is believed that this is still a general approach to assess the efficacy 
of the plant but it was necessary to determine the viability of further investigations.  
The wound pH was seen as a variable that describes the overall functionality of the 
regenerated skin. This concept is based on the presumption that normal intact skin maintains 
a specific pH. In general there were no major differences noted between the treatment groups 
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but interestingly, the wound pH in all treatment modalities stabilized at a later time point 
compared to when the epidermis was in situ. This suggests that that the physiological 
functionality of the skin was established at a time point later than when the perceived 
anatomical integrity was established.  
The only difference in wound pH was at day 2 post-operative where the plant had a 
significantly lower pH as compared to the controls and the reason for this is not quite clear. 
Catabolic events may have contributed to this altered pH, but without objective evidence for 
this, the issue remains unsolved and may be a potential point of interest for further 
investigation. The advantage of the wound pH measurement lies in its simplicity and minimal 
invasiveness of the approach which may have both experimental and clinical applications. 
Assessment of the epidermal thickness has not been commonly determined in wound healing 
investigations. Furthermore in this investigation a novel parameter, epidermal thickness ratio 
was determined to compare the epidermal thickness relative to the unwounded skin. In this 
instance it was necessary as the model included deep partial thickness wounds and minimal 
wound contraction would be expected. Interestingly the scenario that came to light included 
the epidermal thickness, which showed extensive thickening of the epidermis in the Senecio 
and activated carbon treated wounds but not in the negative control treated wounds. However, 
when the wounds were adjusted for regional variation of the thickness of the dorsal skin, this 
was not evident.  
Controlling for regional skin thickness appears to have a great effect on the data as it could 
be seen that in the negative control treatment group, the epidermis did not thicken compared 
to the other treatments. It would therefore suggest that normal wound healing without the 
application of any therapy would not show the thickening followed by thinning of the epidermis. 
When the epidermal thickness ratio was considered, the process of thickening and thinning 
was more apparent in the negative control treated wounds. It is possible that the normal skin 
in the negative control groups was just naturally thinner. Important in this evaluation was the 
time point at which the skin thickness peaked which was 2 days before that of the controls. 
This therefore suggests that proliferative events occurred at an earlier point in time compared 
to the control groups. 
The collagen content of the wounds was assessed which was seen to be similar within all 
treatment groups and regardless of the wound type. However the approach devised here was 
novel and requires further validation, but it could be seen as more sensitive when compared 
to the previously reported colorimetric and histological approaches reviewed in Chapter 1. 
Furthermore it is not subject to observer error as in the score based histological approaches 
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and secondly the potential for assaying normal skin is reduced as compared to the colorimetric 
approaches. 
The issue of whether the plant is safe as a topical agent for wound healing was partially 
addressed here with liver function tests throughout the observational period and liver biopsies 
one month after the observation period. The liver function tests were deranged at some points 
in the observation period but histologically no evidence of hepato-toxicity could be detected. 
The topical administration of the plant is possibly the reason for why there was no toxicity 
detected histologically. Topical application of the plant compounds bypasses the gastro-
intestinal system where the acidic pH of the stomach converts pyrrolizidine alkaloids to their 
free n-oxide bases, which are the molecules responsible for hepatotoxicity. It is however 
possible that the quantity of plant material that the pigs were exposed to was insufficient to 
elicit a toxic response and would require further investigation, but with the lead fractions or 
compounds. 
 
5.3 Mechanistic Investigation 
Attempts were made to identify a pathway by which the plant exerted it activity on the 
keratinocytes that were identified from the experiments in Chapter 2. In terms of the phases 
of wound healing, the phases that theoretically coincide with the differences noted in Chapter 
2 (around days 5 -7) are the inflammatory and proliferative phases. Although this narrows 
down the potential targets for investigation, it is still extremely broad due to the multiple factors 
seen in each of these phases. 
Assessment of the inflammatory phase focused on the inflammatory cytokines with the 
addition of the anti-inflammatory cytokine, IL-10. A limitation of this study was that few of these 
factors were determined. They only represent the messengers present within the wound and 
not the cellular components that react to or produce the messengers. However they may 
identify the state of the wound being either pro-inflammatory or anti-inflammatory. This 
designation should be made relative to the negative control treated wounds, as this is the 
natural course a wound should follow.  
Compared to the negative control treated wounds at day 5 post-operative, it appeared that the 
activated carbon treated wounds displayed more of a pro-inflammatory status with elevated 
levels of IL-8, 1β and 6 together with an increase in the anti-inflammatory interleukin-10, but 
these concentrations were not significantly different. In the Senecio treated wounds, a similar 
picture was seen but the anti-inflammatory interleukin-10 was not as raised, suggesting the 
elevated pro-inflammatory cytokines may be necessary to the wound healing process. 
However in the case of the Senecio treated wounds a significantly raised interleukin-1β 
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concentration was seen compared to the negative control treated wounds. Interestingly 
interleukin-1β is known to play roles in induction of keratinocyte and fibroblast proliferation, 
fibroblast synthetic functions and keratinocyte migration. The above mentioned roles 
associated with interleukin-1β added to the possibility that the Senecio based therapy exerted 
its effects through keratinocyte proliferation.  
Important to this investigation was the effects that pyrrolizidine alkaloids have on epidermal 
growth factor (EGF) that was shown by the work of Toma, et al. (134). Again the role of this 
growth factor is significant but it is well known that multiple growth factors beneficially affect 
wound healing to the extent that certain factors are currently approved for human therapeutic 
intervention. Of significance is that many of these growth factors, including various cytokines 
bind to their respective receptors and induce tyrosine phosphorylation, thereby identifying a 
common link to many of the factors.  
The levels of tyrosine phosphorylation and resultant keratinocyte proliferation were assayed 
through immunofluorescence staining techniques. It was seen that the plant induced sustained 
cellular proliferation through increased tyrosine phosphorylation although. Additionally the 
initial increase from day 5 to 7 was much greater in the Senecio treated wounds compared to 
the controls. The possibility remains that other signalling events may also play a role in the 
sustained proliferation reported here due to the fact that the difference between the plant and 
negative control group was negligible. Again there is also the possibility that interleukin-1β is 
playing a role here. 
The effects of ligand tyrosine phosphorylation are mostly mediated through various signalling 
cascades which were not assessed. Future investigations will be aimed at identifying the 
possible pathways that are activated by the plant in question through micro-array based 
assays. These can identify multiple signalling cascades which are important as the activation 
of many of these cascades simultaneously is a very real possibility. This may allow for future 
interventions where the cascades may be preferentially activated within a wound. 
The level of proliferation from day 5 to day 9 post-operative was seen to decrease in the control 
treated wounds but in the Senecio treated wounds the levels were sustained which may be 
the reason for the increased epidermal thickness and ratio seen in Chapter 2. The reason for 
the decrease seen in the controls is unknown at this point but because the assumption that 
the negative control represents the normal wound healing process, this may be the normal 
response of keratinocytes.  
The fact that at day 2 post-operative the epidermis was absent and but present by day 5 shows 
that important time points were missed. In the initial efficacy experiments in Chapter 2, this 
was not seen to be of any significance but at this stage there was a deficiency in the tyrosine 
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phosphorylation and cellular proliferation data. This is a point to be addressed in future 
investigations but is more appropriate once an active or lead compound is identified and 
isolated. However the investigations here did help identify a target for the identification and 
isolation of potential compounds.  
 
5.4 Plant Extraction and Culture 
It was clear that keratinocyte proliferation was the target that needed to be exploited to identify 
potential lead fractions/compounds. The prior experiments conducted, looked at broad events 
seen in wound healing from where was possible to narrow down to a quantifiable target. 
Additionally the advantage of this was that high-throughput assay modalities could be 
considered. This was due to the nature of plant-based investigations leading to multiple 
potential compounds/fractions. Additionally, compound databases could be accessed to 
produce the same effects or augment the effects of other compounds.  
Initially it was suspected that pyrrolizidine alkaloids may be the class of compounds of interest 
to this investigation, but isolating only these compounds may be extremely naïve as previous 
plant based investigations by a number of authors have shown that many different compounds 
are beneficial to wound healing. It was therefore decided that extraction protocols employed 
should not be specific for pyrrolizidine alkaloids but should allow for extraction of multiple 
potential compounds. For this reason the extraction procedure used here with the chosen solid 
phase extraction cartridges allowed for the fractionation of the plant extracts based on 
chromatographic principles and provided extracts with as many potential compounds as 
possible. Additionally this approach was seen to be easily reproducible through commonly 
established protocols.  
Once multiple fractions are produced, it is commonplace to analyse these fractions for the 
possible compounds that are present. It was decided that a more goal directed approach to 
optimize time and resources was to identify the fractions that show proliferative activity and 
thereafter analyse the fractions for possible lead compounds. With keratinocyte proliferation 
identified as the target for further investigation, the assay chosen to conduct these 
experiments was real time, resazurin-based proliferations. With the introduction of real time 
assays it was shown that two fractions were able to significantly increase the level and rate of 
cellular proliferation, up to 380%, an observation that would quite likely have been missed had 
traditional approaches been used.  
The advantage of developing this assay for this application is that it is highly amenable to high-
though put assays for the reasons previously mentioned. Additionally the resazurin-based 
assay demonstrated here is extremely compatible with automated culture systems. It is 
 
 
146 
 
important to state that the culture experiments conducted here were not high-throughput 
assays by strict definition, but did provide the framework for further development and 
application. 
Analysis of the identified fractions was conducted using gas chromatography and mass 
spectrometry allowed for the identification of a potential alkaloid class. Additionally these 
compounds were not identifiable on the NIST database. The presence of pyrrolizidine 
alkaloids in this plant was not confirmed and still needs to be considered in future 
investigations. 
The identification of two active fractions allowed for comparison between the fractions. An 
assumption was made that similar compounds would be present in both of the fractions were 
potentially the compounds of interest. Here a compound was identified in both fractions based 
on retention time and spectral fragmentation patterns. The fragmentation pattern of the lower 
mass to charge ratios was more in keeping with the Isoquinoline type alkaloids than to the 
pyrrolizidine type alkaloids and may be class of compounds of interest. 
Future investigations will focus on the identified peaks seen here. These would be isolated 
further and tested using the developed proliferation assay. Animal models would be required 
to confirm the efficacy of the lead compounds. Furthermore the isolated compounds would be 
further characterized using physicochemical techniques.  
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